Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,29478,0.165680253282928,0.00422585967962468,0.157397568310864,0.173962938254993,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,24966,-0.19191441012284,0.00461744712442798,-0.200964606486719,-0.182864213758962,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRP,Agouti-related protein,29786,0.199708844814415,0.00353134902256157,0.192787400730194,0.206630288898636,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOF,Apolipoprotein F,24951,-0.0737649581466717,0.00170953479418415,-0.0771156463432726,-0.0704142699500707,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOM,Apolipoprotein M,29545,-0.0814401198804775,0.00189437004840923,-0.0851530851753596,-0.0777271545855954,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,0.105290086192227,0.00199908942708616,0.101371870915139,0.109208301469316,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN1,CCN family member 1,29301,0.21846580588844,0.00515155845525499,0.20836875131614,0.22856286046074,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,29383,0.0943284428593247,0.00202809779990027,0.0903533711715202,0.0983035145471292,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,29489,0.228933246502216,0.00551563079879061,0.218122610136587,0.239743882867846,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,-0.125167882258048,0.00218684099168667,-0.129454090601753,-0.120881673914342,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCG,Pro-glucagon,28797,0.46311195662371,0.00833501531500507,0.4467753266063,0.479448586641119,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,29820,0.129661645368208,0.00303555434392783,0.123711958854109,0.135611331882306,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,28916,0.212719231718411,0.00448590498907271,0.203926857939829,0.221511605496994,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.122168590889502,0.00299971451073661,0.116289150448458,0.128048031330545,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,24922,0.274883645631837,0.00559592943884045,0.26391562393171,0.285851667331964,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.157599136566685,0.00368190736490451,0.150382598131472,0.164815675001898,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,29500,0.245169100198657,0.00341929134851686,0.238467289155564,0.25187091124175,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS4,Galectin-4,29454,0.161784113901429,0.00372334805628118,0.154486351711118,0.16908187609174,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,29478,-0.1459723161286,0.00319413262290188,-0.152232816069488,-0.139711816187712,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFGE8,Lactadherin,29443,0.214528546258717,0.00281477966259656,0.209011578120028,0.220045514397406,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MVK,Mevalonate kinase,28931,0.213251148118801,0.00545274720867706,0.202563763589794,0.223938532647808,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,0.151597161001286,0.00360321398713285,0.144534861586505,0.158659460416066,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,29725,0.226247860097875,0.00443486030608852,0.217555533897942,0.234940186297809,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,-0.0965839816284148,0.00216455514756636,-0.100826509717645,-0.0923414535391847,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,29702,-0.108315945531308,0.00244303498447699,-0.113104294100883,-0.103527596961733,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,-0.109739039431254,0.00188906335245785,-0.113441603602071,-0.106036475260436,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,24938,0.149319974822087,0.00272704995326384,0.14397495691369,0.154664992730484,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS8,Prostasin,29347,0.148991708233757,0.00275239801746888,0.143597008119518,0.154386408347996,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYY,Peptide YY,24111,0.285865748933545,0.00661367092742804,0.272902953915786,0.298828543951304,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,0.135378076883474,0.00322574197494752,0.129055622612577,0.141700531154371,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,29725,0.0927874510621431,0.0023146943086695,0.0882506502171509,0.0973242519071354,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.0914250606365852,0.00224502719568466,0.0870248073330433,0.0958253139401272,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.102826057121076,0.00222915207805269,0.0984569190480925,0.107195195194059,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0959210645249785,0.00245871538492833,0.091101982370519,0.100740146679438,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.204325766357945,0.0046329503349161,0.19524518370151,0.213406349014381,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,29349,0.24134565668209,0.00619442264081715,0.229204588306088,0.253486725058091,1.1125369292536e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,29349,0.149366962115566,0.00384876367287628,0.141823385316729,0.156910538914404,1.11253692925372e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.125837225368728,0.00324715590878963,0.1194727997875,0.132201650949955,1.11253692925473e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGF,Placenta growth factor,29786,0.069428206921523,0.00180037650763366,0.065899468966561,0.0729569448764849,1.11253693006225e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,29786,0.0906464284820605,0.00236040740746355,0.0860200299634319,0.0952728270006891,1.1125372185825e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FURIN,Furin,29566,0.0877571748340377,0.00229733086665333,0.0832544063353972,0.0922599433326783,1.11308644360625e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,29478,0.16046954928965,0.00420664295907277,0.152224529089867,0.168714569489432,1.11650448520811e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.165489160792337,0.00435823999911788,0.156947010394066,0.174031311190608,6.77450174134519e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,0.0792183216876995,0.00209181990008951,0.0751183546835241,0.083318288691875,1.77116735782481e-306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSD,Cathepsin D,27442,0.105408989704031,0.00278428040328228,0.0999518001135977,0.110866179294464,9.16525771627406e-306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,29694,0.157273347056579,0.00417268464001006,0.14909488516216,0.165451808950999,1.01460046095889e-303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0815477624191962,0.00218407944609072,0.0772669667048584,0.085828558133534,3.91057459669934e-298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,0.132616626714867,0.00355133294945767,0.12565601413393,0.139577239295804,4.07201253803461e-298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0597039822480341,0.00160772985887676,0.0565528317246357,0.0628551327714326,4.60448998996929e-295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH,Parathyroid hormone,24195,0.207143396300655,0.00557580591394612,0.196214816709321,0.21807197589199,7.72917017196684e-294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KITLG,Kit ligand,29478,-0.0944592397223279,0.00256732924376182,-0.099491205040101,-0.0894272744045547,8.78977833929564e-290
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.141632076246932,0.00386306452524693,0.134060469777448,0.149203682716416,9.52880581618729e-288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,24922,0.231337904521514,0.00630075035771394,0.218988433820395,0.243687375222633,1.85160791720398e-287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.097860473383447,0.0026714968110162,0.0926243396338553,0.103096607133039,2.20263335264108e-287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0775029324302228,0.0021115229633587,-0.0816415174384059,-0.0733643474220398,3.9859220436679e-287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,0.081147001962854,0.00221367226326123,0.076808204326862,0.085485799598846,3.1198907158574e-286
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,29694,0.346807637103669,0.00955797963408117,0.32807399702087,0.365541277186468,4.17267336954208e-282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,29581,0.10347758477194,0.00286052124702984,0.097870963127762,0.109084206416119,2.01999368212759e-280
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.207183829205503,0.00575565119760137,0.195902752858205,0.218464905552802,1.28883937682602e-277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,29820,0.128983463945473,0.00359910130659967,0.121929225384538,0.136037702506409,2.02798843554714e-275
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFASC,Neurofascin,29786,0.0695725062843197,0.00195251176217646,0.0657455832304539,0.0733994293381856,2.3560660186476e-272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,0.196217033327605,0.00559862587155322,0.18524372661936,0.207190340035849,1.18355574515464e-263
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.132215278697076,0.00380064672822589,0.124766011109753,0.139664546284398,8.56782076564917e-260
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,29426,0.111036109691946,0.00319740736857045,0.104769191249547,0.117303028134344,5.31176908805942e-259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,29674,0.283353382852775,0.00816077294531852,0.26735826787995,0.299348497825599,5.79178442057009e-259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS9,Galectin-9,29453,0.075461988014232,0.00219981863460966,0.071150343490397,0.0797736325380669,6.64448300160549e-253
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,29218,0.0856423051830884,0.00250019800416616,0.0807419170949227,0.090542693271254,3.72267743811348e-252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC13,Mucin-13,28774,0.121327259858392,0.00354608822550081,0.11437692693641,0.128277592780373,1.64131280513309e-251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,29820,0.10329643452812,0.0030393932409391,0.0973392237758791,0.10925364528036,2.00724257155888e-248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.102782853642461,0.00302501839974069,0.0968538175789693,0.108711889705953,3.65020364069424e-248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,0.184536142952837,0.00543848944179714,0.173876703646915,0.195195582258759,1.6436635698118e-247
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBP,Protein AMBP,29683,0.046737557405796,0.00138723195412172,0.0440185827757174,0.0494565320358745,3.13817132788025e-244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,0.0766372287168901,0.0022729093627488,0.0721823263659025,0.0810921310678778,9.4935147989287e-244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST3,Cystatin-C,29530,0.0658577743953378,0.00195719491817937,0.0620216723557062,0.0696938764349693,1.30120847887173e-243
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9,Complement component C9,24951,-0.123630875460064,0.00368451226131021,-0.130852519492232,-0.116409231427896,1.82415722152149e-241
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0798630813937428,0.00239274932197182,0.075173292722678,0.0845528700648075,8.06479834033419e-240
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.16748909973857,0.0050170160920026,0.157655748198245,0.177322451278896,4.30418201594933e-239
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.338512181516331,0.0101673520751743,0.318584171448989,0.358440191583673,1.45962819718558e-238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRN,Agrin,29581,0.0790447329306001,0.00237730748402074,0.0743852102619194,0.0837042555992807,5.0315374679684e-238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,0.0828766698349958,0.00249615616245089,0.077984203756592,0.0877691359133995,2.7400103805146e-237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OCLN,Occludin,24867,0.101019586588831,0.00304041662439944,0.0950603700050077,0.106978803172654,6.97652982274246e-237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,29604,0.13656591568219,0.00412325441727395,0.128484337024333,0.144647494340047,3.08640634434003e-236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.194787728276305,0.00589084064791063,0.1832416806064,0.20633377594621,1.13561101022974e-234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,29426,0.191741319731755,0.00581386321968889,0.180346147821164,0.203136491642345,2.92776734583607e-234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,29435,-0.1026910720406,0.00311561219163326,-0.108797671936201,-0.0965844721449984,5.49233183106958e-234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,29786,0.0745546252873652,0.00226529623443843,0.0701146446678658,0.0789946059068645,2.29554562254474e-233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.157012197742107,0.00477464742969011,0.147653888779914,0.166370506704299,6.24088159566665e-233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0888973497551115,0.00269822313697766,0.0836088324066353,0.0941858671035878,6.52067802339696e-233
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0677112615319092,0.00206216206587089,0.0636694238828023,0.0717530991810162,2.90954348959064e-232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,29169,0.0696957741662853,0.00212393376155436,0.0655328639936388,0.0738586843389319,6.10727592848614e-232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.172360638744554,0.00527611690812435,0.16201944960463,0.182701827884477,3.14692911273278e-229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,0.0606631006512402,0.00186864212296902,0.0570005620902209,0.0643256392122594,3.4021388923663e-227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0766740023766174,0.00236270339917347,0.0720431037142374,0.0813049010389974,4.73506533997574e-227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,28762,0.0713729842312309,0.00219964711547264,0.0670616758849045,0.0756842925775573,7.31352050282053e-227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MENT,Protein MENT,24381,-0.0510941475824465,0.00157359118430042,-0.0541783863036753,-0.0480099088612176,1.89763393560343e-226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0840227071722453,0.00260261964819832,0.0789215726617766,0.089123841682714,6.11496668132687e-224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0862639301389372,0.00269000286634759,0.0809915245208959,0.0915363357569784,8.61458960431062e-222
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,0.123548857756807,0.0038471885229362,0.116008368251852,0.131089347261762,9.81431638766132e-222
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,0.0488124289635675,0.00152438257618794,0.0458246391142391,0.0518002188128958,3.36296498120261e-221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0928092996465385,0.00291204794571379,0.0871016856729394,0.0985169136201375,3.39863298048188e-219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AREG,Amphiregulin,29349,0.1006871698005,0.00316208972229012,0.0944894739448118,0.106884865656189,9.06311082137028e-219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0704759519008917,0.00221206956927267,0.0661402955451172,0.0748116082566661,2.63144049910408e-218
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0670920749853724,0.00211336790411113,0.0629498738933146,0.0712342760774302,1.63892022116904e-217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,0.0784052251978198,0.00248307727849308,0.0735383937319733,0.0832720566636662,3.19426915104627e-215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,29584,0.0745001124574324,0.00236606782035639,0.0698626195295338,0.0791376053853309,4.5275974404079e-214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.108342784035495,0.00343488674119581,0.101610406022751,0.115075162048239,4.65054732910543e-214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,29694,-0.0470323844642905,0.00149837707955785,-0.0499692035402239,-0.0440955653883571,8.69567854085845e-213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,29632,0.104818291536451,0.00334862444510647,0.0982549876240425,0.11138159544886,1.2409846227424e-211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN2,Nectin-2,29433,0.0644286167129923,0.00206451399823241,0.0603821692764567,0.0684750641495278,2.27041317956344e-210
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.197924935154959,0.00635229519096965,0.185474436580658,0.210375433729259,1.16678832805797e-209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MME,Neprilysin,29349,0.17286757732914,0.00555286168595959,0.161983968424659,0.18375118623362,2.33127092968874e-209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0818275185609153,0.00262924967958969,0.0766741891889196,0.0869808479329111,2.75368815329152e-209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0673753359105733,0.00217344791954038,0.0631153779882742,0.0716352938328725,1.14628315409868e-207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.101331520222185,0.00328346673099395,0.0948959254294366,0.107767115014933,3.54147864233695e-205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,0.0604509234840549,0.00196663931126372,0.056596310433978,0.0643055365341318,3.20707812469571e-204
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0720613882641845,0.00234830986331233,0.0674587009320923,0.0766640755962767,1.379959806948e-203
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,29434,0.0990453517165127,0.00323497999724095,0.0927047909219204,0.105385912511105,1.10683442623721e-202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,24329,0.0801405653660354,0.00261359153449549,0.0750179259584243,0.0852632047736466,1.27483610761087e-202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.116450315092772,0.00380626222498476,0.108990041131802,0.123910589053742,2.46066472917827e-202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,0.086775155049344,0.00284149915590524,0.0812058167037697,0.0923444933949183,1.14611587067325e-201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0612832739448049,0.00201259803410563,0.0573385817979578,0.0652279660916519,1.51258740089952e-200
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSO,Cathepsin O,29786,0.063963518804606,0.00210075703576951,0.0598460350144978,0.0680810025947143,1.52886820079736e-200
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,29725,0.0602127031175094,0.00197959423129856,0.0563326984241642,0.0640927078108546,3.8929257106759e-200
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,29683,0.0720701800304635,0.00238104152864351,0.0674033386343222,0.0767370214266048,3.10894066741711e-198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOD,Apolipoprotein D,23787,-0.0914494366435607,0.00301758420375525,-0.0973639016829209,-0.0855349716042004,5.63433786986579e-198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.123854814411727,0.00410661093034866,0.115805856988244,0.13190377183521,9.22080175687709e-197
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,29434,-0.0715587704229852,0.0023742499750862,-0.0762123003741542,-0.0669052404718163,1.43987497314625e-196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,0.072715392831811,0.00241564288186772,0.0679807327833503,0.0774500528802717,4.20293129382994e-196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,29443,0.0489637899710994,0.001627315885654,0.0457742508352176,0.0521533291069812,6.35664267773647e-196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,29443,0.0855260010251326,0.00285770393985692,0.0799249013030131,0.0911271007472522,6.83229465138226e-194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,29697,0.0549562063717432,0.00184134102237069,0.0513471779678967,0.0585652347755898,7.08801798452151e-193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.059186548405088,0.0019876622647987,0.0552907303660826,0.0630823664440935,5.49666841421803e-192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,29604,0.12307754266844,0.00413703095169562,0.114968962003117,0.131186123333763,1.15091231941169e-191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,29478,0.0542658305485427,0.00182600499006152,0.0506868607680221,0.0578448003290633,2.97134275427307e-191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F9,Coagulation factor IX,29545,0.0374426804572466,0.00126030516194422,0.0349724823398359,0.0399128785746573,3.81113450241528e-191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.0748377216162217,0.0025328962778688,0.0698732449115988,0.0798021983208445,4.250753099294e-189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0822816239056157,0.00278125541706722,0.0768303632881639,0.0877328845230674,4.53054174570041e-189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0693377652807373,0.00235299163764403,0.064725901670955,0.0739496288905196,3.99962777169341e-188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.0561805788487142,0.00190943267638815,0.0524380908029935,0.059923066894435,1.52455188905372e-187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYNU,Kynureninase,29786,0.0924350911949182,0.0031437628011923,0.0862733161045813,0.0985968662852551,2.42923170133924e-187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH2,Cadherin-2,29478,0.0721443586539922,0.00245469332441644,0.067333159738136,0.0769555575698485,3.68040632765373e-187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,24922,0.0580056866550836,0.00197144783180857,0.0541416489047388,0.0618697244054284,4.44114872647196e-187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,29725,-0.0336704822077425,0.0011516354665655,-0.0359276877222109,-0.0314132766932741,2.7701923947447e-185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,29400,0.205425789415603,0.00704548280886498,0.191616643110227,0.219234935720978,2.87132586369264e-184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.246090427348845,0.0084471684248785,-0.262646877461606,-0.229533977236083,5.3086975880748e-184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,29434,0.0963055158859842,0.00331527434265545,0.0898075781743796,0.102803453597589,6.08455027648889e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.174809452063468,0.00602172020153928,0.163006880468451,0.186612023658485,1.0651343469467e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.110671778317002,0.00381375085530523,0.103196826640603,0.1181467299934,1.66280391700689e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,28797,0.154345291260065,0.00531919857244172,0.143919662058079,0.164770920462051,1.72817525611734e-182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0758158045869042,0.00262137704523435,0.0706779055782449,0.0809537035955636,2.18389151592754e-181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,24194,0.0551916114075796,0.00191780565754063,0.0514327123188,0.0589505104963592,4.15875484430421e-179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,29434,0.111186303640744,0.00388227750450514,0.103577039731914,0.118795567549574,6.02383794448162e-178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,29581,0.132736350423674,0.00463520442475343,0.123651349751157,0.141821351096191,6.35167797022934e-178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0849011364820148,0.00296771153186734,0.0790844218795548,0.0907178510844748,1.43403825072346e-177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,0.069425077691532,0.00242985743756825,0.0646625571138982,0.0741875982691658,3.71032946930776e-177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,29693,0.111782745475466,0.00394272092453121,0.104055012463385,0.119510478487547,1.69715851226486e-174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,24828,0.0607215608516617,0.00214460897548908,0.0565181272597031,0.0649249944436203,1.35238537669383e-173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,24966,-0.0540310022633012,0.00191370947429393,-0.0577818728329173,-0.0502801316936851,1.17048509933408e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,0.100295091280198,0.00355868805757245,0.0933200626873556,0.10727011987304,1.84659198931329e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.111812647327815,0.00396670171622126,0.104037911964022,0.119587382691609,4.28252585596935e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.122872504063604,0.00436764140873828,0.114311926902477,0.131433081224731,7.11410237554105e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.161313312962859,0.00574019761307721,0.150062525641227,0.17256410028449,1.89731761844173e-171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,0.183509043832673,0.00653178966264814,0.170706736093883,0.196311351571464,2.08095096342282e-171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,29536,0.0647391547054444,0.00230984582134907,0.0602118568956002,0.0692664525152886,1.29330971274208e-170
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,24381,0.1242668979189,0.00444210898489078,0.115560364308514,0.132973431529286,1.57313620477673e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0754531862222964,0.00270623991526869,0.0701489559883698,0.080757416456223,7.08150766730845e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELE,E-selectin,29820,0.0974390859387147,0.0034956013546031,0.0905877072836926,0.104290464593737,7.93325268315738e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UMOD,Uromodulin,29750,-0.104154600707093,0.00374879713447734,-0.111502243090669,-0.0968069583235177,9.57808798001174e-168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,29725,0.246085521591182,0.00888224802917069,0.228676315454007,0.263494727728356,7.98247944615614e-167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,0.0710107978119528,0.00256369555343769,0.0659859545272149,0.0760356410966907,9.57097563710663e-167
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.158042464770677,0.00571433611983527,0.1468423659758,0.169242563565554,3.41773990296335e-166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0734595353174646,0.00265980257363051,0.0682463222731488,0.0786727483617804,8.29526023280759e-166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG2,Secretogranin-2,29559,0.0625065359288099,0.00226414471934145,0.0580688122789007,0.0669442595787191,1.16133617877234e-165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,29674,0.0540347083059155,0.00196388779946234,0.0501854882189693,0.0578839283928617,1.391399079574e-164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,29725,-0.0678370586958299,0.00247187008706704,-0.0726819240664813,-0.0629921933251785,9.16080863015939e-164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD27,CD27 antigen,29566,0.0792843540604645,0.00288982454082036,0.0736202979604565,0.0849484101604724,1.1611954097656e-163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0523495528881738,0.00191766087031281,0.0485909375823607,0.0561081681939869,4.51470969763515e-162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REN,Renin,29478,0.144240753115084,0.00528760644838361,0.133877044476252,0.154604461753916,7.73905086807797e-162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELN,Elastin,24922,0.0664469993597866,0.00244846553699682,0.0616480069072728,0.0712459918123004,7.37192709775501e-160
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.149702808261859,0.00552285719317045,0.138878008163245,0.160527608360473,7.81079066919242e-160
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.114006640682014,0.00420771394088209,0.105759521357885,0.122253760006143,1.05538513089772e-159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0380510161016646,0.00140571573703304,0.0352958132570798,0.0408062189462493,2.08697436524163e-159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,0.0491954542774436,0.00182222614714991,0.0456238910290297,0.0527670175258574,3.22498816598209e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0746175057593152,0.00277451704732888,0.0691794523465505,0.0800555591720798,2.62074002453343e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,29434,0.0994344939444912,0.0037030949029326,0.0921764279347433,0.106692559954239,6.29371281017532e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_E,,29434,0.0541072539086816,0.0020160038242007,0.0501558864132482,0.058058621404115,8.8203118156423e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0928409709384997,0.00347187079667011,0.0860361041770262,0.0996458376999731,1.08609720640473e-155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.0789536741521727,0.00295567180918699,0.0731605574061662,0.0847467908981792,2.34946420612224e-155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,29652,0.0690666440319013,0.00258819620720611,0.0639937794657774,0.0741395085980253,4.75985886912414e-155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0514802578696841,0.00193417140217142,0.0476892819214281,0.0552712338179401,2.96022309404855e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,29434,0.074222583763782,0.00278992916821022,0.06875432259409,0.0796908449334741,4.10218158991533e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,29434,0.100338196802479,0.00377260841446887,0.0929438843101196,0.107732509294838,4.95323441482592e-154
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,29443,-0.0692468799103911,0.0026063970756723,-0.0743554181787088,-0.0641383416420734,1.03661873403825e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,-0.0614416656637708,0.00231399737817217,-0.0659771005249883,-0.0569062308025534,1.53306150028757e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMA,Granzyme A,29786,0.0639109698950791,0.0024093982117448,0.0591885494000593,0.0686333903900989,2.96940076978538e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,29443,0.0687513356950643,0.0026009787767982,0.0636534172925399,0.0738492540975888,3.44556389115484e-152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,29786,0.0758756223186861,0.00287172603575435,0.0702470392886076,0.0815042053487646,4.40108656758909e-152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,28764,0.10941887833303,0.0041421809228334,0.101300203724276,0.117537552941783,5.89536154436206e-152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,29642,0.074735386444165,0.00283241920144926,0.0691838448093244,0.0802869280790055,1.13433803602535e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,24381,0.0502938655659376,0.00190394564745785,0.0465621320969202,0.054025599034955,1.23797683555764e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,29594,0.0566541775952169,0.0021498735404796,0.0524404254558769,0.060867929734557,2.70111077881962e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.096342426752492,0.00365518312012146,0.0891782678370539,0.10350658566793,5.05272651275483e-151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0505265366264763,0.00192111177400266,0.0467611575494311,0.0542919157035215,2.17971431681482e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,29351,0.0582704014062544,0.00222088255296811,0.0539174716024369,0.0626233312100719,5.35555270269954e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,29566,0.0483526283150201,0.00184427974773785,0.0447378400094539,0.0519674166205863,8.66899693910506e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,0.123549680286687,0.00471490032828594,0.114308475643246,0.132790884930127,1.25744122420029e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,29701,0.0433851071196277,0.00166020479261189,0.0401311057261084,0.046639108513147,7.56442136941676e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0358685217459466,0.00137500944281181,-0.0385635402538577,-0.0331735032380354,2.58955455126197e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0654261854661667,0.00251089598927957,0.0605048293271787,0.0703475416051546,5.35274161602959e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F7,Coagulation factor VII,29544,0.0554421055528743,0.00213049142042532,0.0512663423688406,0.0596178687369079,1.25484558587628e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.191196098056804,0.00735058916104436,0.176788943301157,0.205603252812451,1.75402804782377e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,29434,0.109348928772291,0.0042043939263043,0.101108316676734,0.117589540867847,1.86023443413068e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.131346986525661,0.00505328000200002,0.121442557721741,0.141251415329581,2.88253530224339e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,24381,0.0776519481492656,0.00299433163203567,0.0717830581504757,0.0835208381480555,2.73225831922634e-146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,24938,0.0456092549005291,0.00176682391706882,0.0421462800230743,0.049072229777984,4.943306126385e-145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0525487444256935,0.00204866503808134,-0.056564127900333,-0.0485333609510541,1.57231947633063e-143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0622799703857251,0.0024317928960953,-0.0670462844620719,-0.0575136563093783,4.29826736027206e-143
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCA,Calcitonin,29163,0.110420900879403,0.00431776363754229,0.10195808414982,0.118883717608986,1.12576657659928e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS2,Trypsin-2,29594,0.0952719870822324,0.00372614512162088,0.0879687426438555,0.102575231520609,1.21494367983569e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHK,Ketohexokinase,24240,0.114383871915048,0.00447634653194991,0.105610232712426,0.12315751111767,3.88765426158255e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,29443,0.0995735142049062,0.00390143812273986,0.0919266954843361,0.107220332925476,3.93709604286699e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,29581,0.118110527930797,0.00462804614391235,0.109039557488729,0.127181498372865,4.03687329695778e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.090630966367919,0.00355389620569107,0.0836653298047644,0.0975966029310735,7.09152757857508e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,29487,0.05602502432738,0.00219906233867441,0.0517148621435781,0.0603351865111818,1.22024335154673e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,29694,0.0768051400316932,0.00301981037875605,0.0708863116893313,0.0827239683740551,3.48338145777813e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,29725,0.0674215284022094,0.00265408398763172,0.0622195237864512,0.0726235330179676,7.48169541976757e-141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,-0.111168076807903,0.00438367044948842,-0.1197600708889,-0.102576082726906,2.30203559274193e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0885387218426741,0.00349438682672022,0.0816897236623025,0.0953877200230458,3.96717373468807e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.0619557704852568,0.00244772735791053,0.0571582248637522,0.0667533161067615,7.4926223725772e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0775505154675692,0.0030657965411435,0.0715415542469279,0.0835594766882104,1.13090412569818e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HJV,Hemojuvelin,24867,0.0781858477791082,0.00309141535630096,0.0721266736807583,0.0842450218774581,2.30768890951595e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOT,Angiomotin,24381,0.0712600789157217,0.00281905020573393,0.0657347405124832,0.0767854173189602,3.46384266842211e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.05362980544942,0.00212473003930883,0.0494653345723747,0.0577942763264653,4.40489005131698e-139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0628855862836226,0.00249774621720225,0.0579900036979062,0.067781168869339,2.25894428293295e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0787290627323747,0.00312417118304993,0.0726056872135969,0.0848524382511526,2.43020713176891e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,29349,0.0624466935648712,0.00248259978843139,0.0575807979795456,0.0673125891501967,3.75409629480568e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XCL1,Lymphotactin,29725,0.0969827593524137,0.00386015134891423,0.0894168627085418,0.104548655996286,7.47954900713546e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.119269513766877,0.00475247717328256,0.109954658507243,0.128584369026511,3.15922981571664e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,24914,-0.0656353302790701,0.0026161553665162,-0.0707629947974419,-0.0605076657606984,3.36420987392085e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,29433,0.0523432386516588,0.00208999225169109,0.0482468538383442,0.0564396234649733,5.44430232158951e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,0.11053824577824,0.00443648804533896,0.101842729209376,0.119233762347105,1.2836852694732e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,29725,0.0460039016932187,0.00184950820294744,0.0423788656154417,0.0496289377709957,3.48092436510471e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM2,Paralemmin-2,24845,0.0658374327392664,0.00264435503701637,0.0606544968667143,0.0710203686118185,3.61671849692967e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,0.174396402171084,0.00701831058043946,0.160640513433423,0.188152290908745,7.25088816182324e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,29683,0.0997591283895411,0.00401610334696339,0.0918875658294928,0.107630690949589,7.97422324778536e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,29349,0.134316414708217,0.00540742433185487,0.123717863017781,0.144914966398652,8.36937146109208e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,24922,0.0779005668696371,0.00313422593957118,0.0717574840280776,0.0840436497111966,1.00580616471898e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.0477164903182827,0.00192710746149659,0.0439393596937494,0.051493620942816,5.60609737469678e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,0.0396147272308236,0.00159879946460738,0.0364810802801931,0.042748374181454,7.06573589089421e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.046779446923621,0.00189003947118768,-0.0504839242871489,-0.0430749695600932,7.14990455756099e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG2,Desmoglein-2,29443,-0.0462755865924695,0.00187747152437321,-0.049955430780241,-0.042595742404698,8.64614048933753e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0987901953992577,0.00400629780739601,0.0909378516967615,0.106642539101754,1.28074544102199e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,0.0682455789797613,0.00277140333375507,0.0628136284456014,0.0736775295139213,1.49687537795159e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0580925658761938,0.00236644208962544,0.0534543393805279,0.0627307923718597,9.52319159621822e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,29694,0.0385337407650759,0.00157172137136724,0.0354531668771961,0.0416143146529557,1.98449296527091e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.0889417875000745,0.00362955904622676,0.0818278517694701,0.096055723230679,2.65249390412106e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,0.104754932222526,0.00428086217865393,0.0963644423523642,0.113145422092688,6.214135162103e-131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXN,Paxillin,28774,0.0873437739845095,0.0035813904009079,0.08032424879873,0.094363299170289,4.78398353620488e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0451903355595631,0.00185259983994408,-0.0488214312458535,-0.0415592398732727,6.77003133505348e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,28868,0.064937386235543,0.00266467943069941,0.0597146145513721,0.0701601579197138,7.38413965822856e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0956348155085764,0.00392619691060065,0.0879394695637992,0.103330161453354,1.74955511743559e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100P,Protein S100-P,28916,0.090809876311692,0.00373302805989299,0.0834931413143017,0.0981266113090822,2.08378608090964e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.112165559582537,0.00460768072250836,0.103134505366421,0.121196613798654,2.22596203386457e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,0.130397713216549,0.00537169141576333,0.119869198041653,0.140926228391445,6.66391083425021e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.176974417270372,0.00729439631499134,0.162677400492989,0.191271434047755,9.30130025148564e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,24805,0.122087768966301,0.00503723951294648,0.112214779520926,0.131960758411676,2.81811258220257e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,0.0458211804003141,0.00189361366008718,0.0421096976265432,0.0495326631740849,4.10999302799243e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,24951,-0.0873182467875691,0.00361336350170481,-0.0944004392509105,-0.0802360543242277,1.50883905049553e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,29786,0.128626866314707,0.00534925789417062,0.118142320842132,0.139111411787281,1.49256026611342e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18,Interleukin-18,29335,0.0768845800002522,0.00320279626478213,0.0706070993212793,0.0831620606792252,4.02916948744868e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,24966,0.0522253537850709,0.00217560400621383,0.0479611699328918,0.05648953763725,6.60691739109229e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0706396038027358,0.00294544441607028,0.0648665327472381,0.0764126748582336,6.82554500702562e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,29218,0.0570940619255781,0.00238479060593961,0.0524198723379364,0.0617682515132197,1.86288270186308e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0534195030240498,0.00223368741134972,0.0490414756978043,0.0577975303502952,3.31341017782524e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOA,Elongin-A,29349,0.0869818378254702,0.00364100987558397,0.0798454584693256,0.0941182171816148,6.16196299973334e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EZR,Ezrin,29694,0.0398833500060284,0.00167168981443403,0.0366068379697377,0.0431598620423191,1.24671213161797e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD302,CD302 antigen,29349,0.0507720530911066,0.00212835287511644,0.0466004814558783,0.0549436247263348,1.38062225392568e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,0.0881922935693182,0.00370338679455247,0.0809336554519953,0.095450931686641,3.58751689065395e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,29820,0.0979355524632292,0.00411328866444733,0.0898735066809125,0.105997598245546,3.84511897099077e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,0.0569049264821912,0.00239295930858763,0.0522147262373595,0.061595126727023,1.28012011627743e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,29192,0.0612820314034205,0.00258222462118978,0.0562208711458885,0.0663431916609525,2.4755475338959e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,24240,0.0531233297576211,0.00223633109829063,0.0487401208049715,0.0575065387102708,2.5281222620145e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FETUB,Fetuin-B,29545,0.0545818151511858,0.0023018293827053,0.0500702295610834,0.0590934007412881,3.81410022449845e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,29786,0.0693226770936005,0.00292424396478749,0.063591158922617,0.075054195264584,4.31225061229088e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,29725,0.0758528037354048,0.00320992950204208,0.0695613419114023,0.0821442655594073,2.51306211418502e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,29595,0.111916056842252,0.00473893421557782,0.10262774577972,0.121204367904785,3.54975371918123e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,29786,0.0895815505161128,0.00379514145858219,0.0821430732572917,0.0970200277749339,4.61569404155538e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,29218,0.0627522709839931,0.00266088176886865,0.0575369427170106,0.0679675992509757,7.89631490933285e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.0735351488665295,0.00312230207418564,0.0674154368011257,0.0796548609319334,1.56618124904572e-121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDK,Midkine,29455,0.0832079964710977,0.00354073784175738,0.0762681503012532,0.0901478426409421,5.29104603579493e-121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0557755680486813,0.002376558748917,-0.0604336231965586,-0.051117512900804,1.05303266336608e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0639787510439777,0.0027267801765711,-0.0693232401900571,-0.0586342618978983,1.24769607826963e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFI,Complement factor I,24966,0.0327032337815386,0.00139334107651292,0.0299722852715733,0.035434182291504,1.62962879829449e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,29581,0.0664091252749305,0.00283212025745168,0.0608581695703253,0.0719600809795358,1.72394676579943e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,0.108839141715987,0.0046429743925684,0.0997389119065532,0.117939371525421,2.00070429335326e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,24793,0.0729521143002051,0.00311191013250186,0.0668527704405015,0.0790514581599088,3.18267545749236e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,29577,0.106415845509751,0.00454345255812598,0.0975106784958245,0.115321012523678,3.19498513093396e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,29218,0.0848924423213949,0.00362590768768605,0.0777856632535302,0.0919992213892595,4.05858178148162e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,29497,0.080677145371221,0.00346795210772596,0.0738799592400781,0.0874743315023639,1.21534381223587e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,0.0830846037292274,0.00357942990250941,0.076068921120309,0.0901002863381459,3.97021020981297e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,0.0961329635445067,0.00414770399164352,0.0880034637208854,0.104262463368128,8.82164690303123e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COLEC12,Collectin-12,29454,0.0425242399731888,0.00183983006235772,0.0389181730509676,0.0461303068954099,3.77889756470647e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,0.0743603760152401,0.00322156803371806,0.0680461026691527,0.0806746493613275,7.68827709018142e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,24240,0.0827587938247847,0.00358209852729516,0.0757378807112862,0.0897797069382832,7.8373272374631e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,29694,0.0556147809620264,0.00240991029094017,0.0508913567917837,0.0603382051322691,8.32682519163877e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAXX,Protein PAXX,24381,0.0741104123408447,0.0032091486247905,0.0678204810362553,0.0804003436454341,9.65824541894814e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,24914,0.0455635670585003,0.00197335498518204,0.0416957912875435,0.0494313428294571,9.96907870196757e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,29434,0.0942696999395695,0.00408825713745299,0.0862567159501617,0.102282683928977,1.30494958353052e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0905140665033402,0.00392580664644397,0.08281948547631,0.0982086475303704,1.38055215936704e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,0.0591449456454037,0.0025657612727592,0.0541160535507956,0.0641738377400117,1.53079847691456e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,29082,0.0755559868793485,0.00328014240106498,0.0691269077732612,0.0819850659854359,2.32906921203869e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0445431844972852,0.00194734306875838,0.0407263920825187,0.0483599769120516,8.96933006820326e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,29372,-0.100694147971229,0.00440568593262149,-0.109329292399167,-0.0920590035432909,1.29200674123791e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,29736,0.0800001919221049,0.00350118677174771,0.0731378658494793,0.0868625179947304,1.43962859449422e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,29466,0.0843233113563725,0.00370160194692022,0.0770681715404088,0.0915784511723361,6.95861516939458e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSS,Cathepsin S,23389,0.0387169160898123,0.00169987390401594,0.0353851632379411,0.0420486689416835,1.35664774180106e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.11948144530915,0.00525421598732293,0.109183181973997,0.129779708644303,2.56408852921082e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD83,CD83 antigen,29434,0.0537695900240406,0.00237071612953897,0.0491229864101442,0.0584161936379369,6.46501639655408e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,24938,0.0591820854075378,0.00260731532648872,0.0540717473676199,0.0642924234474557,6.47782673596026e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0967260174055819,0.00426411538900289,-0.105083683568028,-0.0883683512431363,9.69594787524217e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,24951,0.0386774715051021,0.00171096518483995,0.0353239797428158,0.0420309632673884,5.09811401110116e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0607795771786513,0.00269780199528292,0.0554918852678968,0.0660672690894058,2.79171944130616e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSTB,Cystatin-B,29030,0.0666144541265961,0.00296496450100877,0.0608031237046189,0.0724257845485733,7.67804494596981e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.059684396739997,0.00265702388599968,0.0544766299234377,0.0648921635565564,8.014368441479e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPH,Hephaestin,24922,0.041588957506989,0.001850950449898,0.0379610946251889,0.0452168203887891,1.0525720864789e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,29820,-0.0256893966958026,0.0011443473869504,-0.0279323175742253,-0.0234464758173798,1.08605068359329e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,0.0738701561386187,0.00329100476277516,0.0674197868035794,0.080320525473658,1.2464260413156e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,29034,-0.0838012736955325,0.00373812856568443,-0.091128005684274,-0.076474541706791,2.27855585255827e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,0.118775267959029,0.00530119249566007,0.108384930667535,0.129165605250523,4.51471588846743e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,29495,0.0725968693693397,0.00324622764897603,0.0662342631773467,0.0789594755613328,7.33638241893546e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0477161243269139,0.00213405116647014,0.0435333840406324,0.0518988646131953,7.93087736576013e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0434700848302299,0.00194908308115716,0.0396498819911618,0.0472902876692979,2.81351265406823e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0649919605951483,0.00291494275914938,0.0592786727872155,0.0707052484030811,3.29026014577171e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.105600873423334,0.00473782898576173,0.0963147286112406,0.114887018235427,3.97808189855237e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.093070184448112,0.00417441529145949,0.0848883304768514,0.101252038419373,4.83763745647574e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLN,Promotilin,29434,0.138097023047768,0.00620222857365259,0.125940655043409,0.150253391052128,6.32005092860737e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0435777986105629,0.0019589599441612,0.0397382371200069,0.0474173601011188,9.8418572195852e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0417664793879493,0.00188028120429215,0.0380811282275367,0.045451830548362,1.99302739889387e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.101240807643211,0.00457240889479293,0.0922788862094167,0.110202729077005,9.53704377856949e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,29218,0.103049810678451,0.00465720429449757,0.093921690261236,0.112177931095666,1.33418198274946e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,29694,0.121128660226732,0.00549002771930031,0.110368205896903,0.131889114556561,5.15877398848941e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH1,Cadherin-1,28477,0.0615475312380124,0.00280083406924078,0.0560578964623005,0.0670371660137243,3.84146767899433e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPO,Erythropoietin,29434,0.116029579920273,0.00529563012021117,0.105650144884659,0.126409014955886,1.445393101664e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,29536,0.0882204178931422,0.00402911382253723,0.0803233548009692,0.0961174809853152,1.97239599464697e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0604040873032242,0.00276267689241492,0.0549892405940909,0.0658189340123574,3.93120158948129e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,24805,0.169621598308974,0.00777901844714663,0.154374722152567,0.184868474465382,1.99361842311611e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,29566,0.049792500078519,0.00228611111793762,0.0453117222873613,0.0542732778696768,2.35805522617731e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0479482774094862,0.00220004628843125,0.0436361866841609,0.0522603681348115,2.50391196813248e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,29694,0.0796181179620173,0.00366088421854666,0.0724427848936659,0.0867934510303688,4.66007567906504e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,0.0437244948110491,0.00201431851612219,0.0397764305194496,0.0476725591026486,1.15556873553904e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,24240,0.0821890140884635,0.00378396457053599,0.074772443530213,0.089605584646714,1.28465005954937e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,0.102429685563444,0.00472231568872654,0.09317394681354,0.111685424313348,1.6415706458165e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.111281410947004,0.00513301749927093,0.101220696648433,0.121342125245575,2.09575143647783e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,0.0693862630171193,0.00320215807778056,0.0631100331846694,0.0756624928495692,2.57008671687585e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVR,Poliovirus receptor,29694,0.055927551013556,0.00258255068841535,0.050865751664262,0.0609893503628501,3.36845882442075e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0406707034239968,0.0018815829681449,0.0369828008064328,0.0443586060415608,8.10003885708928e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHR,Growth hormone receptor,24381,0.0435507307260621,0.00201611414193795,0.0395991470078637,0.0475023144442604,1.59948613583572e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO3,Beta-enolase,24240,0.0910555321540525,0.00422071414820102,0.0827829324235785,0.0993281318845265,2.92462039500837e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0466808201855866,0.00216432471191271,0.0424387437502376,0.0509228966209355,3.2644112329622e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0498957727546545,0.00232289885243353,0.0453428910038848,0.0544486545054243,1.45485408966683e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0941892025045158,0.00438375511660932,0.0855970424759615,0.10278136253307,1.76689825711123e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSM,Oncostatin-M,29293,0.106443252508211,0.00495828695935782,0.0967250100678698,0.116161494948553,1.8908830897928e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,0.165284220829233,0.00769996834156365,0.150192282879769,0.180376158778698,2.04184640158119e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0566478792353069,0.00264039073258133,0.0514727133994474,0.0618230450711663,2.56742306902166e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,28347,0.047204301220327,0.00220222625112127,0.0428879377681293,0.0515206646725247,4.02832154885915e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,29581,0.0634255412067258,0.00296728489679456,0.0576096628090085,0.0692414196044431,1.32177378296879e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,29478,0.0946579999173965,0.0044330880721105,0.0859691472960599,0.103346852538733,2.12949152980345e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN4,CCN family member 4,29725,0.0596154554654247,0.00279790622831935,0.0541315592579188,0.0650993516729307,5.46416751263538e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0614966372796902,0.00288669154746103,0.0558387218466666,0.0671545527127138,6.19066270187418e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0625963180620816,0.00294219463906787,0.0568296165695085,0.0683630195546546,1.07375035071669e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,29349,0.107504941492107,0.00506060086144303,0.0975861638036785,0.117423719180535,2.12573068051401e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.0566015839688326,0.00268440239755965,0.0513401552696157,0.0618630126680495,6.05008073101326e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0722643777949494,0.00343111492150633,-0.0789893630411019,-0.065539392548797,1.27821653862257e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0387832459054773,0.00184859067601701,0.035160008180484,0.0424064836304706,5.10632239787573e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0426389567857658,0.00203468765197461,0.0386509689878955,0.046626944583636,8.26524546028595e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,0.0833909558729967,0.00398503247944257,0.0755802922132893,0.0912016195327041,1.56887277369866e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,0.0670995567878605,0.0032079544881221,0.0608119659911412,0.0733871475845798,1.92163632254619e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSL,Cathepsin L1,29478,0.0355626678398183,0.00170085480476441,0.0322289924224801,0.0388963432571566,2.23926636572563e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,29434,-0.0675445088261314,0.00323311327380373,-0.0738814108427867,-0.0612076068094761,3.20310175720772e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSC2,Desmocollin-2,29135,0.050038711628463,0.00239996430042856,0.045334781599623,0.0547426416573029,7.69050781288085e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,0.124952149763662,0.00598964966197877,0.113212436426183,0.13669186310114,8.37676668429052e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0436004901256099,0.00209922302535635,0.0394860129959114,0.0477149672553083,3.92227219688822e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0754038212440441,0.00363182832135507,0.0682854377341882,0.0825222047539001,4.57571754568309e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PENK,Proenkephalin-A,24381,0.0450577047052246,0.0021710061027304,0.040802532743873,0.0493128766665762,7.42240023099107e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0588638186078021,0.00285060685624681,0.0532766291695584,0.0644510080460459,4.5476548769777e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,24922,0.118211290738068,0.00572532169201608,0.106989660221717,0.12943292125442,6.34651491208808e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,24752,0.0629074177559778,0.00304682514613042,0.0569356404695622,0.0688791950423934,6.45464513742575e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.100973254796938,0.00489241721209476,0.0913841170612318,0.110562392532643,7.92049052954919e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,24229,0.0646211217951567,0.00313694980890196,0.0584727001697089,0.0707695434206046,1.73968534903931e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,29265,0.0330623389393081,0.00160817046558486,0.0299103248267618,0.0362143530518544,2.92328626303535e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0754351564434625,0.00367062479617244,0.0682407318429645,0.0826295810439605,3.50746778600217e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0548797131902071,0.00267107489756246,0.0496444063909846,0.0601150199894295,3.77578421377095e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0626110769394543,0.00304885565821969,0.0566353198493437,0.0685868340295648,4.64778933629002e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0829768951666781,0.00404215261922808,0.0750542760329911,0.0908995143003652,5.40021405860992e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,29820,0.0871198454588432,0.00424678829414092,0.078796140402327,0.0954435505153594,7.04083907917121e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBKS,Ribokinase,28795,0.0711417212993998,0.00347492415488533,0.0643308699558246,0.0779525726429751,1.71534099833534e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,29081,0.0516747613078867,0.00252801837849744,0.0467198452860317,0.0566296773297416,3.23180246748392e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0712220697913737,0.00348655716838793,0.0643884177413333,0.078055721841414,4.14059361960116e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,29169,0.0735360719226736,0.00360863704738439,0.0664631433098002,0.080609000535547,1.14694629608707e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,0.11389032048995,0.00558791704068564,0.102938003090207,0.124842637889694,1.43177747598316e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0291401884756004,0.00143104665675495,0.0263353370283608,0.0319450399228401,1.50723880133107e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,24922,0.097686727450868,0.00480075082217305,0.0882772558394088,0.107096199062327,2.66222416634822e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.0483072335082402,0.00237591297202457,0.043650444083072,0.0529640229334084,2.83179416354022e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,24653,0.0389927465507863,0.00191665586821021,0.0352361010490943,0.0427493920524783,2.94205830506618e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,24381,0.042859196019101,0.0021080870736943,0.0387273453546602,0.0469910466835418,3.91561490908822e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0491016410622311,0.00241731619193945,0.0443637013260298,0.0538395807984325,4.2294538107679e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0392864728764403,0.00193792988384201,0.03548813030411,0.0430848154487707,9.40993488137322e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0425250014643667,0.00210348001931602,0.0384021806265073,0.0466478223022261,3.73928933839621e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,28765,0.0558797251780693,0.00276793295273012,0.0504545765907182,0.0613048737654203,5.23042557553102e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,29566,0.0753228618254895,0.00374232249169713,0.0679879097417632,0.0826578139092159,1.69579384673994e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN5,CCN family member 5,29443,0.0545447660653217,0.00271757199260873,0.0492183249598086,0.0598712071708349,5.20800422013477e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0838505307170969,0.0041752588789337,0.0756670233143868,0.0920340381198069,5.34340965525644e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,0.119102812818544,0.00594298083892946,0.107454570374242,0.130751055262845,9.71329722146027e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAST,Gastrin,24845,0.183181577241392,0.00913541752240064,0.165276158897487,0.201086995585297,9.82007140057109e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0518572538119438,0.00258809703225209,0.0467845836287297,0.0569299239951579,1.03172593882882e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0406058343396873,0.00202534959164379,0.0366361491400655,0.0445755195393091,1.07424657919849e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,29390,0.0395436740436418,0.00197419251480373,0.0356742567146264,0.0434130913726571,1.17328869947606e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RETN,Resistin,29362,0.0590604764312156,0.00295028352011537,0.0532779207317894,0.0648430321306417,1.48189897185853e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFM,Afamin,24966,0.0273317787144084,0.00136654578214772,0.0246533489813988,0.0300102084474179,2.67810013504543e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,29507,-0.0275886851545084,0.0013834516775127,-0.0303002504424333,-0.0248771198665835,6.69645682864173e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAYN,Layilin,29163,0.0486425670246277,0.00244227879525943,0.0438557005859192,0.0534294334633362,1.11433399247593e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,29566,0.0415984630323346,0.00208932283995451,0.0375033902660238,0.0456935357986455,1.25249398401168e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCOF1,Treacle protein,24922,0.0437271541573533,0.00219649310337623,0.0394220276747359,0.0480322806399707,1.67332225280324e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,29786,0.121963827402551,0.00613268441081164,0.10994376595736,0.133983888847741,1.93209987024104e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0324737707239408,0.00163707906420605,0.029265095758097,0.0356824456897847,5.35374632201211e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,24381,0.161588603178679,0.0081404532641152,0.145633314781013,0.177543891576344,5.36336417595837e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,29319,0.10934789037669,0.00551688079415695,0.0985348040201421,0.120160976733237,7.34039920737604e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0546553456658947,0.0027587433144,0.0492482087696707,0.0600624825621187,8.55409014009885e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.11974714132972,0.00605309979208405,0.107883065737235,0.131611216922205,1.59103262071838e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,-0.0352667508802015,0.00178587955625086,-0.0387670748104532,-0.0317664269499498,3.05817337821672e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0672218456062694,0.00340444137662106,0.0605491405080921,0.0738945507044466,3.2598860614016e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0794055963928002,0.00402203330590685,0.0715224111132228,0.0872887816723777,3.35159305524698e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6,Interleukin-6,29349,0.101823362546769,0.00515830946869874,0.091713075988119,0.111933649105418,3.57193217462176e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,24922,0.12650086385001,0.00640628094308249,0.113944553201568,0.139057174498451,3.93233008721454e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,0.170887340280672,0.00866863337191533,0.153896818871718,0.187877861689626,5.97748437956145e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,29443,0.0344387534799019,0.00174723443930552,0.0310141739788631,0.0378633329809407,6.29479981336708e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,29786,0.0638292398277761,0.00324198515986832,0.0574749489144342,0.070183530741118,9.5478742418959e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,29343,0.042417695454622,0.00215571030575816,0.038192503255336,0.046642887653908,1.21527671390198e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD48,CD48 antigen,29536,0.041149179012886,0.00209655962940169,0.0370399221392587,0.0452584358865133,3.18084731834994e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,0.125052703241662,0.00637373435441112,0.112560183907016,0.137545222576307,3.63917572798642e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0684027505788495,0.00348725563491234,0.0615677295344213,0.0752377716232776,5.43071194748453e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0721960027166028,0.00368300032665086,0.0649773220763671,0.0794146833568385,6.70656947263875e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BECN1,Beclin-1,24240,0.0829697216899407,0.00423262075753202,0.074673785005178,0.0912656583747035,6.70855592360263e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0592837486096907,0.00302841494345817,0.0533480553205127,0.0652194418988687,1.08578801512233e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.060932553063426,0.00312644659710942,0.0548047177330915,0.0670603883937604,4.60008630801358e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,29694,0.0785770491130173,0.00403886999821782,0.0706608639165104,0.0864932343095243,8.76715045200279e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUMB,Protein numb homolog,24229,0.114340818177454,0.00587305905141924,0.102829622436673,0.125852013918236,8.85054380961484e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0406717196807671,0.00208971979166955,0.0365758688890948,0.0447675704724394,9.56737742456177e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,29725,0.052189312660749,0.00268629319341875,0.0469241780016482,0.0574544473198497,1.47814190524661e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,29624,0.0921630914300162,0.00474532852370496,0.0828622475235545,0.101463935336478,1.67034042420001e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.0700401992871678,0.00360594603532391,0.0629725450579329,0.0771078535164026,1.67525267835962e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0350619282913181,0.00180565212811922,0.0315228501202044,0.0386010064624318,1.82696912763612e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD160,CD160 antigen,29786,0.0636592608392922,0.00328027834926181,0.0572299152747391,0.0700886064038454,2.22242482580174e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.114484369450524,0.00590598424017024,0.102908640339791,0.126060098561258,3.46356561663363e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,0.0643040503487542,0.00331733600009814,0.0578020717885618,0.0708060289089465,4.31463078638527e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,29169,0.0620303743965957,0.00320509079676119,0.0557483964349438,0.0683123523582476,6.29369780447019e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0435966245350687,0.00225319859779909,0.0391803552833825,0.0480128937867549,6.76514161583697e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,29694,0.038603521392898,0.00199587813384086,0.0346916002505699,0.0425154425352261,7.76742468040999e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB2,Lamin-B2,24845,0.03796112555595,0.00196508566038824,0.034109557661589,0.0418126934503109,1.53650202091284e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,28774,0.0866457296310841,0.00450244164375123,0.0778209440093317,0.0954705152528365,5.1851639904634e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0389551619004952,0.00202704751374518,0.0349821487735546,0.0429281750274357,8.29492308606788e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.0935246168977957,0.00486631397687902,0.0839866415031128,0.103062592292479,1.01468965909857e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,24816,0.0870491503531462,0.00453317454718583,0.0781641282406619,0.0959341724656304,1.37532584924612e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP7,Matrilysin,28870,0.0668839229183999,0.00349372932267878,0.0600362134459495,0.0737316323908503,3.46574506817268e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMD,Osteomodulin,29581,-0.0577713382442487,0.00301851722140607,-0.0636876319982046,-0.0518550444902928,3.70718706703805e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.13069615939652,0.00682957551319869,0.117310191390651,0.14408212740239,4.94603818134655e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.067466920720329,0.00352571532490868,0.060556518683508,0.07437732275715,5.08129167306912e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,28774,0.0820116239404951,0.00428854050844685,0.0736060845439392,0.0904171633370509,5.13561985723792e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.113595055425913,0.00593813550414493,0.101956309837788,0.125233801014037,5.64988475705363e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTDH,Protein LYRIC,24229,0.124706298942161,0.00654184914199102,0.111884274623859,0.137528323260464,1.99707885165116e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,29820,0.0750620668941775,0.00394414741970212,0.0673315379515613,0.0827925958367936,2.81618484816793e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,28797,0.0990151847502174,0.00520523907311437,0.0888129161669133,0.109217453333522,3.4706055098685e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0432525667999752,0.00228099652408821,0.0387818136127623,0.0477233199871881,1.03736811286423e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0444135369422652,0.00234610220182573,0.0398151766266868,0.0490118972578437,1.88047429021939e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,0.088578322426037,0.00468288736622257,0.0793998631882407,0.0977567816638332,2.48965079848052e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAL,Galanin peptides,29581,-0.0852900857510401,0.0045143551548321,-0.094138221854511,-0.0764419496475692,3.80867494253163e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGN,Mimecan,29443,0.0556145313194318,0.00294444842434627,0.0498434124077131,0.0613856502311505,4.21542159121126e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,29435,0.0523084007058039,0.00277209902630385,0.0468750866142484,0.0577417147973595,5.94093276620969e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,24938,0.0540690108280626,0.00286505698817315,0.0484534991312432,0.059684522524882,6.89930807730274e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD209,CD209 antigen,29527,-0.0513318858765234,0.00272301254231493,-0.0566689904594606,-0.0459947812935861,8.36084475508343e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.0919047699057571,0.00487309933183795,0.0823534952153547,0.101456044596159,8.99151646945303e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0757511136486412,0.00402113946869847,0.0678696802899922,0.0836325470072902,1.07610438130298e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COCH,Cochlin,24922,0.061203688385443,0.00324898112692498,0.05483568537667,0.0675716913942159,1.30311551582677e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.05814385670101,0.00308906641556898,0.0520892865264948,0.0641984268755252,1.77797034147118e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFH,Complement factor H,23693,0.0309666912027227,0.00164627817655549,0.027739985976674,0.0341933964287715,2.32667335111306e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,29736,0.0363379325439636,0.00193440200316982,0.0325465046177507,0.0401293604701764,2.84364143142289e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0564370056164897,0.0030056523582439,0.0505459269943316,0.0623280842386477,3.32541056576082e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,24240,0.0675774163218414,0.00360140076972942,0.0605186708131718,0.0746361618305111,5.29981940051756e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,29218,0.115983488408246,0.00618732328705543,0.103856334765618,0.128110642050875,6.06611900594658e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0507223217150263,0.00270687077240332,0.0454168550011158,0.0560277884289368,6.81776816681635e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD63,CD63 antigen,29169,0.0671029009395637,0.00358494646870898,0.0600764058608941,0.0741293960182333,1.01009721856014e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,0.0534175083282848,0.0028558866852074,0.0478199704252783,0.0590150462312913,1.27094529471338e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEP,Leptin,29478,0.0877785285395747,0.00469747588342642,0.0785714758080589,0.0969855812710904,1.7962390645647e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0683607349679594,0.00366642390781911,-0.0755469258272848,-0.0611745441086339,3.85733809709733e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,29328,0.055881909538346,0.00299826454822461,0.0500053110238258,0.0617585080528662,4.40632878141677e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0667042580431959,0.00359212559091785,0.0596636918849969,0.0737448242013949,1.53587761742576e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0253984066202008,0.00137008652383255,0.022713037033489,0.0280837762069125,2.86763125296498e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSN,Gelsolin,24845,-0.0248820308832651,0.00134196293961616,-0.0275122782449128,-0.0222517835216174,3.12601283023793e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,29694,0.0766109242868497,0.00414193365876106,0.0684927343156781,0.0847291142580214,5.90386532986101e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0348263588780441,0.00188319736704887,0.0311352920386283,0.0385174257174599,6.29835449376495e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0569310019293704,0.00307949675827434,0.0508951882831526,0.0629668155755881,7.11392983261222e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0411208881421656,0.00222822092441536,0.0367535751303115,0.0454882011540198,1.26520729275353e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN3,Contactin-3,29443,0.0415161920584931,0.00225328054862792,0.0370997621831824,0.0459326219338038,2.2089210969989e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANG,Angiogenin,29435,0.0433942338585097,0.00235926054784728,0.038770083184729,0.0480183845322904,3.9355263351619e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN8,Septin-8,24801,0.0414700441959083,0.00225895725877133,0.0370424879687164,0.0458976004231001,8.91879853632226e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0543886182427568,0.00296478208149252,0.0485776453630314,0.0601995911224821,9.4056692829105e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.102654082604952,0.0055930158489576,0.0916917715409956,0.113616393668909,9.58397687936176e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0941013096809933,0.00512778045446304,0.0840508599902457,0.104151759371741,1.04227772440372e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB8,Serpin B8,29786,0.0719827057906282,0.0039391508495762,0.0642619701254588,0.0797034414557975,3.41679453566131e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,0.06436494908484,0.00352244972178517,0.0574609476301411,0.071268950539539,3.51051600804938e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,29786,0.0966082752412405,0.00528781040196381,0.0862441668533914,0.10697238362909,3.65141848852996e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.11398161153145,0.00624467665852921,0.101742045280733,0.126221177782168,5.10223803048768e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN1,Ficolin-1,24919,0.0717499157102794,0.00394464838458587,0.0640184048764911,0.0794814265440677,1.88080099637056e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.101571469562974,0.00558688134322947,0.0906211821302446,0.112521756995704,2.2168776162611e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.0814843730400912,0.00448779353313306,0.0726882977151504,0.090280448365032,2.90684598954995e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0629253243365564,0.00346641211241343,0.0561311565962261,0.0697194920768867,3.1250865066988e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,28424,0.116384319132271,0.00641424842806897,0.103812392213255,0.128956246051286,3.66766036181827e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,0.0282027474405318,0.00155818033279932,0.0251487139882452,0.0312567808928185,7.85984226711889e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,28277,0.0291432864106443,0.00161314259149256,0.0259815269313189,0.0323050458899697,1.50844707724895e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.0784484582885666,0.00435036058622007,-0.0869751650375579,-0.0699217515395752,2.62463592099731e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,29349,0.143239678361774,0.00795316656886302,0.127651471886802,0.158827884836745,3.95420975027049e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAB2,Stabilin-2,24938,0.035598497118972,0.00197818246685768,0.0317212594839309,0.039475734754013,6.02812987565373e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,0.0482287196053149,0.00268680960350713,0.0429625727824409,0.0534948664281889,1.1448298734051e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,29786,0.0617101320032704,0.00343973725936211,0.0549682469749206,0.0684520170316201,1.36116618811395e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,24922,0.0712241556025663,0.00396985009374154,0.0634432494188329,0.0790050617862997,1.58479462951521e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0748788496026145,0.00417674426005355,0.0666924308529096,0.0830652683523195,1.75338346750564e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFC1,Cryptic protein,28797,0.0591546590057,0.00330120762405408,0.052684292062554,0.0656250259488459,2.04667613905282e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0661520484971259,0.00370347237480936,0.0588932426424996,0.0734108543517523,6.45659570182621e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAG1,Dystroglycan,29581,0.0591487315405556,0.0033175030897401,0.052646425484665,0.0656510375964462,9.83195051738932e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH9,Myosin-9,24938,0.141154325875209,0.00792474634220611,0.125621823044485,0.156686828705932,1.56638759844431e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,29725,0.0807458968097474,0.004535770818704,0.0718557860050876,0.0896360076144073,1.58586319149718e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC1,Syndecan-1,29478,0.0501044456411919,0.00281611584400183,0.0445848585869483,0.0556240326954354,1.90501374757145e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.101606807772206,0.00572019007536567,0.0903952352244892,0.112818380319923,3.16881323850088e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.12914161233001,0.00726895486847983,0.11489446078779,0.14338876387223,3.52034860783724e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,29478,0.044724713170306,0.00252488934085415,0.0397759300622319,0.0496734962783801,7.59725316818644e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0836152766402533,0.00473755201453926,0.0743296746917564,0.0929008785887503,2.32493518538328e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,0.0499887224544906,0.00283224026139493,0.0444375315421565,0.0555399133668247,2.33832356522531e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0338547723339056,0.00192744969757423,0.0300769709266601,0.0376325737411511,1.02350217978774e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINH1,Serpin H1,24445,0.158728628640458,0.00905360000887579,0.140983572623061,0.176473684657854,2.13925405597217e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,29218,0.0648206314551792,0.00370056535470849,0.0575675233599505,0.0720737395504078,2.40312835463492e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.121123775553448,0.00691736343188811,0.107565743226948,0.134681807879949,2.64103814596315e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMN,Protein amnionless,28931,0.0580438308944843,0.00331792263819376,0.0515407025236245,0.064546959265344,3.57411547074603e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,0.0286592308726598,0.001638077009841,0.0254485999333714,0.0318698618119481,3.95155200425449e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0304557825489879,0.00174215491256589,0.0270411589203587,0.033870406177617,4.40027470720057e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,24951,0.0348867617761085,0.00199551805905543,0.0309755463803599,0.0387979771718572,4.9561576428421e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0512329380194136,0.00293055391326249,0.0454890523494191,0.0569768236894081,4.99477148386389e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0589900076631001,0.00337973110005697,0.0523657347069884,0.0656142806192118,8.1438686976115e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,24805,0.131111498290609,0.00751464935961405,0.116382785545765,0.145840211035452,9.14969252600167e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORT1,Sortilin,29433,0.0454044262844277,0.0026049145908931,0.0402987936862772,0.0505100588825782,1.06452075681874e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,29349,0.039863589891249,0.00228703908738162,0.035380993279981,0.044346186502517,1.06829525409612e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,24966,0.0371993541050278,0.00213452158374234,0.0330156918008928,0.0413830164091628,1.28429712900263e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,29400,0.111839557324043,0.00642097032689132,0.0992544554833364,0.12442465916475,1.32120456868041e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,-0.135773275691074,0.00779980969056661,-0.151060902684585,-0.120485648697563,1.93545598469606e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.0870651374438831,0.00500903006396115,0.0772474385185192,0.0968828363692469,2.51077222190096e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.062406352761691,0.00359538396226547,0.0553594001956507,0.0694533053277313,4.32860710918125e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,0.0619600360606005,0.00357699148343151,0.0549491327530747,0.0689709393681262,6.91671528942976e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,28797,0.0651215766951266,0.00376197256956141,0.0577481104587862,0.0724950429314669,8.55069846459597e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0307918483756424,0.0017788920618497,0.027305219934417,0.0342784768168678,9.79787547041891e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0684902979958161,0.00395667255236903,0.0607352197931727,0.0762453761984594,9.88334737527119e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL11,Eotaxin,29786,0.0454995188625229,0.00263498315219312,0.0403349518842244,0.0506640858408214,1.74420559616969e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,24805,0.118471659343317,0.00687601478374649,0.104994670367174,0.13194864831946,3.86210938686025e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0373109833670418,0.00216813356408855,-0.0415605251526554,-0.0330614415814283,4.79310982567847e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0556261485360148,0.00323188255639188,0.0492916587254867,0.0619606383465429,5.36126831428588e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSG,Basigin,29760,0.0247264657122494,0.00143808585439629,0.0219078174376326,0.0275451139868661,6.13822436427309e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0440427202376015,0.00256232806696092,0.0390205572263581,0.0490648832488449,6.90399985478694e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN1,Perilipin-1,28774,0.0418916543978087,0.00243733049888063,0.0371144866200027,0.0466688221756148,7.03205767967838e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.0981931707221755,0.00571519371042362,0.0869913910497452,0.109394950394606,8.8524956600553e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POSTN,Periostin,24938,-0.0457646403853416,0.00266407830990904,-0.0509862338727633,-0.0405430468979199,9.22004498579447e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.103576802014344,0.00603545690335783,0.0917473064837622,0.115406297544925,1.07708950679937e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS1,Galectin-1,29478,0.0411246921120981,0.00239900797946224,0.0364226364723521,0.0458267477518441,1.49129689169226e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,29443,0.053687289812213,0.00313230775195653,0.0475479666183782,0.0598266130060478,1.55810121631669e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTN,Pleiotrophin,28916,0.0600503132852489,0.00350475721170226,0.0531809891503124,0.0669196374201853,1.7459668094823e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,29594,0.120411435930191,0.00702809459355398,0.106636370526825,0.134186501333557,1.7482233318258e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,0.101749571226389,0.00594111604196597,0.0901049837841361,0.113394158668643,1.99440651862624e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NADK,NAD kinase,29478,0.064625812865745,0.00378619837669712,0.0572048640474186,0.0720467616840713,5.20829131508243e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0730975156556175,0.00428747950318032,0.0646940558293841,0.0815009754818509,7.28483646215312e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.116116744593497,0.00681143495981692,0.102766332072256,0.129467157114738,7.51679165043897e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0419689838379522,0.00246706126044449,0.037133543767481,0.0468044239084234,1.36849029977759e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0547617694987183,0.00322018231863501,0.0484502121541937,0.0610733268432429,1.51411884394251e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,0.0510163922326006,0.00300164594402582,0.04513316618231,0.0568996182828912,1.7828573698105e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,29434,0.0993495519844937,0.00585977368344088,0.0878643955649496,0.110834708404038,3.59864409209041e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,29383,0.0342375036900554,0.00202134917355349,0.0302756593098906,0.0381993480702202,4.76163663324521e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,0.0470535604664954,0.00277972122104546,0.0416053068732463,0.0525018140597445,5.76350594998577e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,0.073980825818685,0.00438166576558102,0.0653927609181462,0.0825688907192238,1.36600538911625e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.129298040637023,0.0076726724677739,0.114259602600186,0.14433647867386,2.3004554244334e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,0.0600067061116962,0.00356489694365913,0.0530195081021243,0.0669939041212681,3.14668675526399e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,24820,0.129128457437769,0.00767851761536626,0.114078562911651,0.144178351963887,4.11089735963307e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,29820,0.0293466412181033,0.00174822167170539,0.0259201267415608,0.0327731556946459,5.96012039993915e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,0.0667063968373499,0.00397505254295374,0.0589152938531605,0.0744974998215392,6.67038120891597e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.0743598556057552,0.00443447508910612,0.0656682844311072,0.0830514267804032,9.18042946710005e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,29313,0.0453698156447715,0.00270774796177278,0.0400626296396968,0.0506770016498461,1.01103989649181e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,28916,0.0679701169801852,0.00405694379555987,0.0600185071408878,0.0759217268194825,1.04676271232867e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA2,Annexin A2,23907,0.0837247427242913,0.00500144611777191,0.0739219083334583,0.0935275771151242,1.51995447065041e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TALDO1,Transaldolase,24888,0.0523345858522155,0.00312784543064624,0.0462040088081489,0.0584651628962821,1.68870199376538e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.0905636078461908,0.00541540610717749,0.0799494118761229,0.101177803816259,1.94271491893792e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,0.0712201129381208,0.00426648961250306,0.0628577932976148,0.0795824325786268,2.89876963574173e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,0.0748405425180941,0.0044839662855922,0.0660519685983334,0.0836291164378549,3.00678939301985e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,24813,0.0874132245192258,0.00523628955231528,0.0771500969966879,0.0976763520417638,3.18420832200188e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,29443,0.0883451537130316,0.00530662071903587,0.0779441771037213,0.0987461303223419,6.0024377295095e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0604314129221371,0.00364451426939413,0.0532881649541246,0.0675746608901496,1.80399827071981e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0627639356261612,0.0037877930799136,0.0553398611895305,0.0701880100627918,2.18252637783613e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0553835229215749,0.00334326119867686,0.0488307309721682,0.0619363148709815,2.33979556318847e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,29640,0.0839509910222849,0.00506989436954405,0.0740139980579786,0.0938879839865912,2.61378144325287e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,0.0338002076572239,0.00204042005902768,0.0298009843415296,0.0377994309729182,2.65315456743664e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POF1B,Protein POF1B,24229,0.0535255947536113,0.00323497456579536,0.0471850446046524,0.0598661449025702,3.71432632004883e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,28797,0.0647919658236567,0.00392139478752488,0.057106032040108,0.0724778996072055,4.81614839510299e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRN,Progranulin,29313,0.0285211932155114,0.00172694504972396,0.0251363809180525,0.0319060055129704,5.36678690509037e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,29478,-0.0594838789474763,0.0036050819706179,-0.0665498396098874,-0.0524179182850652,6.8855528351424e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,0.0469489825547624,0.00284884205505217,0.0413652521268602,0.0525327129826647,1.08836046751834e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,29661,0.0495133650031666,0.00300624063314231,0.0436211333622077,0.0554055966441255,1.11826204868049e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,29345,0.0496382598196652,0.00301798341912945,0.0437230123181715,0.0555535073211589,1.63231234371927e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,29192,-0.032567396912896,0.00198407794701009,-0.0364561896890357,-0.0286786041367562,2.81347205798874e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,29331,0.0328739828968564,0.00200810247611349,0.0289381020436739,0.0368098637500388,5.72026261878488e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0726853110548434,0.00444008408906175,0.0639827462402823,0.0813878758694044,5.74150698512675e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD248,Endosialin,24938,-0.0463114256332078,0.00282906069260007,-0.0518563845907039,-0.0407664666757117,6.44915896002762e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,29498,0.0746946570561335,0.00456877793605005,0.0657398523014754,0.0836494618107916,8.11924344165482e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,-0.030818926318544,0.00188702433306541,-0.0345174940113522,-0.0271203586257358,1.07000350603541e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,24793,0.113927553956104,0.00697764899495561,0.100251361925991,0.127603745986217,1.28894257330243e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,24101,0.0457813660332976,0.00280401087567161,0.0402855047169812,0.051277227349614,1.32410676023241e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.0833519510294656,0.00510528718408291,0.0733455881486631,0.0933583139102681,1.32941494564042e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0428002094392779,0.00262173683911014,0.037661605234622,0.0479388136439338,1.36121371508861e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,28797,0.0717793652513923,0.00442044220951055,0.0631152985207516,0.080443431982033,4.96900805287763e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,0.0473819957692684,0.00291685821941144,0.041664953659222,0.0530990378793148,5.01806611285112e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN2,CCN family member 2,29478,0.0648688452351964,0.00399788234896454,0.0570329958312259,0.0727046946391668,5.97232398596587e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0730766344993734,0.00450749847934914,0.0642419374798491,0.0819113315188977,8.43212968594454e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,24845,0.0308269990601668,0.00190198036874218,0.0270991175374321,0.0345548805829015,8.89550480051717e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,29349,0.0791085628993341,0.00488426045851605,0.0695354124006426,0.0886817133980255,9.58477366819082e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.0693190317286528,0.00428150576850253,0.0609272804223879,0.0777107830349178,1.07315592913036e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0443033199104451,0.00273979030345577,0.0389333309156718,0.0496733089052184,1.64736737462455e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0380609608903258,0.00235553460857397,0.0334441130575208,0.0426778087231308,1.7690542218815e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,24805,0.114016520115293,0.00705403346334715,0.100190614527132,0.127842425703453,1.82221412843415e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.158913905773577,0.00984392867890829,0.139619805562917,0.178208005984237,2.5103877158042e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.0791112109165388,0.004912708328163,0.0694823025933393,0.0887401192397383,4.32426126875638e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0480150727106959,0.00298500109353496,0.0421644705673674,0.0538656748540245,5.70146288563687e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,-0.0444833168496687,0.00276626435060487,-0.0499051949768543,-0.0390614387224832,6.22286909965313e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,28835,0.0435127545793453,0.00270795083135562,0.0382051709498883,0.0488203382088023,7.56943171106814e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0422242059698798,0.00263088006298414,0.0370676810464309,0.0473807308933287,1.0144478532892e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,0.0511279576377647,0.00318777641576541,0.0448799158628645,0.0573759994126649,1.19769930926381e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,28797,0.0456151185943666,0.0028486110500003,0.040031840936366,0.0511983962523672,1.83420655087442e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0332638434630564,0.00207810504296927,0.0291907575788366,0.0373369293472761,2.21474481597986e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,24793,0.040532412942237,0.0025347299698552,0.0355643422013208,0.0455004836831532,2.8656738502244e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,0.0222805605885886,0.00139465571463976,0.0195470353878947,0.0250140857892825,3.28969907609797e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,0.145333954177788,0.00909764932163304,0.127502561507387,0.163165346848188,3.31976516130402e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3,Galectin-3,29544,0.0333132340410057,0.00208570060598568,0.0292252608532737,0.0374012072287376,3.46706405820871e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,28705,0.0777969362456567,0.00487493669531705,0.0682420603228353,0.0873518121684781,4.37632912378307e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,29443,0.06210975714588,0.00389497756069204,0.0544756011269236,0.0697439131648364,5.25713803977307e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH3,Cadherin-3,29694,0.0404278366820802,0.00253533753321775,0.0354585751169734,0.045397098247187,5.26392002892127e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,0.0404907660641809,0.00253998157682387,0.0355124021736061,0.0454691299547557,5.67885396560296e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2,Brorin,29114,0.0444734990502961,0.00279224139846297,0.0390007059093087,0.0499462921912835,7.10349120141819e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,29786,0.1049857088091,0.00659743659717243,0.0920547330786416,0.117916684539557,8.81700620234638e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EREG,Proepiregulin,29163,0.0892146444304352,0.00561001665494145,0.07821901178675,0.10021027707412,1.05092144778904e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0245062721889916,0.0015409990490657,0.0214859140528228,0.0275266303251604,1.16781788882533e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0291353545931499,0.00183389332112387,0.0255409236837471,0.0327297855025526,1.34194753860662e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,29353,0.054841587119896,0.00345281744646447,0.0480740649248257,0.0616091093149664,1.42787509237422e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELP,P-selectin,29594,0.0632003785883499,0.00397922729148557,0.0554010930970382,0.0709996640796616,1.43437029417306e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0617874896124344,0.00389168403363025,0.0541597889065191,0.0694151903183497,1.56607201171096e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAN,Brevican core protein,29218,-0.0378165219313882,0.00238215057264697,-0.0424855370537762,-0.0331475068090001,1.62928880858934e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTBDN,Retbindin,29349,0.0329536326046012,0.00207682543236587,0.0288830547571641,0.0370242104520383,1.83386936086164e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,0.042546492580061,0.00268166969039983,0.0372904199868774,0.0478025651732447,1.90226940026783e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL19,Interleukin-19,28654,0.0780127892898642,0.00494093980909877,0.0683285472640306,0.0876970313156978,6.37371861501565e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.0707146894272253,0.00448196620853984,0.0619300356584872,0.0794993431959634,8.27152804557052e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.0800081104141397,0.00508124259767527,0.0700488749226961,0.0899673459055832,1.23517771316918e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,24804,0.065177197320392,0.00413772960487325,0.0570672472948404,0.0732871473459436,1.24063532383362e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,0.0352836354304129,0.00224193502094203,0.0308894427893666,0.0396778280714593,1.54821166607642e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,24240,0.0445159069129956,0.00283683356995167,0.0389557131158903,0.0500761007101009,3.20464752441221e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,0.0590811856700604,0.00376641741603467,0.0516990075346325,0.0664633638054884,3.5387392408763e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,0.104768830782195,0.00670774892206243,0.0916216428949531,0.117916018669438,8.92402017792387e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,0.0862948698087299,0.00552514799625042,0.0754655797360791,0.0971241598813807,9.14034055488509e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,0.132797621886482,0.00851403826543906,0.116110106886221,0.149485136886742,1.39740075291158e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.081526846264066,0.00522746278262833,0.0712810192101145,0.0917726733180175,1.43590454310531e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0366155348637417,0.00235154791353513,0.0320065009532129,0.0412245687742706,1.91739556951233e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,29434,0.0802090801864949,0.0051536148748549,0.0701079950317793,0.0903101653412105,2.11927339611486e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGRN,Neugrin,24845,0.0242700934882523,0.00155956476531925,0.0212133465482266,0.027326840428278,2.3798135777571e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,24111,0.0738926536793326,0.00475668169502193,0.0645695575570896,0.0832157498015756,3.71173933341604e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBN,Nibrin,28931,0.0570253068325675,0.00367496725343264,0.0498223710158396,0.0642282426492955,4.38487305907872e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,0.063233001672097,0.00407502115556005,0.0552459602071993,0.0712200431369947,4.75857183193903e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.10652056435479,0.00686815137561569,0.0930589876585832,0.119982141050997,5.37291124380656e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN5,Contactin-5,29511,-0.0401974151229332,0.002595181078615,-0.0452839700370186,-0.0351108602088478,6.68803316711002e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0346596579113443,0.00223759456809266,0.0302739725578827,0.039045343264806,7.27796344377559e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,29395,0.089735647399646,0.00581265654851488,0.0783428405645568,0.101128454234735,1.47616920734587e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,29218,0.045214045761334,0.00292937132289503,0.0394724779684598,0.0509556135542083,1.55631071505313e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0704367763774465,0.00457563415621227,0.0614685334312704,0.0794050193236225,2.90609217405631e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSF,Cathepsin F,29566,0.0432365362947533,0.00280877623853302,0.0377313348672286,0.048741737722278,2.9200943859615e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO3,R-spondin-3,29725,0.0305544614862086,0.00198758988322559,0.0266587853150864,0.0344501376573307,4.00332389005946e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA9,Serpin A9,29227,0.0778620796898563,0.00507124998278846,0.0679224297235909,0.0878017296561216,5.39660873983656e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,29435,-0.0340612096038398,0.00221891618522342,-0.0384102853268777,-0.0297121338808019,5.65224363309301e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI3,Elafin,29014,0.0592067862724498,0.00385874182178649,0.0516436523017483,0.0667699202431514,6.3177724392301e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,0.0906114089506982,0.00590841623153872,0.0790309131368823,0.102191904764514,7.05273161257323e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,0.0599099564181396,0.00391389153831638,0.0522387290030395,0.0675811838332396,1.10761254443147e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.0305022668105118,0.00199718030962849,0.0265877934036399,0.0344167402173836,1.85283517059134e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0392125396624023,0.00256763831488099,0.0341799685652356,0.044245110759569,2.07403115885892e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS8,Galectin-8,29694,0.0647040638620308,0.00424255178104083,0.0563886623711907,0.0730194653528708,2.55283407796471e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBIN,Erbin,29349,0.109267297358184,0.00717185865697397,0.0952104543905155,0.123324140325853,3.2552636470319e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.0818671464600864,0.00537399375278035,0.0713341187046369,0.0924001742155359,3.33595602959474e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,24732,0.0499012997781958,0.00328170678682265,0.0434691544760234,0.0563334450803682,5.55678163908127e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.101144300551457,0.00665542783982856,0.0880996619853933,0.114188939117521,5.79848597554812e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,0.0776137580628783,0.00511045723457169,0.0675972618831178,0.0876302542426388,6.81699756404118e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREG1,Protein CREG1,29079,0.0403948630201488,0.00266259727464432,0.0351761723618459,0.0456135536784516,8.66344690580154e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.115263163664859,0.00759522351508909,0.100376525575284,0.130149801754433,8.74408065247262e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.101873908461554,0.00671566179446254,0.088711211344407,0.1150366055787,8.90160990153321e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,29218,0.0648794336536926,0.00427746928113015,0.0564955938626775,0.0732632734447077,9.11583092759639e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPSE,Heparanase,24688,0.100057901582526,0.00660744529591025,0.0871073088025423,0.113008494362511,1.43331953668179e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,24845,0.0406793705581988,0.00268669685117035,0.035413444729905,0.0459452963864927,1.47601292091678e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,0.0816843868739584,0.00539579552120434,0.0711086276523979,0.0922601460955189,1.53419194782451e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,24177,0.0465800482610329,0.00307977611666895,0.0405436870723617,0.052616409449704,1.92126697448939e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,0.0273402251818253,0.00180987580965413,0.0237928685949032,0.0308875817687475,2.29529641004641e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,0.0321454694066746,0.00212816662259315,0.027974262826392,0.0363166759869572,2.54964051968522e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH15,Cadherin-15,29639,0.0610753759188169,0.00404767649024441,0.0531419299979378,0.0690088218396959,2.96793894357202e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,24938,-0.0628163411120677,0.00416479926123671,-0.0709793476640917,-0.0546533345600438,3.54305597058185e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,29820,0.0445905699655225,0.00296978391581239,0.0387697934905303,0.0504113464405148,9.01734294417509e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCA2A,Guanylin,29333,0.0360334225140601,0.0023999351547887,0.0313295496106743,0.040737295417446,9.13868127708801e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,29694,0.129202262805544,0.00860709855846613,0.112332349630951,0.146072175980138,9.53708993655283e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A4,Protein S100-A4,29566,0.0597939391038071,0.0039875582827999,0.0519783248695193,0.0676095533380949,1.21382327459826e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,29760,0.0552128969295246,0.00368723880130845,0.0479859088789601,0.0624398849800892,1.65835755001168e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.072900200266897,0.00487382026015086,0.0633475125570013,0.0824528879767927,2.30650945153299e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0420229305455198,0.00281852870588278,-0.0475472468090501,-0.0364986142819896,4.35551625558501e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.043898091107985,0.00294404808201706,0.0381277568672316,0.0496684253487385,4.61070584025131e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.0987778250064731,0.00662734049305464,0.085788237640086,0.11176741237286,4.7019223048452e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAD,Chondroadherin,24381,-0.0545297121336783,0.00365807305850821,-0.0616995353283544,-0.0473598889390022,4.95682292333097e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,29694,0.0677106394238968,0.00454796490619255,0.0587966282077594,0.0766246506400342,5.96501250793196e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,0.0892294134593759,0.00599985678803869,0.0774696941548201,0.100989132763932,7.59692554840859e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.022362226523239,0.00150505446915746,-0.0253121332827876,-0.0194123197636903,9.41521875410977e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0419864128789381,0.00282797045551063,0.0364435907861373,0.047529234971739,1.18885782891682e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,0.0284373185256534,0.00191770298016062,0.0246786206845386,0.0321960163667682,1.43839095498618e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGMN,Legumain,29581,0.0372626052242591,0.00251310758738815,0.0323369143529783,0.0421882960955399,1.47082962816772e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAP,Prosaposin,24761,0.0296664029077226,0.00200273300257065,0.0257410462226842,0.0335917595927611,1.9678120997184e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,0.0691338661359591,0.00466753599676448,0.0599854955823007,0.0782822366896175,2.0031732181898e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,29468,-0.0400456791938726,0.00270650382433485,-0.0453504266895688,-0.0347409316981763,2.33572833903421e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.0751545871550778,0.00507917759992348,0.0651993990592278,0.0851097752509279,2.50271479461312e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0655626046624017,0.00443254553547913,0.0568748154128626,0.0742503939119408,2.70798100780809e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.117518542163542,0.00794548584012167,0.101945389916903,0.13309169441018,2.75282067486669e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,24845,0.0654169060472364,0.00444165461190783,0.0567112630078971,0.0741225490865758,6.84952047765961e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,29497,0.0248832533327027,0.00169018842068316,0.0215704840281637,0.0281960226372417,6.92935316463841e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTR,Transthyretin,24707,0.0262375975844303,0.00178650393454749,0.0227360498727172,0.0297391452961434,1.26098461286953e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0549434954182772,0.00374403331424377,0.0476051901223595,0.062281800714195,1.38991537943982e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,24111,0.049328809824389,0.00336019406907219,0.0427428294490075,0.0559147901997705,1.39706516261777e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL8,Interleukin-8,29218,0.0697176826751563,0.00475394835539158,0.0603999438985888,0.0790354214517238,1.60258054698457e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA4,Kallistatin,24557,0.0246654754718353,0.00168239781538286,0.0213679757536849,0.0279629751899857,1.83980127833512e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0363521065596608,0.00247964653021851,0.0314919993604326,0.0412122137588891,1.87078984076976e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,24229,0.0361770690178478,0.00246826864378173,0.0313392624760356,0.04101487555966,1.96415652232655e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0386575869091746,0.00264237994888049,0.0334785222093688,0.0438366516089803,2.69807235107627e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,29349,0.0565345123415968,0.00386445060271223,0.0489601891602808,0.0641088355229127,2.70031629126682e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA,Adenosine deaminase,29786,0.035665118548496,0.00243971023200217,0.0308832864937717,0.0404469506032203,3.14259636559116e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0669742519715858,0.00458549160384376,0.0579866884280521,0.0759618155151196,4.12666047247927e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM3,Dynamin-3,24867,0.0564313264360264,0.00386668602175344,0.0488526218333897,0.0640100310386632,4.83158591414464e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.0724242801202905,0.00496743035304367,0.0626881166283249,0.082160443612256,5.54399765989435e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0519855076284126,0.00356689745720526,0.0449943886122903,0.0589766266445349,6.05741522652892e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,-0.0537091880370693,0.00368804759280042,-0.0609377613189581,-0.0464806147551805,7.08538571315845e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,24951,0.0655222947132498,0.00450118917345491,0.0566999639332782,0.0743446254932214,8.3243129880581e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,28797,0.039089525062102,0.00268811781272122,0.0338208141491684,0.0443582359750356,9.75445517803372e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.0682387902009126,0.00469357968973114,0.0590393740090396,0.0774382063927857,1.01684532218419e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,-0.0264261611000073,0.00182288117221778,-0.0299990081975541,-0.0228533140024604,1.83930828215939e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0445354679965767,0.00307247999789508,-0.0505575287924511,-0.0385134072007024,1.90042230723564e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,29566,0.0569668217783027,0.00393055229544847,0.0492629392792237,0.0646707042773817,1.94243400481314e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,29411,0.0613746499350333,0.0042417018858014,0.0530609142388626,0.0696883856312041,2.75252433781018e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,29725,0.0611795501852102,0.00422939211201877,0.0528899416456534,0.069469158724767,2.90532849490256e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.0677398936052602,0.00468359661943556,0.0585600442311665,0.0769197429793539,3.03084931888852e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,28797,0.0622040354117931,0.00430529740346913,0.0537656525009936,0.0706424183225926,3.76085342051169e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,0.0584768590000786,0.0040504129226731,0.0505380496716393,0.0664156683285179,4.40779084049473e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.058945818876778,0.00408452063846241,0.0509401584253917,0.0669514793281644,4.79011406259536e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST7,Cystatin-F,29498,0.0940680165738766,0.0065230117464035,0.0812829135509258,0.106853119596828,5.5228941895129e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPPK1,Epiplakin,24240,0.0748843997474274,0.00519808077307149,0.0646961614322073,0.0850726380626475,7.39448127484062e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,0.086565022696014,0.00601041140070877,0.0747846163506248,0.0983454290414032,7.71390790220766e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON2,Spondin-2,29311,0.0351974433412342,0.0024447318493072,0.0304057689165921,0.0399891177658763,7.78165653342217e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,29694,0.0269265783722308,0.00187170812179562,0.0232580304535113,0.0305951262909502,9.09141920059366e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSE,Cathepsin E,24381,0.0530378619080923,0.00368768696138682,0.0458099954637742,0.0602657283524105,1.03674802977674e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,29218,0.0524270076096914,0.00365021027279959,0.0452725954750042,0.0595814197443786,1.27850647239968e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,29674,0.0521991271852494,0.00363508466252485,0.0450743612467007,0.0593238931237981,1.32580188188123e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,29434,0.0920633879783588,0.00641137474362674,0.0794970934808504,0.104629682475867,1.33784901358578e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,0.125846950524553,0.00876895170880456,0.108659805175296,0.14303409587381,1.49671145768783e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,29174,0.0586348586796647,0.00409051015544958,0.0506174587749835,0.0666522585843459,1.92022883624963e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.0839134549493606,0.00585485596765633,0.0724379372527542,0.095388972645967,2.12401049521307e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,-0.0243311652766496,0.00169972401335029,-0.0276626243428162,-0.020999706210483,2.52776086802646e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN1,Contactin-1,29820,-0.0273721255871396,0.0019126462230704,-0.0311209121843576,-0.0236233389899216,2.6556921858331e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM1,Isthmin-1,29434,0.0393783515518716,0.00275248503871412,0.033983480875992,0.0447732222277513,2.85137948992814e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,29566,0.0829017523533309,0.00579574204460183,0.0715420979459113,0.0942614067607505,2.95306390307711e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,24381,0.051158814757213,0.00357544246817784,0.0441509475195844,0.0581666819948415,2.98706836958043e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0712989241833974,0.00498552039667608,0.0615273042059123,0.0810705441608826,3.08235016099225e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,24867,0.105458646806178,0.00737443905729889,0.0910047462538718,0.119912547358483,3.31151216624681e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.044735139164283,0.0031296080953148,0.038601107297466,0.0508691710311,3.42557372733785e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,0.0636156436449991,0.00445107147675137,0.0548915435505664,0.0723397437394318,3.73022728112426e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.0908709130109269,0.00635926457877402,0.0784067544365298,0.103335071585324,3.87665390383443e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSB,Cathepsin B,29480,-0.0525456653344418,0.00367908054770861,-0.0597566632079507,-0.0453346674609329,4.02417744076391e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,0.0541626449380575,0.00379562013742113,0.0467232294687121,0.0616020604074029,4.84222250054274e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,29566,0.0555281125876762,0.00389523175866503,0.0478934583406927,0.0631627668346596,5.89438224207299e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.105793318693659,0.00742961953950604,0.0912312643962275,0.120355372991091,7.41254809707839e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,29434,0.0852024689334344,0.00598481619796006,0.0734722291854326,0.0969327086814361,7.73102905597541e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,0.137025143144738,0.00962599058756335,0.118158201593114,0.155892084696362,7.90838075233466e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,24845,0.0665732665892641,0.00467917359086235,0.0574020863511738,0.0757444468273543,9.35172063589956e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXIN1,Axin-1,29434,0.0946565549665704,0.00665923818885929,0.0816044481164062,0.107708661816735,1.05829292732859e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,29674,0.057169409743414,0.00402256399187233,0.0492851843193442,0.0650536351674838,1.0878585772397e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,24805,0.0847719346406917,0.00596297083253605,0.0730845118089211,0.0964593574724624,1.09645278847482e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,29478,0.0532232855624663,0.00374749069737333,0.0458782037956145,0.060568367329318,1.25293659690303e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOST,Sclerostin,29433,0.0385249174534859,0.00271269875759419,0.0332080278886012,0.0438418070183705,1.26584292550147e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0570052076041827,0.0040154756581677,0.049134875314174,0.0648755398941913,1.37336184063398e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,0.0642759160237149,0.00453272643976696,0.0553917722017716,0.0731600598456581,1.71217005848828e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,29786,0.0268838864014101,0.00189674987155779,0.0231662566531569,0.0306015161496634,1.87508738444569e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPO,Myeloperoxidase,29443,0.0455804648906987,0.00321729894112526,0.0392745589660932,0.0518863708153042,2.05945345785537e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0615679897544962,0.00434509057797237,0.0530516122216703,0.070084367287322,2.12305088086976e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0435949199777694,0.00307810536502674,0.037561833462317,0.0496280064932219,2.35903662747168e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0315890926501911,0.00223131747206801,0.0272157104049378,0.0359624748954444,2.55828278600207e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,29218,0.0352695130071412,0.00249437554427767,0.0303805369403569,0.0401584890739254,3.05343401515384e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,29581,0.104486324757712,0.00739739968931184,0.089987421366661,0.118985228148763,3.75077976932661e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0310015579765564,0.002195789991587,0.0266978095930459,0.0353053063600669,4.09856739087198e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,24922,0.0741035247405548,0.00526172955472803,0.0637905348132879,0.0844165146678218,7.13431882973084e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.0685007390158328,0.00486545730862685,0.0589644426909242,0.0780370353407414,7.69005061855663e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,29434,0.0656833034199212,0.00466730573482653,0.0565353841796612,0.0748312226601812,7.77458850122054e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAN,Neurocan core protein,29694,-0.0368604368110037,0.00261941065798473,-0.0419944817006537,-0.0317263919213536,7.86510754347401e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,24195,0.0450180743719631,0.0031980407059288,0.0387499145883426,0.0512862341555835,7.93403702200738e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0291509035722321,0.0020743783553976,0.0250851219956528,0.0332166851488114,1.03255043154509e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,29694,0.0296081123930183,0.00210767473390515,0.0254770699145642,0.0337391548714724,1.10579265387111e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.043523139150022,0.00309886830941022,0.037449357263578,0.049596921036466,1.15662882555865e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,29414,0.0894368422500846,0.00637249030026329,0.0769467612615685,0.101926923238601,1.32964354468885e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,24966,0.0168830400684541,0.00120411374711347,0.0145229771241117,0.0192431030127965,1.70810809050234e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0562431528399045,0.00401394095482274,0.0483758285684519,0.0641104771113571,1.83111230419272e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.0764810176198802,0.00546734886429353,0.0657650138458649,0.0871970213938955,2.55354738850929e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,29478,0.0258198142384289,0.00184669987996554,0.0222002824736964,0.0294393460031614,2.79754981414415e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.0708120236110237,0.00506863696290396,0.060877495163732,0.0807465520583155,3.26202758631913e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,28797,0.0283666446589804,0.00203215476688404,0.0243836213158877,0.0323496680020731,3.86893383139816e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,0.0849130237361864,0.0060913997140108,0.0729738802967253,0.0968521671756476,5.00820481932245e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN3,Perilipin-3,29478,0.041528699822468,0.00298706185907995,0.0356740585786713,0.0473833410662648,8.37198911611802e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,29434,0.0790409199329321,0.00568661776387405,0.067895149115739,0.0901866907501252,8.78055071934447e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL32,Interleukin-32,29434,-0.0424136588566865,0.00305274743596003,-0.0483970438311681,-0.0364302738822048,9.52417685556133e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,24922,0.0977727318891715,0.00703673674595315,0.0839807278671033,0.11156473591124,9.94663445291205e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB2,Calretinin,28774,0.0297235990480641,0.00214087876483949,0.0255274766689787,0.0339197214271495,1.09858564323328e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0328617586796395,0.00236700646453952,-0.037501091350137,-0.028222426009142,1.09861672829383e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,29320,0.0408270940140824,0.00294227475874377,0.0350602354869446,0.0465939525412202,1.21666653155699e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0813747503150426,0.00586596135936137,0.0698774660506943,0.0928720345793908,1.35594334539204e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,0.0723736150091648,0.00522735422605329,0.0621280007261003,0.0826192292922292,1.86271900297614e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0460363282973662,0.0033305454310583,0.0395084592524919,0.0525641973422405,2.70143563839531e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.0276133813208193,0.00199892494406734,0.0236954884304474,0.0315312742111913,3.03066447914155e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0671201910733875,0.00486477367168984,0.0575852346768754,0.0766551474698995,3.615605311883e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0558871141062962,0.00405146100855134,0.0479462505295356,0.0638279776830568,3.76695024799856e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0776415923345267,0.005627128939577,0.0666124196129558,0.0886707650560976,3.83237399373272e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN4,Nectin-4,29566,0.0308431670488468,0.00224159027703787,0.0264496501058526,0.035236683991841,6.0592721234336e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,0.0480647824042966,0.00349225935767381,0.0412199540632559,0.0549096107453372,6.15505752508695e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK11,Kallikrein-11,29296,0.0297384218606385,0.00216349776898634,0.0254979662334253,0.0339788774878517,7.36194700583782e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,-0.0407168956238777,0.00296527156147767,-0.0465288278843739,-0.0349049633633815,8.93018122828061e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNG,Interferon gamma,28931,0.109503204855804,0.00797853176618348,0.093865282594084,0.125141127117523,9.83038515967279e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,29694,0.0281715837870343,0.00205277845127316,0.0241481380225389,0.0321950295515297,9.90060028380421e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0283696210193281,0.00206715285841649,0.0243180014168318,0.0324212406218244,9.90904889628564e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2,Complement C2,29545,0.0224870480951125,0.00163909632018245,0.0192744193075549,0.0256996768826701,1.05408246001026e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0650733493513783,0.00474693869672651,0.0557693495057943,0.0743773491969622,1.30018167095553e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.022391394773591,0.00163439386560203,0.019187982797011,0.025594806750171,1.37291566125985e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0392178872775025,0.00286431673097414,0.0336038264847932,0.0448319480702118,1.62045761298951e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15,Interleukin-15,29434,0.0314301302044596,0.00230025323406202,0.026921633865698,0.0359386265432211,2.25140053495324e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,29349,0.0860001129340689,0.00629669594275836,0.0736585888862625,0.0983416369818753,2.43877209676166e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.0744455395550767,0.00545699654431392,0.0637498263282214,0.085141252781932,3.18883675949678e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.062462366166923,0.0045813610653856,0.0534828984787672,0.0714418338550788,3.36900737400426e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.0661551332473202,0.00486319224150465,0.0566232764539711,0.0756869900406693,5.16108456203781e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,29443,0.0323200755012317,0.00237745671027854,0.0276602603490857,0.0369798906533776,5.78984721088472e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,24793,0.0203702636324011,0.0014982097287344,0.0174337725640817,0.0233067547007205,5.9496830422882e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0311517315130955,0.00229844829262186,0.0266467728595567,0.0356566901666344,1.00824146598977e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,29725,0.104677788808978,0.00773933234591974,0.0895086974109758,0.119846880206981,1.46980048659765e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,29395,0.0628426336913585,0.00466324078016068,0.0537026817622436,0.0719825856204735,2.86564822680236e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,-0.0336842881108024,0.00249987887546757,-0.0385840507067188,-0.0287845255148859,2.93265875367003e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.0707689104970037,0.0052512758025109,0.0604764099240823,0.0810614110699251,3.02820666354055e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,29674,0.0292203414517193,0.00216931082201004,0.0249684922405796,0.0334721906628589,3.11102746195743e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0725361975130178,0.00538502828325926,0.0619815420778297,0.083090852948206,3.28112725185435e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,24195,0.0463070352989441,0.0034404745818325,0.0395637051185524,0.0530503654793358,3.8093460052986e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,29786,0.0222227678309131,0.00165208551222412,0.0189846802269538,0.0254608554348723,3.98758491863713e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,0.0736005447044173,0.00546988173859675,0.0628795764967677,0.0843215129120669,4.01173559229474e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.0917722377114501,0.00682654204594786,0.0783922153013923,0.105152260121508,4.44874212287468e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.0272317167113503,0.00202632207215447,-0.0312033079727731,-0.0232601254499276,4.7062355766605e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0219518952696581,0.00163443417217044,0.018748404292204,0.0251553862471121,5.25332066570029e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0550619934350139,0.00409997500089252,0.0470260424332646,0.0630979444367632,5.65638889758513e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C3,Complement C3,23779,0.0441465541187921,0.00328944532755631,0.0376992412767818,0.0505938669608025,6.44999188677461e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0464294379155345,0.00346447402980017,0.0396390688171261,0.0532198070139428,7.78140164007824e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,24421,0.0362912224222259,0.00270860160114972,0.0309823632839725,0.0416000815604794,8.59937094132367e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0215086641953739,0.00160565573400531,0.0183615789567235,0.0246557494340243,8.88369173297076e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,0.0273140070233166,0.00204881761600861,0.0232983244959397,0.0313296895506935,1.99434210892891e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,29434,0.0855368458528636,0.0064178952103237,0.0729577712406292,0.0981159204650981,2.08809831209838e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,24867,0.0732071883745376,0.00549549380969392,0.0624360205075375,0.0839783562415377,2.39368143440874e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0475937077846034,0.00357577347396466,0.0405851917756326,0.0546022237935741,2.78267837940224e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDN1,Endothelin-1,24240,0.0274015009384828,0.00206009476839683,0.023363715192425,0.0314392866845406,3.15754277139315e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,0.0676274439733108,0.00509807897365628,0.0576352091849444,0.0776196787616771,5.03577407970319e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,29329,0.0728101840297323,0.005493038116937,0.0620438293205357,0.0835765387389288,5.50348945913252e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0180658677538212,0.00136647736648777,0.0153875721155052,0.0207441633921373,8.65439912472868e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,24381,0.0504668990003547,0.00381789587911415,0.042983823077291,0.0579499749234185,9.40404403061227e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.095955586576253,0.00726974394824991,0.0817068884376832,0.110204284714823,1.14820854610389e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0468695586349831,0.00355697553511996,0.0398978865861479,0.0538412306838182,1.54477190345245e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0529700563653455,0.0040223494035393,0.0450862515344084,0.0608538611962825,1.72328481354401e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0361158952168004,0.00274478411984611,0.030736118341902,0.0414956720916988,1.97356228157943e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,24240,0.0211919144335056,0.00161245662442258,0.0180314994496373,0.0243523294173739,2.55772804370137e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,0.0702972100174705,0.00535772449300843,0.059796070011174,0.080798350023767,3.38257291134538e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX8,Syntaxin-8,29434,0.0444189746593174,0.00338811897193939,0.0377782614743162,0.0510596878443186,3.70607491424392e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,0.0180265032102932,0.00137480046907163,0.0153318942909128,0.0207211121296736,3.78506545070128e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,29820,-0.0276540364986054,0.0021115224962395,-0.0317926205912348,-0.023515452405976,4.40815663077619e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,0.0695336838971514,0.00530945462069425,0.0591271528405907,0.0799402149537121,4.47323561090279e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,29434,0.0339921061687789,0.00259722542430878,0.0289015443371337,0.0390826680004241,4.96736930706846e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.059643870903656,0.00455850708353708,0.0507091970199233,0.0685785447873887,5.46803089130852e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0342412861839449,0.00261733467386357,0.0291113102231723,0.0393712621447175,5.61078918320992e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,24845,0.0757693345212113,0.00579549609751914,0.0644101621700738,0.0871285068723488,6.24850986992379e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPL,Periplakin,24229,0.0301825501401179,0.00230907608864142,0.0256567610063807,0.0347083392738551,6.50983483479326e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,0.053962906688541,0.00413468951459953,0.0458589152399259,0.062066898137156,7.99024074822149e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0298289667282326,0.00228579547543232,0.0253488075963853,0.03430912586008,8.18331234955993e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0582060559230481,0.00446004420540677,0.0494643692804508,0.0669477425656454,8.45529768543643e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,0.0240347094321103,0.00184186523353616,0.0204246535743795,0.0276447652898412,8.615729480911e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,24229,0.0305078783789424,0.00233797237046822,0.0259254525328247,0.0350903042250601,8.71952676348149e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES2,Cocaine esterase,29349,0.0500031392745512,0.00383388640741351,0.0424887219160207,0.0575175566330816,9.00027543200628e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,0.0557441543139185,0.00427771698043437,0.0473598290322672,0.0641284795955699,1.08787901700134e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,24845,0.0424096597109913,0.00325612778663304,0.0360276492491905,0.0487916701727921,1.18757850022995e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,0.0614436840420758,0.00472234774859422,0.0521878824548311,0.0706994856293204,1.3457771557643e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0441522646418061,0.00339594208886053,0.0374962181476394,0.0508083111359727,1.60434165038151e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,29820,0.0507658355089179,0.00390727459296162,0.0431075773067131,0.0584240937111226,1.71382618732616e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0887664304134712,0.00683485543238746,0.0753701137659918,0.102162747060951,1.84260869098951e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0409198848102529,0.00315051331529168,0.0347448787122812,0.0470948909082246,1.91591547061573e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0273647524297508,0.00210902771132936,0.0232310581155452,0.0314984467439563,2.16024314162647e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP10,Caspase-10,28774,0.0649646589349058,0.00501085866736523,0.05514337594687,0.0747859419229417,2.4822875774207e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,28954,0.0376951294428647,0.00290968812942955,0.0319921407091828,0.0433981181765467,2.81177651501316e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,0.0652109643272401,0.0050349044971372,0.0553425515128511,0.075079377141629,2.91246262287485e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.051795723744364,0.00400193904403179,0.0439519232180617,0.0596395242706663,3.30528517848823e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,29443,0.0242798437472537,0.00187712099194365,0.0206006866030442,0.0279590008914633,3.64799884692433e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCTN3,Tectonic-3,24922,0.0271426044589906,0.00210012900580849,0.023026351607606,0.0312588573103752,4.35520425405236e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,28774,0.0422721491990285,0.00327163002265486,0.035859754354625,0.0486845440434321,4.38464023561239e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALCAM,CD166 antigen,29820,0.0177428557115738,0.00137358534074662,0.0150506284437104,0.0204350829794372,4.55658008597074e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,0.0804464492692902,0.00622676921354995,0.0682419816107323,0.0926509169278481,4.63789139752312e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNXB,Tenascin-X,29443,-0.0233391685595453,0.00181109804321839,-0.0268889207242533,-0.0197894163948373,6.76897397584881e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,0.0774884188392876,0.00601527623313722,0.0656984774223387,0.0892783602562366,7.20257778242493e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,0.0560051042586805,0.0043477845681501,0.0474834465051063,0.0645267620122547,7.24029884372022e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.054033872764712,0.00419467587720283,0.0458123080453944,0.0622554374840295,7.2695940112938e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0363484145922515,0.002825329790553,0.0308107682027677,0.0418860609817354,9.33443937670861e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,0.0225402042849638,0.00175308438831843,0.0191041588838597,0.0259762496860679,1.02979370373727e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0515583786915686,0.00401263300316006,0.0436936180053749,0.0594231393777623,1.15695724688126e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,28719,0.0414033430073637,0.00322326313380295,0.0350857472651099,0.0477209387496174,1.16283310125013e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.103215133270346,0.0080347119797156,0.0874670977901029,0.118963168750588,1.19229591775284e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0330565373814462,0.00257351528487588,0.0280124474230894,0.0381006273398029,1.22115627602832e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0381273783087332,0.00297639492086728,0.0322936442638333,0.043961112353633,1.90597657033042e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,24845,0.0526105647728712,0.00410811854446734,0.0445586524257152,0.0606624771200272,1.98130512522664e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,24229,0.0367681595577389,0.00287316164367268,0.0311367627361405,0.0423995563793374,2.24935216980214e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,29443,0.0516003223666799,0.00403438534086611,0.0436929270985823,0.0595077176347775,2.34123175193414e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID1,Nidogen-1,29518,0.0340018044066355,0.00266421459281541,0.0287799438047173,0.0392236650085537,3.3348966736472e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0314729054426395,0.00246908968114244,0.0266334896676004,0.0363123212176787,4.09059212430202e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0427124311873634,0.00335045595425163,0.0361455375170302,0.0492793248576966,4.16749183234407e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.0755226229262715,0.0059327783633123,0.0638943773341794,0.0871508685183636,5.27595046556901e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0339558178492733,0.0026723536042901,0.0287180047848647,0.0391936309136819,6.82273696569449e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0641369068090547,0.00505191284181964,0.0542351576390882,0.0740386559790212,7.84826598864796e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,28774,0.0463256999852094,0.00365064083597054,0.0391704439467071,0.0534809560237117,8.46116677437579e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK2,Docking protein 2,29478,0.108087969003831,0.0085325938034271,0.0913640851491137,0.124811852858548,1.1137447319007e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0490139808985497,0.00386957621130562,0.0414296115243907,0.0565983502727087,1.17793607616518e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,24845,0.0496437440106206,0.00392422604759224,0.0419522609573398,0.0573352270639014,1.44017232497364e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,0.0649852853519516,0.00514001532319714,0.0549108553184852,0.075059715385418,1.58352437928562e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0239418846716865,0.00189531847618183,0.0202270604583701,0.0276567088850029,1.74804704281086e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,29434,0.06019509631917,0.00476642426316431,0.0508529047633679,0.069537287874972,1.81767456349686e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0540975785178494,0.00428471898010969,0.0456995293168344,0.0624956277188644,1.89468662750491e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN2,Centrin-2,28774,0.0597094567770768,0.00473347091294693,0.0504318537877008,0.0689870597664528,2.19879898429249e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,29163,0.0563926062023432,0.0044764338812743,0.0476187957950456,0.0651664166096408,2.70454665507369e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0537686790927204,0.00426800647657798,0.0454033863986275,0.0621339717868132,2.79865330598528e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0253115921614313,0.00200921813245619,0.0213735246218172,0.0292496597010454,2.80390910210599e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GET3,ATPase GET3,24922,0.0489655692194337,0.00388699878904703,0.0413470515929016,0.0565840868459659,2.82032044993154e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,24805,0.0318376317431539,0.00252786408283581,0.0268830181407957,0.0367922453455121,2.91739265660107e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0515693347907721,0.00409922754829306,0.0435348487961177,0.0596038207854265,3.36640370964861e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,28990,-0.0264994849105562,0.00210664682344603,-0.0306285126845104,-0.022370457136602,3.42636392972825e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,24793,0.0426967635583726,0.00339361023348994,0.0360452875007323,0.0493482396160129,3.44337374667617e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.055215994368991,0.00439245781028944,0.0466067770608237,0.0638252116771583,3.78569574594717e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0425724862215689,0.0033880411382271,0.0359319255906438,0.049213046852494,4.23494229989225e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,24805,0.0609174312068483,0.00484837812439904,0.0514146100830262,0.0704202523306704,4.26436119255361e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,29443,0.0242406239457319,0.001932503902379,0.020452916297069,0.0280283315943947,5.32615594211795e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0479420363966502,0.00383260152733262,0.0404301374030783,0.0554539353902222,8.59181104189104e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,29632,0.0521123772857764,0.00416744114445959,0.0439441926426356,0.0602805619289172,8.67173615829136e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,29536,0.0276413917916382,0.00221295706977437,0.0233039959348804,0.031978787648396,1.03311967209479e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,24845,0.0662989055639654,0.00530988971899364,0.0558915217147378,0.0767062894131929,1.14037507123857e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,24111,0.0697183636414616,0.00558948093896578,0.0587629810010887,0.0806737462818345,1.34777556288444e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX4,Syntaxin-4,29349,0.0518724314919141,0.00416302556502095,0.0437129013844731,0.0600319615993552,1.51278083722193e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,29786,-0.00777524165489623,0.00062406246806996,-0.00899840409231335,-0.00655207921747911,1.53087360644803e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.0901781591744627,0.00724658366024358,0.0759748552003853,0.10438146314854,1.9294501208143e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,29446,0.0378748266556373,0.0030449009984633,0.0319068206986492,0.0438428326126253,1.97632703082473e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN3,Ataxin-3,24845,0.0541198355849629,0.00435116240082365,0.0455915572793486,0.0626481138905773,2.07193993464309e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,24922,0.0564394890771942,0.00454092615353365,0.0475392738162683,0.0653397043381202,2.31407548811813e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA10,Annexin A10,28774,0.0715750722803209,0.00576180419375739,0.0602819360605564,0.0828682085000854,2.43638018237929e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,29478,0.0338869257432684,0.00272872446072971,0.0285386258002382,0.0392352256862986,2.53973376568857e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0388751020620611,0.00313015012208368,0.0327400078227771,0.0450101963013451,2.61643797812034e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.0188029231737309,0.00151407998089753,0.0158353264111717,0.0217705199362901,2.63492561033792e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,29581,0.0670921919163285,0.0054066692376646,0.0564951202105059,0.0776892636221511,2.85393096943368e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.0789195898020137,0.00636397958038554,0.0664461898244581,0.0913929897795694,3.30235553281935e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,-0.0263126274442118,0.00212287737498916,-0.0304734670991906,-0.0221517877892331,3.41071017949968e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0636281518909999,0.00513934549689616,0.0535550347170834,0.0737012690649163,4.07073693302233e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0338828046409664,0.00273746212995625,0.0285173788662521,0.0392482304156806,4.2325818568611e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.026385559542912,0.0021318324105758,0.0222071680181834,0.0305639510676405,4.24962694072815e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,24951,0.0413055187869718,0.00333792977552353,0.0347631764269457,0.0478478611469979,4.54727220999163e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,0.0516864310845211,0.00417823278373945,0.0434970948283918,0.0598757673406504,4.63604729560975e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASC3,Protein CASC3,24195,0.0366236418023819,0.00296197775310561,0.0308181654062949,0.0424291181984689,5.18433218257801e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0230645303408607,0.0018654955210908,-0.0267209015621986,-0.0194081591195227,5.20037705261976e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0491551830745171,0.0039801108784587,0.0413541657527381,0.0569562003962962,5.93169918803054e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZN,Kazrin,24805,0.0907507676601363,0.00734878381029995,0.0763471513919484,0.105154383928324,6.24202085697526e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,24793,0.0354846176817888,0.0028735437568621,0.0298524719183391,0.0411167634452385,6.27024767702553e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0540916367133207,0.00438475118728798,0.0454975243862362,0.0626857490404051,7.35845424300584e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.0968464000287837,0.00786783103966151,0.0814254511910471,0.11226734886652,9.84631417849778e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A12,Protein S100-A12,29023,0.0648373129778116,0.00527169184201195,0.0545047969674682,0.075169828988155,1.11702394952322e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,0.0696278542505052,0.00566112369257481,0.0585320518130586,0.0807236566879518,1.15995980167072e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,24229,0.0475031343172892,0.00386375858930657,0.0399301674822483,0.0550761011523301,1.22948148465508e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17C,Interleukin-17C,28931,0.0607109162227135,0.00494406085818582,0.0510205569406693,0.0704012755047577,1.42228545931725e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN3,CCN family member 3,29795,0.0291813414948806,0.00237674303677697,0.0245229251427978,0.0338397578469635,1.44393328611442e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0460885632036611,0.00376116017317849,0.0387166892642313,0.0534604371430909,2.02292818544003e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.0957968958989949,0.00782191750287964,0.0804659375933508,0.111127854204639,2.11206389964828e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.0672411737117282,0.00549318601900803,0.0564745291144724,0.0780078183089839,2.28382231138926e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,29645,0.0423347537552894,0.00346081337964217,0.0355515595311908,0.0491179479793881,2.51918612197057e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,0.0672667983561634,0.00551216600132621,0.056462952993564,0.0780706437187627,3.75379424809487e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC3B,Tetranectin,24381,-0.0184370999537591,0.00151208026406699,-0.0214007772713304,-0.0154734226361878,4.24786279862466e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0309079247465099,0.00253510525112653,0.0259391184543019,0.0358767310387179,4.31840513798025e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0302953777641705,0.00248631091939496,0.0254222083621564,0.0351685471661846,4.52269183101749e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,24793,0.034001067283364,0.00279017238876884,0.0285323294013771,0.039469805165351,4.61981121193244e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,29322,0.0719366455232582,0.00591270240666707,0.0603477488061908,0.0835255422403257,5.66443961971521e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREH,Trehalase,24938,0.0641077837212522,0.00527967839660219,0.0537596140639119,0.0744559533785925,7.84860332900726e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0890562815078028,0.00733921563271023,0.0746714188676907,0.103441144147915,8.38279689564415e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,29384,0.0965789558900363,0.00797948073509279,0.0809391736492544,0.112218738130818,1.21841341928426e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,24229,0.0372594925481158,0.00307965579924478,0.031223367181596,0.0432956179146355,1.34324879958154e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0463379082152485,0.00383607702419151,0.0388191972478331,0.0538566191826639,1.63234665344227e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH17,Cadherin-17,29478,0.0576475836983982,0.00477344170395473,0.048291637958647,0.0670035294381495,1.68219733321588e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,24793,0.070569186924592,0.00584349889407131,0.0591159290922123,0.0820224447569718,1.7452732234573e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,24240,0.0454313355254405,0.00376780698585087,0.0380464338331728,0.0528162372177083,2.19994026545423e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0651602446843637,0.00540495709508514,0.0545665287779968,0.0757539605907305,2.25696883554761e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0734153202406852,0.00608996916690193,0.0614789806735574,0.085351659807813,2.25916521938287e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0202421070900565,0.00167995609114206,-0.0235348210286949,-0.0169493931514181,2.34539153381282e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD2,Polycystin-2,24111,0.0501358632487426,0.00416026957556504,0.0419817348806351,0.0582899916168501,2.3866962124538e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,24240,0.0653248406677389,0.00542603064654734,0.0546898206005061,0.0759598607349717,2.75332180392933e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,24016,0.0433101710006948,0.00359782507887013,0.0362584338461093,0.0503619081552803,2.80188630506467e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0566572394872593,0.00471495535444907,0.0474159269925391,0.0658985519819795,3.49551497032979e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNST,Consortin,29478,0.0911887355512537,0.00759794124716459,0.0762967707068111,0.106080700395696,4.1550046147945e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,24805,0.0500852158285222,0.00417391365828563,0.0419043450582824,0.058266086598762,4.41055841918553e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,29683,0.050879865409663,0.00424201169620486,0.0425655224851015,0.0591942083342245,4.54101354040044e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,29163,0.0268175123207556,0.00223794056169587,0.0224311488198317,0.0312038758216795,5.20851238818712e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,29566,0.0576842147460194,0.0048140348158692,0.0482487065069158,0.0671197229851231,5.23419909191177e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.0660055509782363,0.00551121479819456,0.055203569973775,0.0768075319826977,5.64645426378864e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,0.0278921272674216,0.00233183201906331,0.0233217365100575,0.0324625180247857,6.74257444074142e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.0605464348914717,0.00506263401946661,0.0506236722133172,0.0704691975696263,7.16070538498666e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,0.0734899016982114,0.00614547854012459,0.0614447637595672,0.0855350396368556,7.26486744255501e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.123670636840317,0.0103479491586887,0.103388656489287,0.143952617191347,7.87546861262596e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,29434,0.0682628062552988,0.00571899404701722,0.057053577923145,0.0794720345874525,9.12914019269942e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPBP,Platelet basic protein,24816,0.0711573262618341,0.00596339959748047,0.0594690630507724,0.0828455894728959,9.86878568369535e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,29166,0.0588163842291782,0.00493413782100856,0.0491454741000014,0.068487294358355,1.10522850334487e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LARP1,La-related protein 1,24793,0.0528111671181636,0.00442971247235563,0.0441289306723466,0.0614934035639807,1.11641356959391e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK10,Kallikrein-10,29466,0.0334165212754482,0.00280390472666703,0.0279208680111808,0.0389121745397156,1.13595094196748e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,28797,0.0492834344483709,0.00414079961064962,0.0411674672114976,0.0573994016852441,1.37947050674037e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0295367729568654,0.00248388452492923,0.0246683592880041,0.0344051866257267,1.60916656018982e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.0670480535937172,0.00564285048802709,0.0559880666371841,0.0781080405502503,1.79890120681631e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMH,Granzyme H,28916,0.0637732272269498,0.00537086465882909,0.0532463324956448,0.0743001219582548,1.92402328682164e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGN,Biglycan,28750,-0.100041618609524,0.00842850120333299,-0.116561480968057,-0.0835217562509912,2.03134036412175e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SBSN,Suprabasin,24905,-0.0288539969872351,0.00243116845595797,-0.0336190871609127,-0.0240889068135575,2.1135402199421e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN2,Matrilin-2,29497,0.0247807219497122,0.0020890031594808,0.0206862757571299,0.0288751681422946,2.19746664971999e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0448511227215688,0.00378563645776692,0.0374312752643456,0.052270970178792,2.71263427753327e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0282331245595755,0.00238378956577112,0.0235608970106641,0.0329053521084869,2.73844781607183e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.0628375003623583,0.00530674351143534,0.0524362830799451,0.0732387176447716,2.83654459981764e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,24867,0.0461350909522816,0.00389806779516817,0.038494878073752,0.0537753038308112,3.12744910872636e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,29396,0.0215436425987851,0.00182146578974292,0.0179735696508889,0.0251137155466812,3.3243749776665e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,24805,0.0282550832193156,0.00238967118530309,0.0235713276961215,0.0329388387425096,3.58723614948224e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,0.0662326010087486,0.00560376769263,0.0552492163311938,0.0772159856863034,3.66811331160375e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.07321310898544,0.00619641857045654,0.0610681285873452,0.0853580893835348,3.84466889000443e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,0.0399555527703644,0.00338204297834118,0.0333267485328157,0.0465843570079131,4.02881874253467e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,0.0216000655662242,0.00183032594752268,0.0180126267090797,0.0251875044233686,4.54755405920593e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PF4,Platelet factor 4,24822,0.0808249823301342,0.00685272646282992,0.0673936384629876,0.0942563261972808,5.06995623462738e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.0678155063421169,0.0057527993279657,-0.0790909930249297,-0.0565400196593041,5.29388090157047e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10,Interleukin-10,28931,0.0677149017837916,0.00574690303329548,0.0564509718385324,0.0789788317290507,5.66280632258412e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,24805,0.058759373905999,0.00498782250203964,0.0489832418020013,0.0685355060099967,5.98236413628897e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARC,SPARC,29566,0.0580331163728797,0.00492999321455309,0.0483703296723556,0.0676959030734037,6.45612068512898e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,0.0210329137740564,0.00178760617985314,0.0175292056615442,0.0245366218865686,6.87842702665331e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,24381,0.0558614521173736,0.00474749824584251,0.0465563555555223,0.0651665486792249,7.0853471125873e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDA,Cytidine deaminase,24890,0.0387670127431249,0.00329606719300071,0.0323067210448435,0.0452273044414063,7.47665237973227e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,24240,0.0508678670478896,0.00432478994843154,0.0423912787489637,0.0593444553468154,7.48634008345089e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,24037,0.0457479617464061,0.00389176728303819,0.0381200978716513,0.053375825621161,8.13043038125487e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,24922,0.0228083042362508,0.00194042848447786,0.0190050644066742,0.0266115440658274,8.14916347412404e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,24381,0.0476966871804506,0.00406291931667842,0.0397333653197609,0.0556600090411403,9.73497795293577e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,24805,0.0559366793289268,0.00476624466499766,0.0465948397855314,0.0652785188723222,1.01104625651715e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0521852561214618,0.00444925061588981,0.0434647249143177,0.0609057873286058,1.06893755546451e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0332058235614638,0.00283154765960108,0.0276559901486456,0.0387556569742819,1.12227511247822e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,28797,0.0793988624694264,0.00678206702685228,0.066106011096796,0.0926917138420569,1.38124446092802e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0490198413318993,0.00419716618290571,0.0407933956134041,0.0572462870503945,1.96489270924289e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,24229,0.0465641581622493,0.00398692929993857,0.0387497767343697,0.0543785395901289,1.97706150920331e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,29434,0.0328337976281599,0.00281349688625306,0.0273193437311039,0.0383482515252159,2.12524305715103e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,24240,0.0250664946886453,0.00214800862031131,0.0208563977928351,0.0292765915844554,2.21069963815818e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0536021810906477,0.00459628658801933,0.0445934593781298,0.0626109028031656,2.3430111466092e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0395359585290798,0.00339030868061854,0.0328909535150675,0.0461809635430922,2.35910944176791e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0214628547044334,0.00184242095641913,0.0178517096298519,0.0250739997790149,2.80461928196304e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,0.0846752079365159,0.00727114873696329,0.0704237564120678,0.0989266594609639,2.83896995430885e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.0230636275333518,0.00198038923054036,0.0191820646414927,0.0269451904252109,2.89779343731478e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0462220920999958,0.00397769547640996,0.0384258089662323,0.0540183752337594,3.79539402666034e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,0.028308573461019,0.00243619829109268,0.0235336248104773,0.0330835221115607,3.82639105200649e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0780704387838703,0.00673645107981647,0.06486699466743,0.0912738829003106,5.46351849403012e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,29434,0.0680003933476754,0.00587040480352438,0.0564943999327676,0.0795063867625832,5.82637226518325e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.026084455641569,0.00225350606479465,0.0216675837545715,0.0305013275285665,6.43383324000712e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0200045194519475,0.00172987390400923,-0.0233950723038056,-0.0166139666000894,7.28710893449587e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0536027530167555,0.00464282996280648,0.0445028062896548,0.0627026997438563,9.34420393787108e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,0.0291155179996935,0.00252247783958146,0.0241714614341138,0.0340595745652731,9.65718974100461e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN2,Ficolin-2,29381,0.0332535804778916,0.00288232230868015,0.0276042287528785,0.0389029322029047,9.99342255747611e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0493651588853099,0.00428951122037021,0.0409577168933842,0.0577726008772355,1.39165411306098e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,28674,0.0362145281130405,0.00314750449784626,0.0300454192972619,0.0423836369288192,1.43991480757278e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,24101,0.0444590804263851,0.00386398138803594,0.0368856769058346,0.0520324839469355,1.47861402850439e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,29443,0.0420242664289318,0.0036601352962869,0.0348504012482095,0.0491981316096541,1.8950349273408e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,0.0255765804075712,0.00222811477565672,0.021209475447284,0.0299436853678584,1.95246268393669e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,0.0185330019642858,0.00161528475432829,0.0153670438458024,0.0216989600827692,2.08069174123303e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.0277275013861432,0.0024179920930956,0.0229882368836758,0.0324667658886105,2.23593866269548e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,29566,0.0573538505754985,0.00500536848350214,0.0475433283478343,0.0671643728031627,2.47176612607526e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.0277933803335529,0.00242723969089098,0.0230359905394066,0.0325507701276993,2.70378891311129e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,29536,0.0460797733125292,0.00402544274768694,0.0381899055270628,0.0539696410979956,2.81595695855797e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,24805,0.0486737574595082,0.00425160462558363,0.0403406123933642,0.0570069025256521,2.85646511399084e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0427687863660092,0.00373938553832581,0.0354395907108906,0.0500979820211278,3.23840993175557e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,0.0712473789852024,0.00623199218069543,0.0590326743110394,0.0834620836593654,3.43819007391975e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0241436930499701,0.00211240135389451,0.0200033863963368,0.0282839997036033,3.46023416901422e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",28774,0.043449304781656,0.00380188212999724,0.0359976158068614,0.0509009937564506,3.50591537403001e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,0.0227392786375621,0.00199085583730656,0.0188372011964413,0.026641356078683,3.76384101257463e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,24381,0.0556869104773048,0.00487437142499612,0.0461331424843124,0.0652406784702972,3.767874627103e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,29291,0.0449528457802108,0.00394069320110787,0.0372290871060393,0.0526766044543822,4.44856523027555e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0414160060220575,0.00363459227712679,0.034292205158889,0.0485398068852261,5.1387182803917e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0503090706029685,0.0044143894743402,0.0416568672332617,0.0589612739726753,5.18617713208065e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.0747345349903969,0.00655918945379142,0.0618785236609657,0.0875905463198281,5.19967480062943e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,28797,0.0784657199733087,0.00689189518258974,0.0649576054154328,0.0919738345311846,5.74330673754063e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0300379411820303,0.00264062629935823,0.0248623136352881,0.0352135687287724,6.41031666422477e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,28931,0.0387409424870638,0.00341153342374915,0.0320543369765154,0.0454275479976121,8.02085009830316e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0371823618686322,0.00327917680447976,0.0307551753318518,0.0436095484054125,9.69096321908163e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.0678125535366475,0.00599082964669587,0.0560705274291236,0.0795545796441715,1.24934270377167e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,24966,0.0425947124622185,0.00376476256046192,0.0352157778437131,0.0499736470807239,1.32017616883261e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,0.0257672307848733,0.00227762638940241,0.0213030830616446,0.030231378508102,1.33835674516501e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPN,Asporin,24922,-0.0219710518464233,0.00194380886635526,-0.0257809172244796,-0.018161186468367,1.49524072040702e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADD1,Alpha-adducin,24381,0.0558602282404405,0.0049474489909183,0.0461632282182406,0.0655572282626403,1.72659244558881e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0247983678385183,0.0021966502896893,-0.0291038024063094,-0.0204929332707273,1.73887944591365e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,24867,0.0383399476527799,0.00339661091016105,0.0316825902688643,0.0449973050366956,1.78049502549369e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.0966462153527438,0.00856497249202101,0.0798588692683826,0.113433561437105,1.82008923625508e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.0815520430319898,0.00723535793685528,0.0673707414757534,0.0957333445882261,2.14385083907654e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0262965070651744,0.00233531422522507,0.0217192911837333,0.0308737229466156,2.36800206424257e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0356713747772562,0.0031699292107207,-0.0418844360302688,-0.0294583135242437,2.63399501669256e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,28916,0.0448249643374146,0.00398914257749873,0.0370062448855171,0.0526436837893121,3.09476451815288e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0376829418745521,0.00335557295534715,0.0311060188820717,0.0442598648670325,3.41592558753663e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,24297,0.0521022889196654,0.00464086120704595,0.0430062009538553,0.0611983768854754,3.55192436871689e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,24966,0.0146675821904919,0.00130707255778047,0.0121057199772422,0.0172294444037417,3.74741024829095e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.046899510953521,0.00418675988729976,0.0386934615744135,0.0551055603326286,4.70635397922418e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0530010489067407,0.0047345705091738,0.0437212907087601,0.0622808071047214,5.09214459620602e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,24381,0.044118319163193,0.0039460669961176,0.0363840278508025,0.0518526104755836,5.9872381038352e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBD,Thrombomodulin,29478,0.0224704469558449,0.00201328823222095,0.0185244020206918,0.026416491890998,7.22501279377454e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0343350500374049,0.00307702561775628,0.0283040798266026,0.0403660202482072,7.65082755846793e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR,GMP reductase 1,29786,0.0388191984834116,0.00348173693381688,0.0319949940931305,0.0456434028736927,8.22411832390333e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,24326,0.0894334834687501,0.00803154867664576,0.0736916480625245,0.105175318874976,9.91548766307629e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLNK,B-cell linker protein,24229,0.0313351111257644,0.00281814786312709,0.0258115413140353,0.0368586809374935,1.18914580276011e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,28774,0.0353170676329399,0.00318288621611573,0.0290786106493531,0.0415555246165267,1.50048788479685e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,29489,-0.0214164921184709,0.00193070816827529,-0.0252006801282905,-0.0176323041086514,1.5528022928056e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,24240,0.0708550968200628,0.00638869990488302,0.0583332450064921,0.0833769486336335,1.63056843693708e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.034033214695578,0.00307142135524681,-0.0400532005518617,-0.0280132288392942,1.77286550553233e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,28797,0.0340358039191139,0.00307226501728326,0.0280141644852388,0.0400574433529891,1.82326472219344e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.0253630189247504,0.00229043384199228,-0.0298522692550553,-0.0208737685944456,1.97497713649763e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID2,Nidogen-2,29443,0.0568959438879062,0.00514244123522682,0.0468167590668616,0.0669751287089507,2.1338015775756e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,24565,0.0856018217672218,0.00773861115710978,0.0704341438992867,0.100769499635157,2.24668270163179e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,28797,0.0408175973538735,0.00369242559569634,0.0335804431863087,0.0480547515214383,2.38014767403568e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.02593479138967,0.00234604224760448,0.0213365485843653,0.0305330341949748,2.43799793014005e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,24229,0.03536274035135,0.00320001857449033,0.0290907039453489,0.041634776757351,2.53962085496163e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,24793,0.0252952707943962,0.00229009285304354,0.0208066888024308,0.0297838527863615,2.68286554614984e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,24867,0.0519442033008441,0.00470390154008349,0.0427245562822805,0.0611638503194078,2.76401807240606e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,29283,0.0297779523093245,0.00270030224190773,0.0244853599151853,0.0350705447034636,3.19559433683188e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,24240,0.0368386587169663,0.00334090835047883,0.0302904783500277,0.0433868390839048,3.32168004701799e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0279170862195286,0.00253445765492865,0.0229495492158684,0.0328846232231887,3.77425287941146e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,24922,0.0638045401830243,0.00579432381321977,0.0524476655091135,0.075161414856935,3.90342399242562e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,24845,0.0527243448123586,0.00479223933619161,0.043331555713423,0.0621171339112941,4.33871772319792e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0498698082989712,0.00453342439925249,0.0409842964764363,0.0587553201215061,4.4148643616233e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A11,Protein S100-A11,29208,0.0351579832966616,0.00319751008164981,0.028890863536628,0.0414251030566952,4.56399476833096e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,24951,-0.0375818606324986,0.00341824491597686,-0.0442816206678133,-0.030882100597184,4.71195477628123e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,0.0360463028160098,0.00327870189517444,0.0296200471014679,0.0424725585305517,4.73644829920788e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0523121938939275,0.00476478981587464,0.0429732058548132,0.0616511819330418,5.59767459576589e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0394980183769747,0.00360043905794723,0.0324411578233981,0.0465548789305512,6.03015171718674e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,24229,0.0343267438897803,0.00313302317398881,0.0281860184687622,0.0404674693107983,7.19645773830616e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,24195,0.101196256939154,0.00923633538334068,0.0830930395878062,0.119299474290502,7.20646179227495e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,29732,0.0529607257366687,0.00484184104550425,0.0434707172874804,0.062450734185857,8.55752427817705e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAX,Protein max,28774,0.0805903842261445,0.0073773044655539,0.0661308674736589,0.0950499009786302,1.00240034627334e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRKL,Crk-like protein,29491,0.0812437281213637,0.0074415062263662,0.066658375917686,0.0958290803250415,1.0726089317303e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,29218,0.0738998685001056,0.00677080564058974,0.0606290894445498,0.0871706475556615,1.11166530355759e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0185328544105274,0.00169855806948314,0.0152036805943405,0.0218620282267144,1.15516912513615e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,24845,0.0713922427718632,0.00654236182997522,0.0585692135851117,0.0842152719586146,1.16344368812983e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,29694,0.0485256593890197,0.00444886025416815,0.0398058932908501,0.0572454254871893,1.19858666734352e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,0.0533187048582106,0.00489126586224075,0.0437318237682187,0.0629055859482025,1.32318127042742e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0430790780499887,0.00395657109999355,0.0353241986940014,0.0508339574059761,1.52045384401284e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0511755501745152,0.00470104306327777,0.0419615057704908,0.0603895945785396,1.5580546751041e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.0585493795693217,0.00538921190251583,0.0479865242403907,0.0691122348982527,1.925274483904e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,24240,0.0526492185047577,0.00484607553720492,0.043150910451836,0.0621475265576793,1.97277469316465e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.0717367917537105,0.00660544322864484,0.0587901230255666,0.0846834604818544,2.01134565587591e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,29368,0.0521925703396271,0.00481709814695942,0.0427510579715867,0.0616340827076676,2.65084038615189e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN3,Centrin-3,24805,0.0592844726729485,0.0054755867585206,0.0485523226262482,0.0700166227196489,2.94923102732986e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,0.0691141043353441,0.00638955970013718,0.0565905673230752,0.0816376413476129,3.29723861949651e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0185330072803918,0.00171454699980898,0.0151724951607662,0.0218935194000174,3.50027430718499e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,0.0261403377059131,0.00241843766343569,0.0214001998855791,0.030880475526247,3.59684512734892e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.0788648740069787,0.00731120247628375,0.0645349171534625,0.0931948308604948,4.46059717897954e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,-0.0189527952893674,0.00175716104004771,-0.0223968309278609,-0.0155087596508739,4.49632533739552e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0894116249197872,0.00832371438099786,0.0730971447330314,0.105726105106543,7.42214516573638e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0406511586836386,0.00378536504844927,0.033231843188678,0.0480704741785992,7.50391914997607e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMB,RGM domain family member B,29694,0.0202908940696241,0.00188993240890608,0.0165866265481681,0.02399516159108,7.70059121445341e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.0722422946071288,0.00673598536224401,0.0590397632971305,0.085444825917127,8.72351946646397e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0451941871112037,0.00421808058235309,0.0369267491697917,0.0534616250526158,9.78537390850428e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0386789422431321,0.00361937034863576,0.031584976359806,0.0457729081264582,1.34733554471462e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F10,Coagulation factor X,24951,0.0207847188607641,0.00194598470231422,0.0169705888442282,0.0245988488772999,1.4286690737318e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,24240,0.0680026654611695,0.00637128200440958,0.0555149527325267,0.0804903781898122,1.55449854826996e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0209260471263185,0.00196068083735279,0.017083112685107,0.02476898156753,1.56276126335595e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,0.0927657679979062,0.00869639239892503,0.0757208388960131,0.109810697099799,1.66053503419121e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,0.0287723926145319,0.00269782158772837,0.0234846623025843,0.0340601229264795,1.6625717562356e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0226648301419575,0.00212566193857873,0.0184985327423432,0.0268311275415718,1.73920958581064e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,29474,-0.0162652761478233,0.0015270340125469,-0.0192582628124152,-0.0132722894832314,1.91595963294166e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0296232612671258,0.00278149127258496,0.0241715383728593,0.0350749841613923,1.98537040790166e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.0277870722378967,0.00261023563481724,0.0226710103936549,0.0329031340821385,2.0881386003972e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,24381,0.0555749029810065,0.00522481279702327,0.0453342698988409,0.0658155360631721,2.29726329803388e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0231586514779287,0.00217855635253245,0.0188886810269651,0.0274286219288923,2.46313168170854e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP1,Neuropilin-1,29628,-0.0207090145612963,0.00195204617840754,-0.0245350250709751,-0.0168830040516176,3.0206438361274e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0386323273489095,0.00364176853923109,0.0314944610120166,0.0457701936858025,3.05450993190696e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0285654334636148,0.0026941211042464,0.0232849560992918,0.0338459108279377,3.29469502877823e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0267210862840721,0.00252424243020116,0.0217735711208778,0.0316686014472664,3.86536292676677e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,24867,0.0564816592038814,0.00533561921867279,0.0460238455352827,0.06693947287248,3.9434145977092e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0460343200774722,0.0043571297293414,0.0374943458079631,0.0545742943469813,4.9215600926989e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,28931,0.068229987930715,0.00648133819043961,0.0555265650774533,0.0809334107839766,7.21421554681408e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,29434,0.0432987282553476,0.00411450038806001,0.03523430749475,0.0513631490159452,7.48823473911814e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,29786,0.0308354129971216,0.00293710574376241,0.0250786857393473,0.036592140254896,9.72705839256643e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0287763644022276,0.00274242537170996,0.023401210673676,0.0341515181307791,1.03279923427064e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,23498,0.0914105679126062,0.00871801213671703,0.0743232641246408,0.108497871700572,1.15061230254076e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.0671079919073226,0.00640095197636334,0.0545621260336505,0.0796538577809948,1.15714366386641e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPOCK1,Testican-1,29218,-0.0189466991261431,0.00180759375123455,-0.0224895828785628,-0.0154038153737234,1.16412523239446e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.0873607514264972,0.00834030740080454,0.0710137489209203,0.103707753932074,1.25483538362285e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA12,Serpin A12,28628,0.0824207284343064,0.00787208626612121,0.0669914393527088,0.0978500175159039,1.31995147925923e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON1,Spondin-1,29497,0.0241643684491215,0.00230832511469893,0.0196400512243116,0.0286886856739314,1.33876063385408e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0403562291053463,0.00385753626701196,0.0327954580220028,0.0479170001886897,1.46889760663941e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGA4,Pepsin A-4,24951,0.0526236217774368,0.00503094026244265,0.0427629788630492,0.0624842646918244,1.48944977647569e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.0740934252488565,0.00708545284746379,0.0602059376678275,0.0879809128298856,1.50703649657458e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFB,Complement factor B,24538,0.0242632907444117,0.00232044982427001,0.0197152090888425,0.0288113723999809,1.55181344213596e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,24805,0.025717002139035,0.00245963523378518,0.0208961170808161,0.030537887197254,1.56072006560999e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.0765167088215484,0.00732039086918275,0.0621687427179502,0.0908646749251466,1.58126955626816e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,29386,0.0497246897640282,0.00476864954016722,0.0403781366653005,0.059071242862756,2.05880433929838e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFLAM,Pikachurin,24805,0.0226850997283643,0.00217653502760616,0.0184190910742563,0.0269511083824724,2.20704280474668e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0219253782239497,0.00210434762956267,0.0178008568700068,0.0260498995778925,2.24429884546015e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.0635007510799621,0.00609564976347102,0.0515532775435589,0.0754482246163653,2.33032574116766e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,29218,0.0590345023041884,0.00566837249368934,0.0479244922165573,0.0701445123918195,2.3530975434778e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.038955046734629,0.00374011554584277,0.0316244202647772,0.0462856732044809,2.3842113180485e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0391188219477413,0.00375638377081531,0.0317563097569433,0.0464813341385393,2.41489323012339e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,23862,0.0593127481767398,0.0057036560205416,0.0481335823764783,0.0704919139770014,2.83536265566607e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0559844232182721,0.00538851594407348,0.0454229319678881,0.0665459144686561,3.11615364346562e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,0.0640964992235596,0.00617923167233982,0.0519852051457736,0.0762077933013457,3.70933537647689e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0216595923966464,0.00208967625070592,0.0175638269452628,0.02575535784803,3.95345275073716e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,24381,0.0380405717520875,0.00366965487979234,0.0308480481876945,0.0452330953164805,3.98244778869577e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.0560428772831038,0.00540969043093963,0.0454398840384622,0.0666458705277455,4.17588906923021e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0204603616957236,0.00197540969347427,0.0165885586965141,0.0243321646949332,4.26932143337257e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,0.067434692614996,0.006524055575864,0.0546475436863025,0.0802218415436894,5.33692615345558e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.0790848034662973,0.00765969299983005,0.0640718051866304,0.0940978017459642,6.11514055393777e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0369644556404742,0.00358497607577129,0.0299379025319625,0.0439910087489859,6.93112416905757e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,0.0230553220470356,0.00223786671373761,0.0186691032881099,0.0274415408059613,7.56789825133204e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A14,Protein S100-A14,24867,0.03849258218596,0.003736002807084,0.0311700166840753,0.0458151476878446,7.65168149587949e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,29169,0.0379151526588041,0.0036827909200388,0.0306968824555281,0.0451334228620801,8.16645105334603e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,24381,0.0623309334596722,0.00605865906954535,0.0504559616833633,0.0742059052359811,8.97869829411842e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,29694,0.0215989404038735,0.00210117094196884,0.0174806453576146,0.0257172354501324,9.59459719000657e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,24845,0.0330050453117895,0.0032140279241325,0.0267055505804898,0.0393045400430892,1.08850676158468e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,0.070572849800224,0.00687530518739483,0.0570972516329302,0.0840484479675179,1.14204343213268e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0393554394173632,0.0038477846287355,0.0318137815450416,0.0468970972896847,1.63200138901516e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,29443,-0.0227108194731428,0.00222139151141239,-0.0270647468355111,-0.0183568921107745,1.7068097267468e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.0646644698816382,0.00632394191736792,0.0522695437235971,0.0770593960396793,1.70698880512511e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0305373788892491,0.00299193382667864,0.024673188588959,0.0364015691895393,2.03847679981781e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,24381,0.0781568781499376,0.00765729364402922,0.0631485826076403,0.0931651736922349,2.06894707026258e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0245406275805527,0.00240488927106759,0.0198270446092602,0.0292542105518451,2.11613141961264e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,28916,0.026085622655886,0.00255707498772627,0.0210737556799425,0.0310974896318295,2.15069763953581e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0604311776874495,0.00592656690936146,0.048815106545101,0.0720472488297979,2.25326894792057e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0335915987629709,0.00329621207673218,0.0271310230925759,0.040052174433366,2.39388135992366e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,24845,0.0772386266441086,0.00757907690477474,0.0623836359107501,0.0920936173774671,2.42814232301539e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0143851470786966,0.0014121748422957,0.011617284387797,0.0171530097695962,2.54301929779047e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0381421973692599,0.00374955833689005,0.0307930630289554,0.0454913317095644,2.89194922695108e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH1,Somatotropin,29433,-0.126583221973713,0.0124597794793729,-0.151004389753284,-0.102162054194142,3.30119957150569e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,29349,0.0232599101728137,0.00229181986538144,0.0187679432366661,0.0277518771089613,3.66641884727718e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLVRB,Flavin reductase,29443,0.0463218897966655,0.00457004097869489,0.0373646094784236,0.0552791701149075,4.18998422328126e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0350897963180708,0.00346420766544764,0.0282999492937934,0.0418796433423482,4.49785551687146e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZU1,Azurocidin,28534,0.0544175804669015,0.00537287142445664,0.0438867524749665,0.0649484084588365,4.54884354343019e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,28774,0.0439575198210421,0.00434270908180603,0.0354458100207023,0.052469229621382,4.83516281807153e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.0781010183621976,0.00772058010108471,0.0629686813640716,0.0932333553603237,5.13669538510517e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,0.0290526907281124,0.00287276121149693,0.0234220787535784,0.0346833027026464,5.29069495424673e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEPR,Leptin receptor,29478,-0.0220610341744414,0.00218262504643103,-0.0263389792654463,-0.0177830890834366,5.59573711192745e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,0.0561338432274629,0.00556478995005634,0.0452268549253525,0.0670408315295734,6.8790061918957e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,0.0811880959171564,0.00804922142609088,0.0654116219220182,0.0969645699122945,7.05018851831829e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,0.0321380443766802,0.00318833988357073,0.0258888982048815,0.0383871905484788,7.42937136257759e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,0.0179068000961162,0.00177999955940799,0.0144180009596765,0.0213955992325558,9.06444287400945e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0251191211756424,0.00249703095240119,0.020224940508936,0.0300133018423487,9.11141676716641e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,28722,0.0637719729488472,0.00634139448421271,0.0513428397597903,0.0762011061379041,9.41973567863106e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,0.0324655356768005,0.00323105798416488,0.0261326620278373,0.0387984093257637,1.02457054188836e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,0.0178152912999737,0.00177390999134579,0.0143384277169359,0.0212921548830114,1.09726618686442e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.0630589728441112,0.00628336998273171,0.0507435676779571,0.0753743780102654,1.17666216349778e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0274246175347888,0.00273394372333316,0.0220660878370559,0.0327831472325218,1.21411254714421e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,29420,0.0670480631352737,0.00668875964508602,0.0539380942309051,0.0801580320396423,1.3048837198291e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGN,Secretagogin,28931,0.031053309791491,0.00309911278228075,0.0249790487382207,0.0371275708447613,1.35958740486258e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0304902872687486,0.00304404778996263,0.0245239536004218,0.0364566209370753,1.40915023429441e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,29786,0.0445219379386593,0.0044454192296821,0.0358089162484824,0.0532349596288362,1.4237357322848e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,28916,0.0331117163516604,0.00330743611587669,0.0266291415645421,0.0395942911387787,1.48530214541708e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,0.0205557783205929,0.00205384165590419,0.0165302486750207,0.0245813079661651,1.52622728421669e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,28884,0.0289934607738681,0.0028986580744284,0.0233120909479885,0.0346748305997478,1.62506470497447e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,29581,0.0234883250933639,0.00234880626029299,0.0188846648231897,0.0280919853635382,1.65903881662657e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.0213630867133715,0.002138239184643,0.0171721379114713,0.0255540355152718,1.81833502153775e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,29581,0.064765505973853,0.00649143098006025,0.0520423012529349,0.0774887106947711,2.09133974492944e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.0604050346312835,0.00606056661444805,0.0485263240669653,0.0722837451956016,2.35910875084593e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0254860453104148,0.00255800034376997,0.0204723646366256,0.0304997259842039,2.44029927845196e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.0600953348356727,0.0060329094916914,0.0482708322319575,0.0719198374393878,2.49581970097811e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP1,Caspase-1,28774,0.0474969853535055,0.00477039526479391,0.0381470106345095,0.0568469600725016,2.57395779386644e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,0.0437046030424903,0.00438917317033885,0.0351018236286262,0.0523073824563545,2.58971733205878e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,24938,0.0382487756278601,0.00384268850788662,0.0307171061524024,0.0457804451033179,2.68713705011211e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTD,Biotinidase,24966,0.0145268646593748,0.00146084831656068,0.0116636019589159,0.0173901273598337,2.95542410590816e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,24892,-0.0514192679982909,0.00517196411129447,-0.061556317656428,-0.0412822183401537,3.02226849304034e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,-0.0315161930238765,0.00317836797405413,-0.0377457942530226,-0.0252865917947304,3.86093189699249e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0472134380890044,0.00476197660703104,0.0378799639392236,0.0565469122387853,3.98033042422584e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,24381,-0.0226751065964688,0.00228714057482274,-0.0271579021231214,-0.0181923110698163,3.99571071487984e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,29725,-0.0237013973215301,0.00239302060222631,-0.0283917177018937,-0.0190110769411666,4.32648313597813e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,28774,0.0357060695059388,0.00361045070020039,0.028629586133546,0.0427825528783316,5.02453954228558e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0293211446425362,0.00296816376735212,-0.0351387456265464,-0.0235035436585261,5.6018111858446e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IST1,IST1 homolog,24636,0.0692607368780164,0.0070140509838358,0.0555131969496982,0.0830082768063345,5.92026397384649e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,24726,0.0241300401787121,0.00244945257945608,0.0193291131229782,0.028930967234446,7.46300142819011e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,29214,-0.0232510395248188,0.00236669984169872,-0.0278897712145483,-0.0186123078350893,9.60257518871803e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.0647972403114635,0.00659597566235344,0.0518691280132508,0.0777253526096763,9.78704530171232e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0150009528683085,0.00152925759355665,0.0120036079849375,0.0179982977516795,1.1126590080944e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,29566,0.0150419720907971,0.00153393444596593,0.0120354605767039,0.0180484836048903,1.14732849223828e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPO,Lactoperoxidase,28452,0.0414752871546773,0.00423373212458128,0.033177172190498,0.0497734021188567,1.26712036197408e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,0.0166011905780001,0.00169780721616321,0.0132734884343203,0.01992889272168,1.54028255515721e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,0.0418740775433748,0.00428583842680885,0.0334738342268295,0.0502743208599202,1.65676003216137e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,24240,-0.0293990281647889,0.0030107622914667,-0.0353001222560637,-0.0234979340735142,1.756734208414e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,28916,0.0579109186326243,0.00593356889778485,0.046281123592966,0.0695407136722827,1.81283089563663e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS27,Serine protease 27,29395,0.0275906382848194,0.00282935462247396,0.0220451032247704,0.0331361733448683,1.96455521843635e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,24229,0.0199382357919832,0.00204594239891045,0.0159281886901187,0.0239482828938476,2.12512935252723e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,24111,0.0270546488866364,0.00277791448872141,0.0216099364887424,0.0324993612845304,2.2563357916597e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLGN,Calmegin,24195,0.0309034482100263,0.00317813635775238,0.0246743009488316,0.0371325954712209,2.62356239048341e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,-0.0197438430023295,0.00203361834696216,-0.0237297349623753,-0.0157579510422836,2.98805657713838e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0237580642526007,0.00244938448220156,0.0189572706674856,0.0285588578377157,3.26854595294681e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0274319432313172,0.00282834997332158,0.021888377283607,0.0329755091790275,3.33555246977305e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,29478,0.046504972936243,0.00479844058824691,0.0371000293832791,0.055909916489207,3.53016332497403e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TWF2,Twinfilin-2,24938,0.0572615799865326,0.00591313926170382,0.0456718270335932,0.0688513329394721,3.86602043637547e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD226,CD226 antigen,24229,0.0288386440247449,0.0029783868791803,0.0230010057415515,0.0346762823079383,3.91979812684409e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,28931,0.0540436769585656,0.00558313541093559,0.0431007315531319,0.0649866223639994,3.96952637189658e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.045907198433089,0.00474697725691862,0.0366031230095285,0.0552112738566495,4.32637719845541e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMD,Dystrophin,24240,0.0353163760278537,0.00365211969495716,0.0281582214257377,0.0424745306299697,4.42862447069337e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0466403373025933,0.00482804626440921,0.0371773666243512,0.0561033079808353,4.86228090262795e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0394688590137006,0.00408713203133034,0.0314580802322932,0.0474796377951081,5.03776697735994e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.038225484040064,0.00395947478390115,0.0304649134636178,0.0459860546165103,5.17065964691516e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0233309304140394,0.0024174523714264,0.0185927237660437,0.0280691370620352,5.24680228988392e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0230261890807429,0.00238576623170373,0.0183500872666036,0.0277022908948822,5.30783077286526e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTN3,Myeloblastin,28671,0.0321417205044783,0.0033367214554576,0.0256017464517814,0.0386816945571752,6.2794038176263e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0348212674361107,0.00362140269915069,0.0277233181457754,0.0419192167264461,7.51585708831657e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0404031789467269,0.00420731700108762,0.0321568376245952,0.0486495202688586,8.36630557818262e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLN,Mesothelin,29293,0.0377938583987099,0.00393754534171126,0.0300762695289558,0.045511447268464,8.74807041341213e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.0184813187131723,0.00192891171719767,0.0147006517474649,0.0222619856788797,1.03076764449339e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCHE,Cholinesterase,24528,0.0190065904705859,0.00198414072792523,0.0151176746438524,0.0228955062973193,1.0668729371553e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,29566,0.0419465993687333,0.00439586787722717,0.033330698329368,0.0505625004080986,1.50087075532325e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,29786,0.0409475975135026,0.00429222569412742,0.0325348351530129,0.0493603598739924,1.53412527363202e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17A,Interleukin-17A,28879,0.0286356926977116,0.00300232874930159,0.0227511283490805,0.0345202570463428,1.56916015146439e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0291986641799449,0.00306146311759807,0.0231981964694527,0.0351991318904371,1.59668855588027e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.056909323345348,0.00597144790908108,0.0452052854435491,0.0686133612471469,1.68551002402411e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,28931,0.0193132631179775,0.00202829331888741,0.0153378082129582,0.0232887180229968,1.82773871642487e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX7,Syntaxin-7,24229,0.0334351140287611,0.00351210673973402,0.0265513848188824,0.0403188432386398,1.888896392388e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0333126262327265,0.00350159970697834,0.0264494908070489,0.040175761658404,2.0071346755759e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,0.0696540436240293,0.00733814520583888,0.0552712790205851,0.0840368082274735,2.43022207262682e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,0.0368990214015965,0.00389089495453764,0.0292728672907027,0.0445251755124902,2.6741537971096e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.0607525175186473,0.00641045034314429,0.0481880348460845,0.0733170001912102,2.8460362605742e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN1,Pantetheinase,24951,0.0487340682213289,0.0051447590558794,0.0386503404718053,0.0588177959708525,2.96478975213321e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNLY,Granulysin,29443,0.034689647669545,0.00366493639805242,0.0275063723293623,0.0418729230097277,3.1386749279062e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0444615545490857,0.0046995340297772,0.0352504678507224,0.053672641247449,3.32489543619909e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0256413080312886,0.00271191454841558,0.0203259555163941,0.0309566605461832,3.51329034808488e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0327395606296173,0.0034633054401749,0.0259514819668745,0.0395276392923601,3.56518873524403e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,29757,0.0199053080268752,0.00210861388257289,0.0157724248170324,0.0240381912367181,3.99064226302496e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,24195,0.0327653282855999,0.0034708743219081,0.02596241461466,0.0395682419565398,4.05031529397585e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOC,Brother of CDO,28916,-0.0155208493086375,0.0016481939968812,-0.0187513095425247,-0.0122903890747504,4.98076399208022e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0384935308999844,0.00408949199915146,0.0304781265816476,0.0465089352183213,5.17428831213166e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.0679497470295291,0.00722682941186187,0.0537851613822799,0.0821143326767784,5.70340854509523e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,24845,0.0202284183780126,0.00215457437141183,0.0160054526100454,0.0244513841459798,6.58595752768298e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,0.0605866581741161,0.00645514632518419,0.0479345713767551,0.0732387449714772,6.68922127541974e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,0.0160225322643482,0.00170759103719013,0.0126756538314556,0.0193694106972409,6.85022743494098e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.0649590370128259,0.0069220952913111,0.0513917302418562,0.0785263437837957,6.85688591547884e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.047945273750764,0.00511043999430619,0.0379288113619239,0.0579617361396041,7.03585284324913e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,0.0355570501061105,0.00379398072293909,0.0281208478891499,0.0429932523230711,7.70766897570051e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,29343,0.0714548761165071,0.00763630997532938,0.0564877085648615,0.0864220436681527,8.74823385087472e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,0.0149194667507131,0.00159458602171705,0.0117940781481477,0.0180448553532785,8.81897023228845e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.0708245945581086,0.00757354511900801,0.0559804461248529,0.0856687429913643,9.33853289568204e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,0.0150851585224639,0.00161353427964836,0.0119226313343531,0.0182476857105746,9.44350379630561e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSPN,Persephin,29434,0.0617125784220417,0.00660131653230328,0.0487739980187272,0.0746511588253561,9.49654095499024e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEXN,Nexilin,24951,0.0455292300095776,0.00487160576308542,0.0359808827139301,0.055077577305225,9.8566146409466e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPART,Spartin,24381,0.0511385386778621,0.00547386217589978,0.0404097688130985,0.0618673085426257,1.02075502079478e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI2,Serpin I2,24805,0.0374494645447718,0.00401231730657264,0.0295853226238895,0.0453136064656542,1.10621300634585e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,29434,0.0460588690384848,0.00493772875961967,0.0363809206696303,0.0557368174073394,1.15269229695714e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0321138367743523,0.00344256827890149,0.0253664029477054,0.0388612706009993,1.16111138406368e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0387351595122774,0.00415257087551881,0.0305961205962606,0.0468741984282943,1.16612454392671e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,0.0177335140521949,0.00190184790997588,0.0140058921486422,0.0214611359557476,1.20633654721096e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,29163,-0.031786063750866,0.00341028732340416,-0.0384702269047382,-0.0251019005969938,1.23539268492099e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,29383,0.0309840897452802,0.00332478581284976,0.0244675095520947,0.0375006699384658,1.25251581537842e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOE,Apolipoprotein E,24966,0.0478108295405166,0.00513308239739286,0.0377499880416266,0.0578716710394066,1.32638497445759e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0351288266276683,0.00378213287264689,0.0277158461972804,0.0425418070580562,1.67439166092982e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0593744415964578,0.00639793922152627,0.0468344807222663,0.0719144024706493,1.82836163900464e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,29434,0.0439473233058063,0.00473654134198005,0.0346637022755254,0.0532309443360872,1.83543065348468e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,24845,0.0464439149420018,0.00500545588910037,0.0366332213993651,0.0562546084846386,1.85210394731479e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.0427440503519383,0.00461941648391546,-0.0517981066604126,-0.033689994043464,2.32381474712335e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0597159531753743,0.00646827369106829,0.0470381367408804,0.0723937696098681,2.8640174249887e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,0.023663275439861,0.00256415783616812,0.0186375260809715,0.0286890247987505,2.96423534485141e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0338224652168955,0.00366735856259081,0.0266344424342175,0.0410104879995735,3.1251134281612e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,28931,0.0188013554039396,0.0020389872138705,0.0148049404647534,0.0227977703431258,3.13954499032775e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,29478,0.0427019381777766,0.00463352745159292,0.0336202243726544,0.0517836519828987,3.28716247530535e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,24922,0.042487365437985,0.00461238267703826,0.03344709539099,0.05152763548498,3.45947370442976e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.017906826457539,0.00194505976181398,0.0140945093243836,0.0217191435906944,3.63312053623961e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAT,Catalase,24587,0.0348559909676159,0.00378695722177517,0.0274335548129365,0.0422784271222952,3.70800719909464e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.0237511830283301,0.00258115473310072,0.0186921197514527,0.0288102463052075,3.79504940386779e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,28931,0.0307989907367019,0.00334842964182927,0.0242360686387165,0.0373619128346872,3.88325267784987e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,29349,0.0483341274005739,0.00526304058497671,0.0380185678540196,0.0586496869471283,4.43185854503912e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,29478,0.082464896389786,0.00897994133223143,0.0648642113786124,0.10006558140096,4.44939740080954e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0211639382507696,0.00230605688498412,0.0166440667562007,0.0256838097453384,4.69112488701078e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,29725,0.0294791215350242,0.00321342071674393,0.0231808169302061,0.0357774261398423,4.85520486544272e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,24381,0.0287383208687649,0.00313268254804899,0.0225982630745889,0.0348783786629409,4.92219672333031e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,28931,0.0323141607364624,0.00352483926261638,0.0254054757817344,0.0392228456911905,5.15015815866067e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.026759639508734,0.00291939014874246,0.0210376348171988,0.0324816442002692,5.28171053292807e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,28591,0.0542392273099147,0.00592451168802876,0.0426271844013783,0.0658512702184511,5.78513328553402e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,29192,0.0307058606685094,0.00335460423112321,0.0241308363755079,0.0372808849615109,5.86942631014322e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.043070016724674,0.00470620214624969,0.0338458605180246,0.0522941729313234,6.0276526149947e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F12,Coagulation factor XII,24966,0.0268534308718847,0.00293441126364941,0.0211019847951319,0.0326048769486376,6.04855923205542e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,29478,0.0291966264865069,0.00319346500420555,0.022937435078264,0.0354558178947497,6.47661794316309e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0360588779663417,0.00394570588311339,0.0283252944354394,0.0437924614972439,6.79317437476252e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,0.0239412837424358,0.00261978159310358,0.0188065118199528,0.0290760556649188,6.79357254287032e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22,Interleukin-22,24793,0.0436065767842051,0.00477926499253405,0.0342392173988384,0.0529739361695718,7.76782319206699e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,28916,0.0286515234399088,0.00314071630260499,0.022495719486803,0.0348073273930145,7.79681821999762e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,24867,0.0426847621482216,0.00467958824517624,0.0335127691876761,0.051856755108767,7.9570612232211e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB6,Serpin B6,29623,0.0378352754190812,0.00415137627151137,0.0296985779269189,0.0459719729112434,8.43391734927439e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0315001048602334,0.0034561840068482,0.0247259842068109,0.0382742255136559,8.52923319785391e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,0.0203430401731166,0.00223447823431957,0.0159634628338503,0.024722617512383,9.22763403767191e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,28797,0.0309927242579553,0.00340634521777356,0.0243162876311191,0.0376691608847914,9.73086697991108e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,29279,0.038523801573154,0.00423485215182346,0.0302234913555801,0.046824111790728,9.87223029657724e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MILR1,Allergin-1,28931,0.0321835754934137,0.00354593025650628,0.0252335521906614,0.039133598796166,1.19379631407983e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",24966,0.0106326050647115,0.00117341298830398,0.00833271560763566,0.0129324945217873,1.38162969451367e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,24329,0.0659375046177053,0.00728094163518331,0.051666859012746,0.0802081502226646,1.44995503842795e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,0.0306084992071713,0.00338522269316989,0.0239734627285583,0.0372435356857843,1.65062065366133e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,24610,-0.0690368935166686,0.00764441441743758,-0.0840199457748463,-0.0540538412584909,1.82241225278172e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.052278849742546,0.00579043067155188,0.0409296056263043,0.0636280938587877,1.84400316597977e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,24111,0.0423321805100685,0.00469121265026922,0.0331374037155408,0.0515269573045961,1.95055051100338e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,29349,0.0568456313499048,0.0063044946011456,0.0444888219316594,0.0692024407681502,2.05365099647986e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0178206938150395,0.00197714778153356,0.0139454841632337,0.0216959034668453,2.14376681312238e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROK1,Prokineticin-1,29434,0.0388371355112581,0.00431362543160823,0.030382429665306,0.0472918413572103,2.31770950254821e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0557251741457646,0.00619502270594021,0.0435829296421218,0.0678674186494074,2.52377047280539e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,29218,0.0634407722668516,0.00705445606772021,0.04961403837412,0.0772675061595832,2.54734063779659e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,-0.0216487051390104,0.00240826166898121,-0.0263688980102136,-0.0169285122678072,2.63210789888553e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.0455668359011224,0.00507633013373561,0.0356172288390006,0.0555164429632442,2.96114129323524e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,24111,0.0421177695079393,0.00469490859573365,0.0329157486603013,0.0513197903555773,3.1488673857834e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,0.023185470574485,0.00259298389040411,0.018103222149293,0.0282677189996771,4.05329684246838e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB1,Calbindin,29349,0.0274565379064525,0.00307086895764758,0.0214376347494633,0.0334754410634418,4.07883857476931e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,0.0274087474486845,0.00306549807702482,0.0214003712177159,0.0334171236796531,4.07947018340355e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,29379,0.0648218563280979,0.00725753252312976,0.0505970925827636,0.0790466200734323,4.43558726439939e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,29344,0.0550126458034943,0.00616112793604854,0.0429368350488392,0.0670884565581494,4.54422009978699e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,28774,0.0232092391139801,0.00260142918837673,0.0181104379047617,0.0283080403231985,4.85685766499085e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,0.0203575573350541,0.00228500581243395,0.0158789459426835,0.0248361687274246,5.49400945780845e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,0.0557206578125507,0.00625754257943505,0.043455874356858,0.0679854412682434,5.6618743597513e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.0142536856818133,0.00160343524746063,0.0111109525967904,0.0173964187668361,6.54776884673042e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,0.0368197240770904,0.00414250981568468,0.0287004048383485,0.0449390433158324,6.55587883934011e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA3,Annexin A3,29640,0.0434389453084172,0.00489075069466152,0.0338530739468806,0.0530248166699538,6.93842259533749e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,24445,0.0213263551197646,0.00240078628847217,0.0166208139943591,0.02603189624517,6.94200645731007e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0398173115189921,0.00448531560911797,0.0310260929251209,0.0486085301128633,7.24200891262395e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,24111,0.0269541461707799,0.00303813053646887,0.0209994103193009,0.0329088820222589,7.67604613118209e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,0.0415925965062247,0.00469670376242274,0.0323870571318761,0.0507981358805732,8.77414050804987e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0236982832255295,0.00267922276438043,-0.0289495598437151,-0.0184470066073438,9.63261081068644e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,28774,0.0304971792422468,0.00345087415225393,0.0237334659038291,0.0372608925806645,1.03322723454509e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0303937087366238,0.00343936907569807,0.0236525453482555,0.037134872124992,1.04711826528816e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,0.0370762701760461,0.00420262160803645,0.0288391318242947,0.0453134085277976,1.18348358096178e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.02233335478796,0.00253124417942084,0.0173721161962951,0.0272945933796248,1.1876008461043e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,24867,0.0360810393063444,0.00409039714620269,0.0280638608997871,0.0440982177129017,1.20830821058809e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.0515808231285593,0.0058485028569267,0.040117757528983,0.0630438887281357,1.21184917561757e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.0516778861294406,0.00586364519276508,0.040185141551621,0.0631706307072602,1.29360880917416e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.0691467512823861,0.00784799575580269,0.0537646796010128,0.0845288229637593,1.30967152128122e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,28931,0.0407831186201139,0.00463891090999384,0.031690853236526,0.0498753840037019,1.55550554257415e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGT,Angiotensinogen,24951,0.0143733303734495,0.00163484572799019,0.0111690327465888,0.0175776280003103,1.5640948428743e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.0685697352978573,0.00780402700385799,0.0532738423702957,0.083865628225419,1.62719925333133e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM17,Splicing factor 45,24867,0.0474675638093431,0.00540203768302046,0.036879569950623,0.0580555576680632,1.63369499996928e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,0.0422193165744706,0.00480828490491777,0.0327950781608318,0.0516435549881094,1.7296765864928e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.0160936967969141,0.00183636462821574,0.0124944221256113,0.019692971468217,2.00400371440869e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,24793,0.043658332957738,0.00499311212518527,0.0338718331923748,0.0534448327231011,2.39614698325977e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPF,Centromere protein F,24445,0.0335410477343257,0.0038402128049037,0.0260142306367144,0.0410678648319369,2.60898437570257e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,0.0387239898956121,0.00443656079245015,0.0300283307424098,0.0474196490488144,2.74776115073721e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.0659379344218318,0.00756122147363432,0.0511179403335085,0.080757928510155,2.93874302436807e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,-0.0108119318662449,0.00124079652333054,-0.0132438930519727,-0.008379970680517,3.09257607962463e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,0.0365160748631284,0.00419070905900814,0.0283022851074725,0.0447298646187844,3.12498368568917e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,24793,0.0238401380334258,0.00273763934003427,0.0184743649269586,0.0292059111398929,3.27400342847468e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0162636937667869,0.00186801482581317,-0.0199250028253807,-0.0126023847081931,3.29801101220914e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLG,Plasminogen,24421,0.0136228237900791,0.00156688567748519,0.0105517278622081,0.01669391971795,3.7084556795089e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,29349,0.0521594564912492,0.00600869445661779,0.0403824153562783,0.06393649762622,4.13466736363182e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0267631398026507,0.00308616687106174,0.0207142527353697,0.0328120268699317,4.46640156954273e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,0.040761582505089,0.00470246260799299,0.0315447557934228,0.0499784092167553,4.6135354163266e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.048450523002269,0.00559241211769142,0.0374893952515939,0.0594116507529442,4.843404862721e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,24755,0.0539030275813054,0.00622235008974401,0.0417072214054071,0.0660988337572036,4.87911267683054e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,28916,0.0815550173136121,0.00942200257870602,0.0630878922593483,0.100022142367876,5.1441495726023e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.0135220214602775,0.00156711638356304,0.0104504733484939,0.016593569572061,6.51802402077561e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,24793,0.0256679595651768,0.00297602783815734,0.0198349450023884,0.0315009741279652,6.79221664870743e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOB,Elongin-B,24111,0.0241343112385013,0.00279890988329393,0.0186484478672452,0.0296201746097574,6.93190870516337e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0480024961911593,0.00558956584916819,0.0370469471267897,0.058958045255529,9.29887023949442e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,24845,0.0428518031220732,0.00500394369796132,0.033044073474069,0.0526595327700774,1.15634558398909e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,0.0718877898682211,0.00841313776194402,0.0553980398548108,0.0883775398816314,1.36295550719954e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,-0.0365663811126058,0.00428761230226602,-0.0449701012250472,-0.0281626610001644,1.55416106321367e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.025379394793189,0.00297690328605791,0.0195446643525155,0.0312141252338625,1.59592963194211e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,24381,-0.0172017958223201,0.00202049318413444,-0.0211619624632236,-0.0132416291814166,1.78101706428831e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0320875488979203,0.00377096472405188,0.0246964580387786,0.039478639757062,1.8499288649498e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,0.0530027492732206,0.00625002738621992,0.0407526955962296,0.0652528029502116,2.367164274159e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,24805,0.0256287273995534,0.00302821435954253,0.0196934272548501,0.0315640275442568,2.74051094866176e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0439660442279925,0.00519647215347881,0.033780958807174,0.0541511296488109,2.80059574733783e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,24805,0.0411028936648872,0.00486195802167194,0.0315734559424102,0.0506323313873642,2.96815639727502e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,0.031462135966583,0.00372430247204254,0.0241625031213796,0.0387617688117864,3.10647497578146e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0252071243807268,0.00298568442278746,0.0193551829120634,0.0310590658493902,3.24493012736231e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.0689224419722558,0.00817002145475995,0.0529091999209263,0.0849356840235854,3.43205301579345e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,24101,0.0261553115654388,0.0031025283797577,0.0200743559411137,0.0322362671897639,3.63765351233993e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.0561295856322759,0.00665967162547772,0.0430766292463396,0.0691825420182122,3.6654327415124e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,24445,0.0315245310457539,0.0037415046366639,0.0241911819578926,0.0388578801336151,3.78313961389952e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7,Complement component C7,24374,0.0193285087066109,0.00229696543252035,0.014826456458871,0.0238305609543508,4.14897841024662e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.0155804905966658,0.00185318824414071,-0.0192127395551816,-0.01194824163815,4.41395218657543e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0280009810106781,0.00333127388951805,0.0214716841872227,0.0345302778341335,4.48676639189687e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP7,Caspase-7,24845,0.0497914577643686,0.00592899807249911,0.0381706215422703,0.0614122939864668,4.78280750979568e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,29443,0.0142667730382865,0.00169944084988852,0.010935868972505,0.017597677104068,4.8659774160481e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,0.0568386907369169,0.00676988666344811,0.0435697128765586,0.0701076685972752,4.87103341529337e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,-0.0339667800042009,0.00404793500818951,-0.0419007326202524,-0.0260328273881495,5.02527218043194e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.0504729336442301,0.00602439373520146,0.0386651219232352,0.062280745365225,5.65990806437542e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.0544956463554483,0.00650680560348672,0.0417423073726143,0.0672489853382823,5.80907846842292e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.0500129690470976,0.00597665813118046,0.0382987191099839,0.0617272189842113,6.11983435130973e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,0.0197178548726908,0.00235662482841481,0.0150988702089978,0.0243368395363838,6.17386259513695e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,29453,0.045265321369624,0.00541333485891788,0.034655185046145,0.0558754576931031,6.44486857501793e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,0.0131480784530956,0.0015750895597733,0.0100609029159399,0.0162352539902513,7.33041866987953e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0407533009394368,0.00488744756384625,0.0311739037142982,0.0503326981645755,7.93075383902668e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,29349,0.048212478200242,0.00578860106791772,0.0368668201071232,0.0595581362933607,8.51321738134249e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,29443,0.0709133160019083,0.00851444351720524,0.0542250067081861,0.0876016252956306,8.53177879031575e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0175966079192548,0.00211303596928408,0.013455057419458,0.0217381584190516,8.60407387614612e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,29581,0.0122830790470591,0.00147971293758615,0.00938284168939028,0.015183316404728,1.07596416810819e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,29039,0.040006448906875,0.00483059446197589,0.0305384837614022,0.0494744140523477,1.26389819906761e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA5,Annexin A5,28650,0.0177141543264479,0.00214105838776732,0.0135176798864239,0.0219106287664718,1.35609108878449e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0246673584804326,0.00298544891154834,0.0188158786137979,0.0305188383470674,1.49840778983222e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,28984,0.0197619910890282,0.00239680501929915,0.0150642532512019,0.0244597289268546,1.71869625568404e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSV,Cathepsin L2,29618,-0.0239791123343332,0.00291108241116247,-0.0296848338602116,-0.0182733908084547,1.83503320803316e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0326504289053677,0.00396415836980151,0.0248806785005567,0.0404201793101786,1.84755652435729e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.0565754922353412,0.00688888436330124,0.0430732788832707,0.0700777055874116,2.26924005777472e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,29443,-0.0164747966833014,0.00200683467815174,-0.0204081926524788,-0.012541400714124,2.31397524599942e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFD,Complement factor D,24966,0.0113484987195903,0.00138229130419891,0.00863920776336041,0.0140577896758201,2.31938488273247e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,28706,0.0435786453583373,0.00531252181882281,0.0331661025934446,0.05399118812323,2.44153946475011e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,0.048142056826683,0.00586899710608176,0.0366388224987628,0.0596452911546033,2.44335458837159e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,28774,0.0410520288710127,0.00501026367295632,0.0312319120720184,0.0508721456700071,2.63975578578886e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.0603600020098623,0.0073690746122064,0.0459166157699377,0.0748033882497868,2.71684361431712e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0222051831793403,0.00271313965513922,0.0168874294552674,0.0275229369034132,2.86900928846752e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,24229,0.0369832087609617,0.00451968716187661,0.0281246219236835,0.0458417955982399,2.91095135590073e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASN,Vasorin,29065,-0.0158462323839839,0.00193744457478132,-0.0196436237505553,-0.0120488410174125,2.97929942932969e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO1,R-spondin-1,29218,0.0201395571689289,0.00246401376502943,0.0153100901894712,0.0249690241483866,3.11633480153138e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA11,Annexin A11,29373,0.0382903493201442,0.00468866328809044,0.029100569275487,0.0474801293648015,3.29851186183967e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,24833,0.0272448557384033,0.00334211649918085,0.0206943074000088,0.0337954040767978,3.74777080976664e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,24025,-0.0361333859778274,0.00443460194907733,-0.0448252057980189,-0.0274415661576358,3.87686649968652e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAEP,Glycodelin,29218,0.0754109016013301,0.00925777712679024,0.0572656584328212,0.0935561447698389,3.92057252180135e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.0508784693274337,0.00625237630457882,0.0386238117704592,0.0631331268844082,4.22338202397496e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENR,Density-regulated protein,24229,0.0330669412436277,0.00406365472388872,0.0251021779848059,0.0410317045024496,4.23648894756655e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FST,Follistatin,29536,0.0288786878335868,0.00355233990184478,0.021916101625971,0.0358412740412025,4.47841064667078e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,24240,-0.0372048474494972,0.00457633864679133,-0.0461744711972082,-0.0282352237017862,4.50294280686143e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,0.0335542742992691,0.004127850241019,0.0254636878268719,0.0416448607716663,4.53817288472296e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED8,Protein TMED8,24805,0.0590566735005245,0.00726826064955065,0.0448108826274053,0.0733024643736438,4.66955598021043e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,-0.0217468230406426,0.00267823361035069,-0.02699616091693,-0.0164974851643552,4.8510902900291e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40LG,CD40 ligand,29786,0.0443088339045002,0.0054594940217084,0.0336082256219517,0.0550094421870486,5.00515902397745e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,24966,-0.0174339062761519,0.00214864932692969,-0.0216452589569341,-0.0132225535953698,5.12631147440096e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,28774,0.034913747377803,0.00431209794496606,0.0264620354056695,0.0433654593499364,5.8684394507711e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,-0.0342945265741406,0.00423725987155434,-0.0425995559223871,-0.0259894972258941,6.05774639534661e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TF,Serotransferrin,24966,0.012352523708655,0.00152678342120906,0.00936002820308519,0.0153450192142247,6.20752505630538e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,0.0676263043896245,0.00836288576029894,0.0512350482994386,0.0840175604798104,6.41921543964827e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,0.0171376833218464,0.00212855711351639,0.0129657113793543,0.0213096552643385,8.55501222734847e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0183859849873804,0.00228385598771468,0.0139096272514596,0.0228623427233011,8.61726180384109e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,-0.0145710795922211,0.00181040161716479,-0.0181194667618641,-0.0110226924225781,8.69187824149762e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0376591293084873,0.00468034252588427,0.0284856579577542,0.0468326006592205,8.91664426279915e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,29301,0.0376436620515114,0.00467950490099575,0.0284718324455597,0.046815491657463,8.99400113610315e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR2,Complement receptor type 2,29594,0.0263302701777508,0.00327768189005089,0.019906013673251,0.0327545266822505,9.84669587085308e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,24381,0.0220489709647963,0.0027444511305623,0.0166698467488942,0.0274280951806984,9.85724388080773e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,0.0133128189229936,0.00165725443001696,0.0100646002401603,0.0165610376058268,9.86335373073986e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,0.022175625895551,0.00276175808141551,0.0167625800559766,0.0275886717351254,1.01531956716371e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRELP,Prolargin,29454,0.0131356823529082,0.00163670095341825,0.00992774848420843,0.016343616221608,1.04670819181023e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,0.0400915833749785,0.00499810168963792,0.0302953040632882,0.0498878626866688,1.09238936427229e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,0.0395510222334085,0.00493731800418224,0.0298738789452113,0.0492281655216057,1.19082524720874e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.019862111227561,0.00248426026342226,0.0149929611112534,0.0247312613438687,1.34178260982431e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,0.0456281342662472,0.00570912625549053,0.0344382468054857,0.0568180217270086,1.38490164879267e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,24240,0.0294270979065701,0.0036822162199354,0.0222099541154967,0.0366442416976435,1.39004951744046e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0159201894054964,0.00199274346900742,0.0120144122062419,0.019825966604751,1.41955821919923e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,0.035312800799792,0.00442094484267202,0.0266477489081548,0.0439778526914291,1.425561906651e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.0560648858982486,0.00702372321415492,0.0422983883985049,0.0698313833979922,1.49898482404399e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,24966,-0.0127614736782314,0.00159935971701856,-0.0158962187235878,-0.00962672863287504,1.53679899116583e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN9,Septin-9,29349,0.0159252499676585,0.00199697691495368,0.0120111752143493,0.0198393247209677,1.58297174848398e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0274820763701261,0.00344622288146424,0.0207274795224562,0.034236673217796,1.58437826764948e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0653015039151341,0.00819097390867821,0.0492471950541249,0.0813558127761434,1.61323843592673e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,-0.0238605820208963,0.00299602874486759,-0.0297327983608368,-0.0179883656809559,1.72406213089381e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,0.0241953899121514,0.00304243675836729,0.0182322138657516,0.0301585659585513,1.89161512556955e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0353054077588786,0.00443935975012948,0.0266042626486248,0.0440065528691324,1.90236383959796e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,29453,0.052321963182778,0.00661006137229883,0.0393662428930723,0.0652776834724837,2.54859382146671e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.0151760484154365,0.00192139348018224,0.0114101171942793,0.0189419796365937,2.92115626171718e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,0.0406698647423677,0.00515562578436031,0.0305648382050215,0.0507748912797139,3.16403924483141e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,29478,0.0447438926442014,0.0056767209407126,0.0336175196004047,0.0558702656879981,3.3325093006144e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.063045347949994,0.00802367932387764,0.0473189364751938,0.0787717594247942,4.0546756448568e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,0.0266498600742,0.00340245550724621,0.0199810472799975,0.0333186728684026,4.97647755211207e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,29478,-0.0196113411256599,0.00250648094440427,-0.0245240437766922,-0.0146986384746275,5.27700543618345e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0333587576001632,0.00427340567736804,0.0249828824725219,0.0417346327278046,6.1333062257005e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0447340850040348,0.00574032911598773,0.0334830399366989,0.0559851300713708,6.76140931607721e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,29688,0.0511723244990772,0.0065678719363739,0.0382992955037843,0.06404535349437,6.84758647651095e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX6,Syntaxin-6,28797,0.036915427065821,0.00474009730585412,0.0276248363463469,0.0462060177852951,7.04117643785123e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.0154493760636421,0.0019853089085726,0.0115581706028398,0.0193405815244444,7.37942466969043e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0388989923746761,0.0050070136184384,0.0290852456825368,0.0487127390668154,8.22122125470445e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,24229,0.0145129725503087,0.00186862651790719,0.0108504645752106,0.0181754805254068,8.3770709752767e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP6,Gastrotropin,28872,0.0307165473178221,0.00395785373953088,0.0229591539883415,0.0384739406473026,8.7100526697738e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0371431956759506,0.00478958963099302,0.0277555999992043,0.0465307913526969,9.17915840369297e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,29121,0.0311873824646777,0.00402522889632931,0.0232979338278722,0.0390768311014831,9.63973510834174e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRAXIN,Draxin,29218,0.0233214062922208,0.00301601182182144,0.0174100231214508,0.0292327894629909,1.08811089095258e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,0.041308798644365,0.00534239854537115,0.0308376974954375,0.0517798997932924,1.09719131334995e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,24195,0.0441879099897681,0.00571746493932672,0.0329816787086877,0.0553941412708484,1.12966778664452e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,29545,0.0140460837472931,0.00181801352490017,0.0104827772384888,0.0176093902560975,1.14432274498842e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0400433920142698,0.00518820426580536,0.0298745116532913,0.0502122723752483,1.21837885071408e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0197375951840173,0.00255704020137668,0.014725796389319,0.0247493939787156,1.21837920349567e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,29349,0.0510852425754969,0.00662995133849709,0.0380905379520426,0.0640799471989512,1.34729570235848e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,24195,0.0372600171384216,0.00483614094703132,0.0277811808822402,0.046738853394603,1.36394483624584e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX16,Syntaxin-16,28797,0.0315121477447183,0.0040919504548285,0.0234919248532544,0.0395323706361821,1.39319875538564e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,28867,0.0322718911633182,0.00420385807851428,0.0240323293294302,0.0405114529972062,1.68347708460019e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,0.064150400436631,0.00836166677139899,0.047761533564689,0.0805392673085731,1.75784601804019e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0345281661460395,0.00450109401808369,0.0257060218705955,0.0433503104214835,1.75963349423947e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,29536,0.0467294869950936,0.00609536075539332,0.0347825799145227,0.0586763940756645,1.82311550790533e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0405955943271467,0.00531007150073846,0.0301878541856993,0.051003334468594,2.16591914401862e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,24951,-0.0141584718104121,0.0018539230424414,-0.0177921609735973,-0.010524782647227,2.30250102063828e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,28745,0.0302048225897213,0.00395801694273308,0.0224471093819645,0.0379625357974781,2.39586048404497e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,29523,0.0296700220272954,0.00389086757071559,0.0220439215886929,0.037296122465898,2.50284343381972e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.0508054509386067,0.00666672517931719,0.037738669587145,0.0638722322900684,2.61223861013284e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXN,Thioredoxin,24647,0.023521300366898,0.00310234837136252,0.0174406975590274,0.0296019031747685,3.52879386707722e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0365121814604908,0.00481705198624736,0.027070759567446,0.0459536033535357,3.58567866061173e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.0261878215354696,0.00345703481091191,-0.0329636097648569,-0.0194120333060822,3.71265337747923e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,0.0565262157909296,0.00749056549953969,0.0418447074118318,0.0712077241700274,4.63086413135264e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,0.0256547557266462,0.00340414214676233,0.0189826371189921,0.0323268743343004,4.97499824495885e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0225171022847526,0.00298802380726305,0.016660575622517,0.0283736289469882,5.01957138497918e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSR,Insulin receptor,24229,0.00903706308904881,0.00120164450605844,0.00668183985717428,0.0113922863209233,5.64274738978799e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,24805,0.0324906354932892,0.00432474032468533,0.0240141444569059,0.0409671265296724,5.98588312758285e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,28774,0.0234982310147665,0.00313607698239958,0.0173515201292633,0.0296449419002697,6.93176814570929e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,28774,0.0176530613708636,0.00235681972685409,0.0130336947062295,0.0222724280354976,7.07397780595907e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,24845,0.0526631427038186,0.00703404723244311,0.0388764101282301,0.0664498752794071,7.28690197380795e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,0.0463881984431212,0.00619655920013312,0.0342429424108603,0.0585334544753821,7.32997185656671e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.0166242805007114,0.00222398926944571,0.0122652615325978,0.020983299468825,7.93999839729201e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,0.0258236189388639,0.00345839710103155,0.019045160620842,0.0326020772568857,8.43517918727809e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0200047024470329,0.00268059990645782,0.0147507266303756,0.0252586782636903,8.75082005066093e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0196798041183074,0.00263709254491926,0.0145111027302657,0.0248485055063492,8.75608127457419e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,24938,0.0437673134264053,0.00586812114165266,0.0322657959887661,0.0552688308640445,9.03757321323382e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,28669,-0.0472748823229163,0.00634255834997877,-0.0597062966888747,-0.0348434679569579,9.33937441952893e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",29725,0.0383302536620435,0.00515088257208691,0.0282345238207531,0.0484259835033338,1.02247399572758e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP2,Caspase-2,29434,0.0354270666703019,0.00476618418543223,0.0260853456668547,0.0447687876737491,1.09046185394171e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MB,Myoglobin,29820,0.0274220948962559,0.00369100540261426,0.0201877243071319,0.0346564654853798,1.11982300080004e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLB,Beta-klotho,28774,-0.0386679234947735,0.00520578968643543,-0.048871271280187,-0.0284645757093601,1.13424439970856e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,24016,0.0293854708022183,0.00396797351855094,0.0216082427058584,0.0371626988985781,1.34796999302186e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,28931,0.0293808085654373,0.0039682236481356,0.0216030902150915,0.037158526915783,1.35722839017523e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMTN,Smoothelin,24776,0.0493398095308275,0.00667136458634384,0.0362639349415936,0.0624156841200615,1.45066029010263e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNN,Tenascin-N,24938,0.022688043028958,0.00307230478887077,0.0166663256427713,0.0287097604151447,1.57590400321647e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,24720,-0.0146832527958037,0.00198985210607846,-0.0185833629237175,-0.0107831426678899,1.6442912305982e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,-0.019206325173412,0.00260291972613766,-0.0243080478366418,-0.0141046025101822,1.64780116815241e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0592643174840402,0.0080408027208342,0.0435043441512052,0.0750242908168753,1.7537519055845e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0315498391391178,0.00428488259163571,0.0231514692595118,0.0399482090187238,1.84488043693403e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0339534226641294,0.00461187794635013,0.0249141418892831,0.0429927034389756,1.8576754466059e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNR,Tenascin-R,29218,-0.0218186866226677,0.00296667775412946,-0.0276333750207614,-0.0160039982245739,1.96551326319472e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,0.0221600642973634,0.00301492707580144,0.0162508072287925,0.0280693213659342,2.04238324754891e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,29725,0.0222491222891868,0.00302832366280132,0.0163136079100963,0.0281846366682774,2.07902361412789e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0361799955268839,0.00492964201391655,0.0265178971796075,0.0458420938741603,2.21458697065367e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0115278194921377,0.0015719606941501,0.00844677653160349,0.0146088624526719,2.30250888685024e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,0.0396543065278318,0.0054068827744126,0.0290568162899831,0.0502517967656805,2.30364534526051e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.024697625073527,0.0033720660227375,0.0180883756689615,0.0313068744780925,2.47680676280667e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0770698445490555,0.0105436273194482,0.0564043350029371,0.097735354095174,2.74728941747631e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,24711,0.0249755453523729,0.00341738739904978,0.0182774660502353,0.0316736246545104,2.78603507506362e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",24445,0.02369749970033,0.00324401898312193,0.017339222493411,0.030055776907249,2.85800473002967e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMS,Spermine synthase,24101,0.0331032314221275,0.00453323341925484,0.024218093920388,0.041988368923867,2.91573717852937e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0161317425813944,0.00220942038172447,0.0118012786332144,0.0204622065295743,2.93693668010074e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,24951,-0.0309648009071848,0.00424221660987987,-0.0392795454625494,-0.0226500563518203,2.98136408371826e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0114765930191067,0.00157238651685449,0.00839471544607189,0.0145584705921415,2.98946847638738e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0413404717868725,0.00566421961589225,0.0302386013397237,0.0524423422340213,2.99893275581014e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.020452679465422,0.00280737947833169,0.0149502156878919,0.0259551432429521,3.30472870000999e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0259613517798248,0.00356501640327549,0.0189739196294048,0.0329487839302448,3.36705362205935e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,24111,0.0393200101210746,0.00540133644965515,0.0287333906797505,0.0499066295623987,3.44861996312895e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN4,Contactin-4,29443,-0.0122722823208885,0.00169173058306847,-0.0155880742637027,-0.00895649037807426,4.13780271528502e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,0.0265368068040066,0.0036587015062317,0.0193657518517924,0.0337078617562207,4.17674257071517e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.0388576305962697,0.00536551042730031,0.0283412301587611,0.0493740310337783,4.52545723329002e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.0388765681191303,0.00537343432312515,0.028344636845805,0.0494084993924556,4.77306827040916e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,24793,0.0228790608283913,0.00316518248787753,0.0166753031521514,0.0290828185046313,5.03039706575388e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,0.026775214007067,0.00370672759446479,0.0195100279219161,0.034040400092218,5.21979316604522e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0275088103489356,0.00380964922964455,0.0200418978588323,0.0349757228390389,5.2929430844515e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0195730408165271,0.00271119222833143,0.0142591040489975,0.0248869775840567,5.37394630168289e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.029443520989538,0.00408964381881487,0.0214278191046609,0.0374592228744152,6.1865836651916e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,28931,0.0303177651893264,0.00421511051189875,0.0220561485860048,0.0385793817926479,6.50946624243959e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,0.020555079008444,0.00286581516984582,0.0149380812755462,0.0261720767413418,7.53781764424952e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,24922,0.0363636083930604,0.00507045406123226,0.0264255184330451,0.0463016983530756,7.61585344145525e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0167056792959055,0.00233317538763106,-0.0212787030556623,-0.0121326555361486,8.28764431666811e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0114626706825582,0.00160206474658827,0.00832262377924517,0.0146027175858712,8.56636730785942e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,29725,0.0106490929342646,0.00148906060626139,0.00773053414599224,0.0135676517225369,8.77848834816098e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,28916,0.0245876147239693,0.00344160324100248,0.0178420723716044,0.0313331570763341,9.26409250582668e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD276,CD276 antigen,29454,0.0180698077483349,0.00253033254974372,0.0131103559508372,0.0230292595458326,9.461086988401e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,24867,0.0138498880442849,0.00194107350992622,0.0100453839648295,0.0176543921237403,9.93188073772246e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP3,Caspase-3,29820,0.0440685649199458,0.00618191497664712,0.0319520115657174,0.0561851182741741,1.03679887316145e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,29761,0.0299547055101154,0.00422017113175822,0.0216831700918692,0.0382262409283615,1.29425073761353e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0306771167728989,0.00432463870140455,0.022200824918146,0.0391534086276518,1.34298059485206e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,29163,0.0377115865339914,0.00531680016120245,0.0272906582180346,0.0481325148499482,1.34313853084506e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0205386479645848,0.00289907790729355,0.0148564552662894,0.0262208406628801,1.43235961645282e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0336276404748661,0.00475471026683278,0.0243084083518739,0.0429468725978584,1.55651310972084e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.029577096127463,0.0041886324588966,0.0213673765080256,0.0377868157469003,1.68646558427967e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0213497615475635,0.00303406455683741,0.0154029950161622,0.0272965280789648,2.01247959376692e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0454563825163912,0.00646999810770502,0.0327751862252894,0.0581375788074931,2.18459893454437e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0246174969536157,0.00350594882413585,0.0177458372583094,0.0314891566489219,2.25074356213586e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK4,Kallikrein-4,29725,0.0310034567760768,0.00442378419978201,0.022332839744504,0.0396740738076495,2.46274726621546e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,24789,0.0281826903128109,0.00403164319027427,0.0202806696598733,0.0360847109657484,2.8110760199085e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,0.0408664187054598,0.0058462599272248,0.0294077492480992,0.0523250881628204,2.81608755499996e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,0.0621223671267119,0.00888941853204724,0.0446991068038993,0.0795456274495245,2.85301714175723e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,0.0100870672102314,0.00144411507921752,0.00725660165496501,0.0129175327654977,2.92335475117864e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.022833768173608,0.00326956819624453,0.0164254145089687,0.0292421218382473,2.93493938452153e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD1,Polycystin-1,24922,0.0131179970068466,0.0018785758877071,0.00943598826694068,0.0168000057467525,2.96309149355377e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0338859027342727,0.00485319474767506,0.0243736410288296,0.0433981644397158,2.98083537036056e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,24381,0.0141491905082026,0.00202785544304303,0.0101745938398382,0.0181237871765669,3.08354757122998e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPT,Dermatopontin,29820,0.0128981891027938,0.00185273475272334,0.00926682898745604,0.0165295492181315,3.4314149783219e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST5,Cystatin-D,28890,0.0271415107317399,0.00390334054317517,0.0194909632671165,0.0347920581963632,3.64154921580443e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0304553296170264,0.00438354244975378,0.021863586415509,0.0390470728185438,3.80834126440404e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,0.0185861627079282,0.00267668613021509,0.0133398578927066,0.0238324675231498,3.91303116433502e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0361627284062521,0.00521010026912481,0.0259509318787675,0.0463745249337367,3.99381549506716e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,0.0355642899211527,0.00512480914433265,0.0255196639982608,0.0456089158440447,4.01287242914274e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,24966,0.0102157907026081,0.00147787135018974,0.00731916285623621,0.01311241854898,4.87640928351156e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,24195,0.0248363192442667,0.00359481467049703,0.0177904824900925,0.0318821559984408,5.00439411712357e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,29434,0.0188570406047919,0.00273087484386725,0.0135045259108121,0.0242095552987717,5.1176555356324e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRN1,Secernin-1,29434,0.0270585929984129,0.00392292943140562,0.0193696513128579,0.034747534683968,5.39774473894255e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,24111,0.0598103188491346,0.00868195254071266,0.0427936918693378,0.0768269458289314,5.75524509219529e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGA,Chromogranin-A,24938,0.0427322147740013,0.00620322996206115,0.0305738840483614,0.0548905454996411,5.76418496116241e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0342052267601867,0.0049655196372529,0.024472808271171,0.0439376452492024,5.7713945339617e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0194120426765694,0.0028261156922269,0.0138728559198046,0.0249512294333341,6.62721034200365e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.0133243037652535,0.0019439780249544,0.00951410683634293,0.0171345006941642,7.31480032082715e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0123784755097648,0.00180882282500846,-0.0159237682467813,-0.0088331827727482,7.91751586137347e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,-0.018188403597865,0.00266228813491833,-0.0234064883423049,-0.012970318853425,8.54832969669377e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,0.0251328807088304,0.00368233627927426,0.0179155016014529,0.032350259816208,8.94533238826899e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.0572219412378251,0.00839469996850782,0.0407683292995498,0.0736755531761004,9.51176855717494e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK1,Docking protein 1,24845,0.0657327846443717,0.00964406919682337,0.0468304090185979,0.0846351602701455,9.5834917088915e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RP2,Protein XRP2,29349,0.0200497749207919,0.00294399713997306,0.0142795405264447,0.0258200093151391,9.92096847923858e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,0.0231290459325112,0.00339937838497153,0.016466264297967,0.0297918275670554,1.03771160375254e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0320865366495259,0.00472257620452787,0.0228302872886513,0.0413427860104005,1.11395559107041e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0117913054426865,0.00174103023308493,0.00837888618584006,0.015203724699533,1.28854227954527e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0334622854372999,0.00495849747024985,0.0237436303956102,0.0431809404789896,1.52696754133255e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGB,Secretogranin-1,29590,0.0194758973540517,0.00289198328281623,0.0138076101197319,0.0251441845883715,1.67569033551252e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,29478,0.0319877844950512,0.00475066928744123,0.0226764726916664,0.041299096298436,1.68876041749588e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,24445,0.0139359641180742,0.00207134429046365,0.00987612930876543,0.0179957989273829,1.75835624051397e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,24951,-0.0116890259361625,0.00173845086215822,-0.0150963896259926,-0.00828166224633235,1.80846908821237e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0357559398694627,0.00532245844483428,0.0253239213175875,0.0461879584213379,1.87747369919392e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,28490,0.0124275047472232,0.00185049530093359,0.0088005339573934,0.0160544755370531,1.90589557379861e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,24445,0.0351568585513941,0.00524819755175084,0.0248703913499624,0.0454433257528257,2.14637520904813e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,0.0267552046420349,0.00399543812265851,0.0189241459216242,0.0345862633624456,2.18232692536614e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.0470322002744609,0.0070314973938887,0.0332504653824391,0.0608139351664828,2.29954580745545e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,0.0311269183696349,0.00465685280512664,0.0219994868715867,0.0402543498676831,2.36583703718779e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,24793,0.0242125864353349,0.00363622504894433,0.017085585339404,0.0313395875312658,2.82008383544646e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,24195,0.0321488698440162,0.0048325430465396,0.0226770854727985,0.0416206542152338,2.94153491567854e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.0459484465182221,0.00691943022081135,0.0323863632854318,0.0595105297510123,3.18190505487616e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0210474728136163,0.00317219189586408,0.0148299766977227,0.0272649689295099,3.31398969857703e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.0438144458986698,0.0066180113972685,0.0308431435600235,0.056785748237316,3.64195150846695e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,24793,0.0240666999306203,0.00364020152042592,0.0169319049505855,0.0312014949106551,3.88534563756685e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0333401405227122,0.00504461359409948,0.0234526978782772,0.0432275831671472,3.94603648990193e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,28757,0.0508978351083724,0.00770806641860106,0.0357900249279143,0.0660056452888304,4.09410081249778e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0189118112891171,0.00286704425456322,0.0132924045501732,0.024531218028061,4.30311748438383e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,28722,0.0328992186764344,0.00499436942723246,0.0231102545990588,0.0426881827538101,4.55751741390621e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0343277806098449,0.00522492787436763,0.0240869219760844,0.0445686392436055,5.13076217471727e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0336755327577281,0.0051267076758371,0.0236271857130874,0.0437238798023688,5.17951224008149e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,28797,0.0202722463626764,0.00308721316437545,0.0142213085605005,0.0263231841648523,5.23812699113434e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.0269492566108768,0.00410796597278438,0.0188976433042194,0.0350008699175341,5.46060317108104e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XG,Glycoprotein Xg,29693,0.014832839510168,0.00226359363996403,0.0103961959758385,0.0192694830444975,5.73984379442684e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.00941756477147271,0.00144040890736288,0.00659436331304147,0.0122407662299039,6.33117000647494e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,0.016183308812912,0.00247700733228985,0.0113283744416239,0.0210382431842001,6.55531739550134e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0267108754526422,0.00409676727614133,0.0186812115914052,0.0347405393138792,7.14708024928272e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.021802784284346,0.00334506023275645,0.0152464662281433,0.0283591023405486,7.24753736066437e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,24111,0.0176996597510404,0.00271791093187678,0.0123725543245619,0.0230267651775189,7.55020895205308e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0215037554417562,0.00330884321844494,0.0150184227336041,0.0279890881499083,8.22453571882383e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRGN,Neurogranin,24951,0.0419519216377385,0.0064625717258504,0.0292852810550717,0.0546185622204053,8.65708159725726e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17D,Interleukin-17D,28931,0.0155515861070472,0.0024014718328124,0.0108447013147349,0.0202584708993595,9.5787503907063e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,24229,0.0245513100330445,0.00379785180984738,0.0171075204857436,0.0319950995803453,1.03552133739195e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,24922,0.0244390926539347,0.00378270773206886,0.0170249854990797,0.0318531998087896,1.06115864746412e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,29434,0.035436676782059,0.00548593014561833,0.0246842536966471,0.0461890998674709,1.06648592783319e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0186834679398917,0.00289472785521965,0.0130098013436612,0.0243571345361222,1.10443707222694e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH5,Cadherin-5,29820,-0.0137384683881492,0.00213649176790583,-0.0179259922532446,-0.00955094452305377,1.29205072221353e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,24845,-0.0190797954013888,0.00296905928889865,-0.0248991516076302,-0.0132604391951474,1.33198150851135e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,29713,0.00959043066540375,0.001492625565098,0.00666488455781167,0.0125159767729958,1.33681772480192e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB1,Lamin-B1,24756,0.0266847475269175,0.0041596516436172,0.0185318303054278,0.0348376647484072,1.43237016313463e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMB,Granzyme B,29434,0.0292905532139479,0.00458471236328473,0.0203045169819098,0.0382765894459859,1.69752673319359e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0328983276124385,0.00514951510090261,0.0228052780146694,0.0429913772102076,1.69940848170967e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0200875716602627,0.00316101735672715,0.0138919776410775,0.0262831656794479,2.11786914876955e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,24793,0.036536170886621,0.00574903299873916,0.0252680662090923,0.0478042755641498,2.11796585953175e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.039272107393214,0.00617954213373807,0.0271602048110874,0.0513840099753406,2.11864717929837e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,0.0201057278133177,0.00316573959732512,0.0139008782025605,0.0263105774240749,2.16985892558905e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,0.0252031905728483,0.00397458976635302,0.0174129946307964,0.0329933865149002,2.32187103935702e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,29400,0.039083031794165,0.00617655629766518,0.0269769814507413,0.0511890821375887,2.52522566022607e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.0287703129547051,0.00455358360767445,-0.037695336825747,-0.0198452890836631,2.68451778106385e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.037745916554385,0.00597455427900969,0.026035790167526,0.049456042941244,2.69226653916907e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,24229,0.0534991689442864,0.00849491516612297,0.0368491352186854,0.0701492026698874,3.07111054198568e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,24867,0.0198055843298088,0.00314882258049653,0.0136338920720356,0.025977276587582,3.23088974729829e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0210183295496779,0.00334255548065449,0.0144669208075951,0.0275697382917607,3.26716398979234e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,29518,0.019929348323466,0.00318450498641168,0.0136877185500991,0.0261709780968329,3.94732611596799e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,24240,0.0518444854909627,0.00830624196241462,0.0355642512446301,0.0681247197372954,4.40213523449817e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,24381,0.0419373235301049,0.00672353728427337,0.0287591904529291,0.0551154566072807,4.522447277326e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.0114467363642508,0.00183545093383993,0.00784925253392455,0.0150442201945771,4.53554670310462e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,29443,0.0393588685485548,0.00631932904854136,0.0269729836134138,0.0517447534836959,4.77803514006726e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.0250891932117835,0.00402908581530156,0.0171921850137924,0.0329862014097745,4.81795015282046e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F3,Tissue factor,29541,-0.0119626654961092,0.00192196073025826,-0.0157297085274154,-0.00819562246480301,4.90525805108506e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C5,Complement C5,24966,0.00666546081550055,0.00107159092956643,0.00456514259355035,0.00876577903745076,5.04550523401481e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,29478,-0.0306494714699487,0.00492951000508719,-0.0403113110799196,-0.0209876318599778,5.11749664124094e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,0.0382253293472963,0.00615331386815946,0.0261648341657038,0.0502858245288888,5.29592346835394e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0299436622499719,0.00482783477420147,0.020481106092537,0.0394062184074067,5.65497255552422e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.0463557394979549,0.00748801841896216,0.0316792233967891,0.0610322555991207,6.08681814310774e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,24381,0.0144566105180383,0.00234122852589078,0.00986780260729239,0.0190454184287843,6.72950890689471e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,0.0243692014146216,0.00394711370746141,0.0166328585479972,0.0321055442812459,6.74833122287917e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBN1,Drebrin,24229,0.0223130688128196,0.00363259166487905,0.0151931891496567,0.0294329484759826,8.25155514067766e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,29478,0.037371588509,0.00608620949711376,0.025442617894657,0.0493005591233429,8.33795486304656e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA1,Annexin A1,24281,0.0185876681152813,0.00303086515419025,0.0126471724130684,0.0245281638174942,8.76829797758836e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0250087144914159,0.00408285421829319,0.0170063202235613,0.0330111087592706,9.16833860259033e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,-0.0103276239898696,0.00168758507121731,-0.0136352907294555,-0.00701995725028367,9.48992933987729e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,0.0132757523367399,0.00216937213692761,0.00902378294836179,0.017527721725118,9.49981547277061e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD84,SLAM family member 5,29434,0.0134175302635235,0.00219619708250569,0.00911298398181237,0.0177220765452347,1.01235617933516e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,24867,0.0334699250187866,0.00548320848280102,0.0227228363924966,0.0442170136450766,1.04926942985716e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,29443,0.0188874518276676,0.00309772000855769,0.0128159206108945,0.0249589830444406,1.09276964421317e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0265072274023113,0.00435023690507708,0.0179807630683602,0.0350336917362623,1.12014633011849e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0187741899060624,0.00308267518580973,0.0127321465418753,0.0248162332702495,1.14409999659537e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0312533229889354,0.00513890070997872,0.0211810775973771,0.0413255683804936,1.20633495816242e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,24922,0.0419080442094792,0.00691813211347215,0.0283485052670738,0.0554675831518846,1.40051108911344e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK13,Kallikrein-13,28845,0.0187738938775276,0.00310233698918424,0.0126933133787265,0.0248544743763287,1.45242005739602e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,28852,0.0312088761832,0.00516146842602865,0.0210923980681839,0.0413253542982162,1.49833518786007e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,24111,0.025709303094027,0.00425249899573505,0.0173744050623863,0.0340442011256677,1.50956459269536e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0416638374422348,0.00689262728656065,0.0281542879605759,0.0551733869238937,1.5150613834815e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00897955174954192,0.00148660308867794,-0.0118932938033507,-0.00606580969573316,1.56054574881007e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,24793,0.017898543673455,0.00296348270607364,0.0120901175695506,0.0237069697773593,1.56600564720034e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0240728568932081,0.00398739414033398,0.0162575643781536,0.0318881494082627,1.5906439693806e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,24922,0.0224640826559211,0.00372684565550603,0.0151594651711293,0.0297687001407129,1.68709791391532e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP8,Caspase-8,29632,0.026024549389749,0.00432561188186136,0.0175463501013007,0.0345027486781972,1.80445060332009e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.015947371257369,0.00265213161737263,0.0107491932873186,0.0211455492274194,1.84684850261385e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0230237240832898,0.00383557515650053,0.0155059967765488,0.0305414513900309,1.96786726470291e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0325466949301599,0.00542479325077737,0.0219141001586362,0.0431792897016835,2.00613612316871e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.0120472272734646,0.00200944011186489,0.0081087246542094,0.0159857298927198,2.05472501626964e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0376568241381199,0.00630018897468553,0.0253084537477363,0.0500051945285035,2.30310462179475e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,24240,0.0125898778389286,0.00211237242910027,0.00844962787789211,0.0167301277999652,2.55623484778581e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,29327,0.0248363564211865,0.00416813181514926,0.016666818063494,0.0330058947788791,2.5726197342129e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,28931,0.0226599167341561,0.00380765541810428,0.0151969121146717,0.0301229213536405,2.69333607265853e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0278667651486256,0.00469586461801613,0.018662870497314,0.0370706597999372,2.98338166707626e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,0.0343242239947832,0.00578708524705265,0.02298153691056,0.0456669110790064,3.04106858860102e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRTN,Neurturin,28931,0.0206301282878841,0.00347851578400055,0.013812237351243,0.0274480192245252,3.05019594382246e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.01719216652424,0.00290301736672285,0.0115022524854632,0.0228820805630168,3.21978076732667e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,24229,0.0139751522528782,0.00236163567760699,0.00934634632476852,0.0186039581809879,3.31121210869875e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0244500474702362,0.00414041521460337,0.0163348336496136,0.0325652612908588,3.56893275587225e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,0.0256269697318962,0.00434349457537403,0.0171137203641631,0.0341402190996293,3.6819721132914e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,29165,-0.0199118505883009,0.00338029787692398,-0.0265372344270719,-0.0132864667495299,3.8910717908133e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.022157671474124,0.00376511931448194,0.0147780376177394,0.0295373053305086,4.02411051772415e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.014425903522185,0.00245123375770604,0.00962148535708118,0.0192303216872889,4.02757366845335e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,29820,-0.0113736534939121,0.00193281825869474,-0.0151619772809538,-0.00758532970687041,4.03542721068241e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7,Interleukin-7,29434,0.0264774471076092,0.00452611112331345,0.0176062693059148,0.0353486249093035,4.96970852843409e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0196797005009149,0.00336902033654864,0.0130764206412796,0.0262829803605503,5.23306392673621e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0199888240706307,0.00342254305006142,0.0132806396925103,0.026697008448751,5.27601118644133e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN10,Ataxin-10,28774,0.0297381524601904,0.00511473121531559,0.0197132792781719,0.039763025642209,6.15620938185659e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.0207442047371717,0.00357027015493057,0.0137464752335078,0.0277419342408356,6.30221862518455e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.0132179588212188,0.00227588231897664,0.00875722947602463,0.017678688166413,6.40549019889203e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.0290417614091333,0.00500469016783472,0.0192325686801772,0.0388509541380893,6.5837444287927e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.0442049954414686,0.00761740515556713,0.0292748813365571,0.0591351095463802,6.58703522068457e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,0.0207902671630912,0.00359867747214057,0.0137368593176957,0.0278436750084867,7.68901721725333e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,24016,0.0146882010594892,0.00254998164091652,0.00969023704329281,0.0196861650756856,8.50804587930483e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,29478,0.0308818969886775,0.00536581854815939,0.0203648926342851,0.0413989013430699,8.73446782696617e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK8,Kallikrein-8,28443,0.0145119386137938,0.00252774389074311,0.00955756058793731,0.0194663166396503,9.5040486387049e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,24195,0.0242169749150068,0.0042193977423564,0.0159469553399882,0.0324869944900253,9.61261379761999e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,29434,0.0359341404653351,0.00626431484129984,0.0236560833763874,0.0482121975542828,9.77009964547879e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,28774,0.0144121066520816,0.00252439466318305,0.00946429311224284,0.0193599201919204,1.14669492361901e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK14,Kallikrein-14,29725,-0.0184714306599922,0.00324284581195093,-0.0248274084514161,-0.0121154528685684,1.23767534367643e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.019028722562408,0.00334193110624923,0.0124785375941595,0.0255789075306565,1.25355252579869e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,28797,0.0323039850394234,0.00568237411782301,0.0211665317684903,0.0434414383103565,1.32119499430354e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,24920,0.0147063509271664,0.00260557831887804,0.00959941742216539,0.0198132844321673,1.67774903775122e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0170973837453683,0.00303034042410578,0.011157916514121,0.0230368509766157,1.69852538358176e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.02090912725106,0.00370871712101519,0.0136400416938702,0.0281782128082497,1.7381484841751e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,0.0194525298430383,0.00345550981833493,0.0126797305991019,0.0262253290869748,1.82453289130898e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00627821641575132,0.00111527880928855,0.00409226994954576,0.00846416288195689,1.82588992086029e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0347094993287049,0.00616585526358301,0.0226244230120822,0.0467945756453276,1.82918131627819e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0409018325502078,0.00726686826829916,0.0266587707443415,0.0551448943560742,1.83708167245177e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,24381,-0.00857361831538671,0.00152699071678681,-0.0115665201202889,-0.00558071651048457,1.99029071707224e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,-0.014603141216576,0.00261205678010651,-0.0197227725055847,-0.00948350992756722,2.28633608553398e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,-0.00938624194183323,0.00168237962790659,-0.0126837060125301,-0.00608877787113632,2.43821465331755e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,24111,-0.0141290212290857,0.00253482216236152,-0.0190972726673143,-0.00916076979085713,2.51663473466058e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,24240,0.0168310173195854,0.00302174661277176,0.0109083939585527,0.022753640680618,2.57497030885403e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0339318692563744,0.00611443565696039,0.0219475753687321,0.0459161631440168,2.89537735679593e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.0435411282668902,0.00786068990036983,0.0281341760621654,0.0589480804716151,3.06691902038488e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRL,Prolactin,29694,0.0295000218365876,0.00532658228098298,0.0190599205658609,0.0399401231073142,3.08069318801468e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0244177270754488,0.00440973041190141,0.0157746554681221,0.0330607986827756,3.10375864910573e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM,Paralemmin-1,24657,0.0116830854690674,0.00211437431037469,0.00753891182073301,0.0158272591174018,3.31771990267027e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,29725,-0.0232020017045079,0.0042054601661995,-0.031444703630259,-0.0149592997787569,3.47483376957057e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0239829938279926,0.00434785665150806,0.0154611947910368,0.0325047928649484,3.50246310120066e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,-0.0153551520561398,0.00278841222727535,-0.0208204400215995,-0.0098898640906801,3.68522169481696e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.0492305342630904,0.00894288824269921,0.0317024733074,0.0667585952187809,3.72831369642785e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,0.0300404429696494,0.0054585883745107,0.0193416097556084,0.0407392761836903,3.76445830237143e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0216512938129876,0.00393782708070625,0.0139331527348034,0.0293694348911719,3.87393821046515e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,29491,0.0249553682883512,0.00454308774979744,0.0160509162987482,0.0338598202779542,3.98331876042711e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0148686857833545,0.00271267473178451,0.00955184330905683,0.0201855282576521,4.2657873547827e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0130701718947402,0.00238637919309464,0.00839286867627469,0.0177474751132057,4.36171413964096e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,0.0370907850560856,0.00677176121187908,0.0238181330808026,0.0503634370313686,4.36223861508287e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0208478058310616,0.00380821393330873,0.0133837065217765,0.0283119051403467,4.4328084972582e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,29443,-0.0308086135544082,0.00563787812973949,-0.0418588546886976,-0.0197583724201188,4.67774480854899e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0106096700649033,0.00194377031011516,0.00679988025707755,0.014419459872729,4.84699361169174e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,28931,0.0315344771523696,0.00578447879043664,0.0201968987231138,0.0428720555816254,5.03356906120732e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,24966,0.012608105635857,0.00231521428503272,0.00807028563719284,0.0171459256345211,5.20708210317218e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LXN,Latexin,29117,-0.0256570887350086,0.00473118069034897,-0.0349302028880925,-0.0163839745819246,5.90804381637695e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGN,Cingulin,24195,0.0153352853440692,0.00282895580176264,0.00979053197261438,0.0208800387155239,5.98907397222411e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0281373087312128,0.00519474765966371,0.0179556033182719,0.0383190141441537,6.13581951106325e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,24229,0.0149616005892866,0.00276471838275453,0.00954275255908777,0.0203804486194855,6.30503324621838e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.0155594403393515,0.00287568201139672,0.00992310359701393,0.0211957770816891,6.3271419177453e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,24101,0.0324488820464585,0.00600844465494172,0.0206723305227728,0.0442254335701443,6.70670756387002e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR1,Complement receptor type 1,24903,0.0136860194823528,0.00254626460157014,0.0086953408632753,0.0186766981014303,7.72968463713266e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB9,Serpin B9,29218,0.0125191050611891,0.00233216227526876,0.00794806700166234,0.0170901431207159,8.02100663505311e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00775655322854612,0.00144530786081833,-0.0105893566357501,-0.00492374982134218,8.09244343328132e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0150040175934154,0.00281001183568007,0.00949639439548249,0.0205116407913483,9.39164956971496e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,29566,0.0297404295357611,0.0055744523095478,0.0188145030090474,0.0406663560624747,9.61778121623853e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.010245872446303,0.00192069862086728,0.00648130314940312,0.0140104417432029,9.6554147112227e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,24111,0.0226644446623951,0.00424894436191297,0.0143365137130457,0.0309923756117445,9.68662890314251e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,29313,0.0260670848192791,0.00489184421352535,0.0164790701607694,0.0356550994777887,9.96578293342228e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,-0.0123359573521338,0.00231502993813684,-0.016873416030882,-0.00779849867338555,9.98112329466347e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCP1,Plastin-2,24938,0.0178113806573828,0.00335209313550994,0.0112412781117834,0.0243814832029823,1.0845659951703e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.0153538503019529,0.00289421571723195,0.00968118749617829,0.0210265131077275,1.13468606782181e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0218391183591152,0.00412782997446728,0.0137485716091593,0.0299296651090711,1.22897240186208e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.0446263040540605,0.00845231878997702,0.0280597592257056,0.0611928488824155,1.30262937901726e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK6,Kallikrein-6,29519,0.011365377080506,0.0021527770305809,0.00714593410056741,0.0155848200604445,1.30521747517921e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,29565,0.0143362130000743,0.00271679453094219,0.00901129571942758,0.019661130280721,1.32323746865489e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN15,Lipocalin-15,24867,0.0232185918371719,0.00440875002216381,0.0145774417937308,0.031859741880613,1.4022130205832e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0123753638946855,0.00234986833056811,0.00776962196677201,0.016981105822599,1.40277386399362e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.0440830758857253,0.00839068637384146,0.027637330592996,0.0605288211784545,1.50017432797783e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0236754886542038,0.0045122556470543,0.0148314675859774,0.0325195097224302,1.55764597510563e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FN1,Fibronectin,24966,0.00992194539784446,0.00189156650944338,0.00621447503933543,0.0136294157563535,1.5725038935526e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,0.0200363493388038,0.00381987625732849,0.01254939187444,0.0275233068031677,1.57351990342445e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0151002881953172,0.00287914991623543,0.00945715435949574,0.0207434220311386,1.57848039764377e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0155572760708689,0.00297298552959379,0.0097302244328651,0.0213843277088728,1.68247203723703e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,0.0234324961503888,0.00447981601225259,0.0146520567663738,0.0322129355344039,1.700312025527e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,0.00977817117488648,0.00187061245551688,0.0061117707620734,0.0134445715876996,1.73429674756623e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.108566196894293,0.0207867294839746,0.067824207105703,0.149308186682883,1.77376764310219e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0366961862971512,0.00702987406705296,0.0229176331257274,0.050474739468575,1.80372397582024e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO1A,Coronin-1A,28847,0.0325704377354171,0.00627854148905704,0.0202644964168653,0.0448763790539689,2.14483874814891e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0322072024413335,0.00621240828217863,0.0200308822082633,0.0443835226744036,2.18547569040713e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0238386138505148,0.00459885142328749,0.0148248650608713,0.0328523626401583,2.19373025840633e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A13,Protein S100-A13,24229,0.0128883579655688,0.00249024177932783,0.00800748407808623,0.0177692318530513,2.29059991956239e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.0128959093779858,0.00249518945923717,0.00800533803788095,0.0177864807180907,2.38048187035481e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,28753,-0.0168444319727681,0.00326148577929236,-0.0232369441001812,-0.0104519198453551,2.42494894980842e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELL,L-selectin,24966,-0.00846540207788166,0.00164124674839117,-0.0116822457047284,-0.00524855845103497,2.51630362117053e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_A,,24867,0.0119269617464216,0.0023144514010907,0.0073906370002838,0.0164632864925593,2.57958348321323e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,24016,0.0132960405811472,0.00258364336426023,0.0082320995871971,0.0183599815750972,2.6785663124855e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTC,Probetacellulin,28797,0.0269301498380735,0.00524358460686149,0.016652724008625,0.037207575667522,2.82733302144661e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0134673812499112,0.00262253231195637,0.00832721791847675,0.0186075445813457,2.83887701520286e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0212972329494982,0.00415683843215501,0.0131498296224744,0.0294446362765221,3.01977084287975e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00779212020271086,0.00152321832499683,-0.0107776281197046,-0.00480661228571708,3.15122988229963e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,0.0307238656233131,0.00601830958433119,0.018927978838024,0.0425197524086023,3.33180359447011e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,0.0233804746454176,0.0045876495426384,0.0143886815418464,0.0323722677489889,3.48718720406915e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0251791420089182,0.00494111571292135,0.0154945552115924,0.0348637288062441,3.49802974334671e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.0434313150363228,0.00852480966333104,0.026722688096194,0.0601399419764517,3.51457945312204e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,0.027749699374654,0.00545705981998375,0.0170538621274858,0.0384455366218222,3.69733203965182e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_DRA,,29322,0.0129005584566969,0.00254284774722572,0.00791657687213447,0.0178845400412593,3.93417455035441e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP9,Caspase-9,24229,0.0225604763348642,0.00445928372964226,0.0138202802247653,0.031300672444963,4.24061085160977e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0176425031458633,0.00349171586328822,0.0107987400538184,0.0244862662379082,4.38761137423421e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0180421966879408,0.00357134155085624,0.0110423672482626,0.025042026127619,4.40021264606326e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,29349,0.0479751948292645,0.00950034017618656,0.0293545280839389,0.0665958615745902,4.4482727330835e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,0.0177694711193051,0.00351986417594131,0.0108705373344601,0.0246684049041501,4.48828587247392e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,24867,0.0105968068809037,0.00210123297681286,0.00647839024635054,0.0147152235154569,4.61179632227935e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,24805,0.0159015751398213,0.00315817601800698,0.00971155014452763,0.022091600135115,4.81069657671336e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,24867,0.0244640252702727,0.00486939846235547,0.014920004284056,0.0340080462564894,5.09477225506954e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0144314235390889,0.00288098913534369,0.00878468483381526,0.0200781622443625,5.49825799368097e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0172406540636915,0.00345406984360217,0.0104706771702313,0.0240106309571518,6.03472873580362e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,28797,0.0255358894649552,0.00513184902895875,0.0154774653681961,0.0355943135617144,6.52982213832981e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0137196595740101,0.00276129662497263,0.00830751818906374,0.0191318009589565,6.79131481555906e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPTC,Opticin,29349,-0.0157835661939461,0.0031786390867358,-0.0220136988039483,-0.00955343358394396,6.89047582621293e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0269820741291744,0.00546582041510554,0.0162690661155676,0.0376950821427813,8.00613724337451e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL34,Interleukin-34,28722,0.012535872537398,0.00254214102150217,0.00755327613525379,0.0175184689395423,8.21708957309682e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,24951,0.0091434300838898,0.00185610083582829,0.00550547244566635,0.0127813877221133,8.44025352670294e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,24951,-0.0209305583170702,0.00425305408431457,-0.0292665443223267,-0.0125945723118136,8.65189412728568e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,0.0129495054162813,0.00263357471225103,0.00778769898026931,0.0181113118522933,8.84050203730173e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,29434,-0.00917225222264672,0.00186595019327027,-0.0128295146014564,-0.005514989843837,8.89899502287732e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,28774,0.013192421419181,0.00268718583816361,0.00792553717638029,0.0184593056619817,9.186405083733e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,0.0827478888287604,0.0169245372279081,0.0495757958620606,0.11591998179546,1.0186512477011e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.0094770241906739,0.00193849542139617,0.0056775731647374,0.0132764752166104,1.01955481500325e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD8,Frizzled-8,24101,0.0151941248501846,0.00312367626295171,0.00907171937479922,0.0213165303255699,1.15657213691818e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0218330796390187,0.00449634789967708,0.0130202377556516,0.0306459215223858,1.20683281941662e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.030093317647819,0.00620793700129784,0.0179257611252752,0.0422608741703627,1.25640581455991e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,0.0101504308181711,0.00209930791560057,0.00603578730359395,0.0142650743327482,1.33852330662355e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,24240,0.010179248397078,0.00210626850256393,0.00605096213205267,0.0143075346621033,1.35425844952831e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.0349330320699045,0.00723316949345432,0.020756019862734,0.049110044277075,1.3766956472632e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0159007690913531,0.00329702363011546,0.0094386027763268,0.0223629354063794,1.42420336370404e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2,Ataxin-2,24101,0.0376992772572792,0.00786711617869633,0.0222797295470344,0.053118824967524,1.66104448642508e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.0138904595447182,0.00291118842185882,0.00818453023787495,0.0195963888515615,1.83822140059352e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0384369816255202,0.00806919422817134,-0.054252602312736,-0.0226213609383044,1.91250038186457e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.0127087724288502,0.00266832083950703,0.00747886358341647,0.017938681274284,1.91989454894598e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0153023111138985,0.00321382183931977,0.00900322030883171,0.0216014019189652,1.93359376101523e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX3,Syntaxin-3,24845,0.0129130818629973,0.00271302242436505,0.0075955579112418,0.0182306058147528,1.95004546095764e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,28797,0.011920007850618,0.0025064428103163,0.00700737994239803,0.0168326357588379,1.98670648275215e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',24111,0.0144181050417845,0.00304179876766916,0.0084561794571529,0.020380030626416,2.14945573335822e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,24833,0.0104983412485594,0.0022198443741006,0.00614744627532225,0.0148492362217966,2.26517350535675e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST1,Cystatin-SN,21656,0.0352423650061632,0.00745340566008792,0.0206336899123908,0.0498510400999355,2.2776906401073e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRH,Corticoliberin,28751,-0.0289410342403594,0.00612448443322911,-0.0409450237294885,-0.0169370447512304,2.30675534152058e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,24195,0.0218015424660344,0.00462526791886126,0.0127360173450663,0.0308670675870025,2.44764473467569e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,0.0221616283505027,0.00470780319085788,0.0129343340964213,0.0313889226045842,2.52027747060466e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,24556,0.0204663860493403,0.00436459084686556,0.0119117879894838,0.0290209841091968,2.75766460039786e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.0094864986063506,0.00202444082076821,0.00551859459764492,0.0134544026150563,2.80097013384475e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0190293137370912,0.00406152370961095,0.0110687272662537,0.0269899002079286,2.8088171655178e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,24111,0.0206743740940545,0.00442361626050319,0.0120040862234683,0.0293446619646408,2.97512968547751e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBLN2,Fibulin-2,24938,0.0103732861291469,0.00222007713093099,0.0060219349525222,0.0147246373057717,2.99125347557587e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0197098281884854,0.00422115427584372,0.0114363658078318,0.0279832905691391,3.03850736783361e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.017269282726501,0.00370820431650411,0.010001202266153,0.0245373631868491,3.22440526343603e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0147687089961976,0.00318229974580823,0.00853140149441352,0.0210060164979818,3.48683984988141e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,24229,0.00709797921977297,0.00153744747208369,0.00408458217448894,0.010111376265057,3.91835758773977e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC16,Mucin-16,29349,0.0613921454141817,0.0133039473573329,0.0353164085938092,0.0874678822345541,3.95554158769573e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.0124175081742585,0.00269610814118387,0.0071331362175381,0.0177018801309789,4.13142842870541e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,28931,0.0199508639347147,0.00433461648604637,0.0114550156220638,0.0284467122473656,4.18854945723826e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFP,Properdin,24966,0.00746412117921101,0.00162867998207335,0.00427190841434724,0.0106563339440748,4.60732888300293e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,24195,0.0224353703338889,0.00491913227413349,0.0127938710765873,0.0320768695911906,5.11995639799082e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,29732,-0.0114609233487572,0.00251841449959639,-0.0163970157679662,-0.00652483092954833,5.36413620592404e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARTN,Artemin,28931,0.0143221217243475,0.00315029677112912,0.00814754005293442,0.0204967033957606,5.48243505635288e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,0.0240583021390442,0.0052930691171436,0.0136838866694427,0.0344327176086456,5.51377760524255e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,24867,0.00972465080665506,0.00214751731053082,0.00551551687801464,0.0139337847352955,5.97298757498981e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.0177285195588497,0.00391806155382279,0.010049118913357,0.0254079202043424,6.06837956827283e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.0102803346571949,0.00228030904818122,0.00581092892275967,0.0147497403916301,6.56546032831075e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG1,Arginase-1,29216,0.0164089689907266,0.00364175186080878,0.00927113534354145,0.0235468026379118,6.63827721342334e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.00896493570064107,0.00199108915606341,0.00506240095475679,0.0128674704465254,6.74626935349323e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0131369608068061,0.0029213990014529,-0.0188629028496537,-0.00741101876395837,6.9303935687387e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,24845,0.0163684234595319,0.00364457273954742,0.00922506089001894,0.0235117860290448,7.11494034017461e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,-0.00904164807087324,0.00201358826348839,-0.0129882810673105,-0.00509501507443601,7.13843291886935e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.00660754837777674,0.00147621708295728,0.00371416289518047,0.009500933860373,7.63403911022492e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,-0.0147376723400887,0.00329328855681754,-0.0211925179114511,-0.0082828267687263,7.66752170587181e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,-0.00593750873331235,0.00132883712791933,-0.00854202950403424,-0.00333298796259046,7.92282256357906e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.00895201929737814,0.00200538876192892,0.00502145732399746,0.0128825812707588,8.07485349395968e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.017274911956732,0.00388169539475251,0.00966678898301713,0.024883034930447,8.61023129398833e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0214171221436807,0.00481295684564144,-0.0308505175611379,-0.0119837267262235,8.62882382215167e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0245373696088185,0.00552262552517397,-0.0353617156381595,-0.0137130235794775,8.90103220341327e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO2,Gamma-enolase,29694,0.0204042672058817,0.00460095544633239,0.0113863945310702,0.0294221398806932,9.24931678429441e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11,Coagulation factor XI,24606,-0.00971650100833229,0.00219394787283303,-0.014016638839085,-0.00541636317757954,9.51783408920573e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,0.0142850176421221,0.00323187486493929,0.00795054290684109,0.0206194923774031,9.911318993175e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,29434,0.0161762703227386,0.00366244372840523,0.00899788061506436,0.0233546600304129,1.00531293349512e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,24938,-0.0155590865761927,0.00352887142039439,-0.0224756745601658,-0.00864249859221974,1.04243235622962e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.0103483913204271,0.00234800237932097,0.00574630665695796,0.0149504759838962,1.05108283423667e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,0.0122716779982235,0.00278787109117633,0.00680745065951789,0.0177359053369291,1.07728820963132e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,29443,0.00744811610173108,0.00169279969379341,0.004130228701896,0.0107660035015662,1.08690890014749e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,24845,0.0299232943859381,0.0068403375630158,0.0165162327624271,0.0433303560094491,1.22187206469517e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,0.0335479743812743,0.00769848049727853,0.0184589526066084,0.0486369961559402,1.31858005497304e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.00941644751428734,0.00216586502299426,-0.0136615429593561,-0.00517135206921858,1.38162996537902e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,0.0257511545506088,0.00593233563673348,0.0141237767026112,0.0373785323986065,1.42439051132357e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,28774,0.0205380819725345,0.00474492516279183,0.0112380286534625,0.0298381352916064,1.50682113728792e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,0.012163014992346,0.00281787190723321,0.00663998605416892,0.0176860439305231,1.59129004571854e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.013875620117184,0.00321975170831677,-0.0201863334654849,-0.00756490676888317,1.64127229676437e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0117738265014022,0.00273257537144806,0.00641797877336401,0.0171296742294404,1.64869715533475e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0203746900029233,0.00472941673952843,0.0111050331934476,0.029644346812399,1.65314030997621e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0221150348060769,0.00514133390695616,0.0120380203484428,0.032192049263711,1.70259085640636e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,24867,0.0181446384925029,0.00422087442293754,0.0098717246235453,0.0264175523614605,1.72389223040253e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,28916,0.0159038296696854,0.00370182382260983,0.00864825497737014,0.0231594043620007,1.74306480394191e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL33,Interleukin-33,28931,0.0117539354940821,0.00274277581157286,0.00637809490339929,0.0171297760847649,1.82986886233474e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST6,Cystatin-M,28830,0.0147051401116802,0.00343456343348156,0.00797339578205633,0.0214368844413041,1.86223748683569e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.0137979012128472,0.00323405669553848,-0.0201366523361026,-0.00745915008959174,1.99235835670312e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPS,Colipase,29400,0.0212668836141181,0.00498581359255406,0.0114946889727121,0.031039078255524,2.00096769529294e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,0.01205027098014,0.00283993486710294,0.00648399864061822,0.0176165433196618,2.21202303572795e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,24381,0.010874777153136,0.0025630575840668,0.00585118428836509,0.015898370017907,2.21472140937736e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,24381,0.0230432404044563,0.00543219987045714,0.0123961286583603,0.0336903521505523,2.22381634628971e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,0.0293431539432153,0.00694800885193772,0.0157250565934174,0.0429612512930133,2.41666811147093e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.0295754120401012,0.0070232054091115,0.0158099294382426,0.0433408946419597,2.54886582481183e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.0117340210171109,0.00278707773325933,0.00627134865992259,0.0171966933742992,2.56124021792332e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,29434,0.01785764971786,0.00424622137374164,0.00953505582532635,0.0261802436103936,2.6123059992526e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.010549133829019,0.00250888786537444,0.00563171361288508,0.0154665540451529,2.62334974871034e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBN2,Fibrillin-2,24195,0.0180117847341457,0.0042840915693014,0.009614965258315,0.0264086042099765,2.62784103062141e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0428485264337902,0.0102062243246332,0.0228443267575092,0.0628527261100713,2.69765075528204e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,24867,0.00758627392742212,0.00180847074832009,0.00404167126071476,0.0111308765941295,2.73991764827017e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,0.0112898570409849,0.00269400884538795,0.00600959970402447,0.0165701143779452,2.79046552079801e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0181336948574489,0.00433601207998206,0.00963511118068409,0.0266322785342138,2.89798435069696e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,24445,-0.0101733515424469,0.00243799621302229,-0.0149518241199706,-0.00539487896492317,3.01874975903404e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,-0.0174402321132306,0.00418316284691423,-0.0256392312931825,-0.00924123293327872,3.06622994103025e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,0.0129666843388355,0.00311666350235129,0.00685802387422692,0.019075344803444,3.18738832055993e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,-0.0147517941110628,0.00356582571723806,-0.0217408125168494,-0.00776277570527622,3.53047538689001e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,0.0402955544483771,0.00975050050551232,0.0211845734575729,0.0594065354391813,3.59751762330308e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0163348392954374,0.00395963686728346,0.00857395103556183,0.024095727555313,3.7139638491776e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,0.0123384853875157,0.00299394358892204,0.00647035595322847,0.0182066148218029,3.78253642143314e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,24111,-0.00920534903045,0.00223379306560642,-0.0135835834390386,-0.00482711462186142,3.78574463925591e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.0130854669776641,0.00318844074940737,0.0068361231088257,0.0193348108465026,4.07121777746422e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,24069,0.0285014154652851,0.00696455828889343,0.014850881219054,0.0421519497115163,4.28414098937324e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0203887909612921,0.00499722084962215,0.0105942380960326,0.0301833438265515,4.51735521477005e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,24966,0.00745802417219957,0.00183050141629493,0.0038702413962615,0.0110458069481376,4.62942502224759e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,0.0304951003026246,0.00751714320529597,0.0157614996202445,0.0452287009850047,4.99181766397059e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.012704339698877,0.00313316692567456,0.00656333252455484,0.0188453468731991,5.03326944851807e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOSB,Protein fosB,28774,0.0110190143942497,0.0027258072997007,0.00567643208683632,0.0163615967016631,5.30270366562707e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,-0.00773224990632986,0.00192116922141783,-0.0114977415803088,-0.00396675823235091,5.72026421600509e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,-0.0170119541789211,0.00423185108980275,-0.0253063823149345,-0.00871752604290771,5.83467614608038e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,0.018326075093297,0.00456573747189178,0.00937722964838912,0.0272749205382049,5.99221835653434e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.0114910287701592,0.00286393277925204,0.00587772052282521,0.0171043370174932,6.02711867796261e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.00860249091598282,0.00214869118119235,0.00439105620084581,0.0128139256311198,6.25692735182824e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.0049599513473744,0.00124087450145948,0.00252783732451383,0.00739206537023498,6.42679193655445e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,29820,0.00888518843594033,0.00223689069541548,0.004500882672926,0.0132694941989547,7.14044742550231e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,0.0196704406140271,0.00496586584535548,0.00993734355713036,0.0294035376709238,7.48104057909924e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,28774,0.011873512059767,0.00300899420420942,0.00597588341951657,0.0177711407000175,7.96540035056458e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,24381,-0.00959130335353084,0.00243150386152385,-0.0143570509221176,-0.00482555578494409,8.01579841497604e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,24111,-0.0112469379407992,0.0028515182953568,-0.0168359137996985,-0.00565796208189989,8.02957864564673e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,0.00983940624212592,0.00249702762975032,0.00494523208781529,0.0147335803964366,8.15208080482014e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,24229,-0.0084457161355447,0.00214373187011971,-0.0126474306009793,-0.00424400167011007,8.1803449004234e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,24381,0.0312139084687906,0.00794062163380677,0.0156502900665294,0.0467775268710519,8.48569924075299e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0175451659043308,0.00446763572942416,-0.0263017319340022,-0.00878859987465948,8.61895901141881e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00803189541334705,0.00205048365579732,-0.0120508433787098,-0.0040129474479843,8.98775770954795e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00759373082432389,0.00194077468448941,0.00378981244272464,0.0113976492059231,9.14612299755768e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL,Podocalyxin,29349,-0.00416596920516246,0.00106703282634371,-0.00625735354479613,-0.00207458486552879,9.47270931217987e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,0.022171926529859,0.00567884866405863,0.0110413831483041,0.0333024699114139,9.47487613472054e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0158261298953586,0.00406056292526429,0.0078674265618406,0.0237848332288766,9.74462632978882e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,29114,0.028603551936563,0.00734595239243848,0.0142054852473835,0.0430016186257424,9.89127697635489e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0161446664788933,0.00414899053128294,-0.0242766879202078,-0.00801264503757871,0.000100006476137931
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0157094240707057,0.00405160245032437,0.00776828326806998,0.0236505648733415,0.000105833129551044
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,28797,0.0208271394008375,0.00537504905072506,0.0102920432614164,0.0313622355402586,0.00010695688110876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,24793,0.0168758865909928,0.00436746640086982,0.00831565244528789,0.0254361207366976,0.00011182960360323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,29456,-0.0171348426288488,0.00449850329146432,-0.0259519090801189,-0.00831777617757878,0.000139807698141637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,24867,0.0185528025249036,0.00487629107631669,0.00899527201532285,0.0281103330344843,0.000142318752270561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.00934188322650538,0.00246183789282833,0.00451668095656184,0.0141670854964489,0.00014812747936448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,24273,-0.00922734745327398,0.00243333384781483,-0.013996681794991,-0.00445801311155692,0.00014976489824502
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,28931,0.0158612524432742,0.00418942087001715,0.00764998753804058,0.0240725173485078,0.000153385465750696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.0131016994295159,0.00346915884833039,0.0063021480867883,0.0199012507722434,0.000159282026984554
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,24615,0.0171509751277086,0.00455168475064319,0.00822967301644793,0.0260722772389692,0.000164911617177546
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,0.0132978809631337,0.00354550856169436,0.00634868418221273,0.0202470777440546,0.000176794009317271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.0075522865659638,0.00201758496204656,0.00359782004035254,0.0115067530915751,0.000182023119756211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,-0.0107679080373753,0.00287783035914401,-0.0164084555412975,-0.00512736053345301,0.000183148088696398
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0141663750559824,0.00378913261698362,0.00673967512669448,0.0215930749852703,0.000185406889613177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,24149,0.0180021066651568,0.00482383563791975,0.00854738881483412,0.0274568245154796,0.000190471307987831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,24546,0.0090467110437231,0.00242440377857198,0.00429487963772202,0.0137985424497242,0.000190757125835141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRNN,Cornulin,28580,-0.0175221269361044,0.00470352072210945,-0.0267410275514389,-0.00830322632076988,0.000195441794874871
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA4,Annexin A4,29341,0.0188758667493798,0.00506888167571641,0.00894085866497566,0.028810874833784,0.000196557573653725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00831067779579139,0.00223960418813962,0.00392105358703773,0.012700302004545,0.000207009081137224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0125399577896544,0.00338412061245501,-0.0191728341900663,-0.00590708138924263,0.000211421534846165
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0117293044030399,0.00317989520138825,0.00549670980831894,0.0179618989977609,0.000225911820519514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00936629975166948,0.00254761023187809,-0.0143596158061505,-0.00437298369718842,0.00023687548568652
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,24240,0.0189033733876728,0.00517804867394228,0.00875439798674592,0.0290523487885997,0.000262102003881475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,24016,-0.00672790489499351,0.00184409309708824,-0.0103423273652865,-0.00311348242470056,0.000264484479156654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.00812920124521705,0.00223043914649045,-0.0125008619723383,-0.00375754051809577,0.000268303996366094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,24407,0.00797976769119806,0.00218948917963096,0.00368836889912139,0.0122711664832747,0.000268385120244484
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100G,Protein S100-G,24867,-0.0119448731610315,0.003288653902798,-0.0183906348105156,-0.00549911151154742,0.00028163866010561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.00669350205037492,0.00184369968947785,0.00307985065899833,0.0103071534417515,0.000283471677585948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,24111,-0.0107722548875042,0.00296761021741754,-0.0165887709136426,-0.00495573886136584,0.000284070938944876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.0252823437249526,0.0069720898592005,0.0116170476009196,0.0389476398489856,0.000288191401224056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,-0.00705891991857448,0.00195090902755495,-0.0108827016125822,-0.00323513822456679,0.00029718284274459
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,-0.00617814960664999,0.00170877716323879,-0.00952735284659802,-0.00282894636670196,0.000300222230547569
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,24111,-0.00919968852216694,0.00255100709571229,-0.014199662429763,-0.00419971461457086,0.000311225268383571
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRK1,Protein BRICK1,28774,0.0113195416356354,0.00314776662567908,0.00514991904930436,0.0174891642219664,0.000323620498337637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSD1,Tryptase delta,24867,0.00951471839531185,0.00264864410653794,0.00432337594649749,0.0147060608441262,0.000328407532107982
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.00584570421352359,0.00162924438605069,0.00265238521686425,0.00903902321018294,0.000333777405929237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.010070049859415,0.0028072065132015,0.00456792509354002,0.0155721746252899,0.000334870089873984
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,24938,0.0131349915375113,0.00366330166950843,0.0059549202652748,0.0203150628097478,0.000336997130153527
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00566042549145378,0.00158302339086929,0.00255769964534997,0.00876315133755759,0.000349847034400321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.00694407236053974,0.00194732565266718,0.00312731408131207,0.0107608306397674,0.000363215053880552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM3,Paralemmin-3,24111,0.0186226343761638,0.00522551262380808,0.00838062963349999,0.0288646391188276,0.000366243387080669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,24229,0.0115372332064669,0.00324023131208936,0.00518637983477174,0.017888086578162,0.000370688789950599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,29478,0.0192371297191208,0.00541525355910811,0.00862323274326891,0.0298510266949727,0.000382334575771557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCT,Secretin,24195,0.0117458658161806,0.00332318458903353,0.00523242402167488,0.0182593076106863,0.000409277557027995
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.0270935289950856,0.00766725151954592,0.0120657160167756,0.0421213419733956,0.000410616921666192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,0.01178952110233,0.00334624337747568,0.00523088408247762,0.0183481581221823,0.000427012619611599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,0.0121000310191402,0.00343865071059813,0.00536027562636784,0.0188397864119125,0.000434118374498176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA11,Serpin A11,29820,0.0101275077032295,0.00288246543945362,0.00447787544190041,0.0157771399645586,0.0004429193899924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0142298866149936,0.00405031683457589,0.00629126561922484,0.0221685076107623,0.000443290969921388
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX5,Syntaxin-5,24229,0.010143314256326,0.00289533141040026,0.00446846469194145,0.0158181638207105,0.000460300846113038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,24111,0.02738576653247,0.00785598101950799,0.0119880437342343,0.0427834893307056,0.000491216137548943
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS53,Serine protease 53,24845,-0.00918745845143236,0.00264148077114636,-0.0143647607628792,-0.0040101561399855,0.000505757339988108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,28797,0.013528069713792,0.00390480764038468,0.005874646738638,0.0211814926889459,0.00053206031407448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,23902,0.0107853711390881,0.00311377587040816,0.00468237043308807,0.0168883718450881,0.000533615748812906
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.00198644864964603,0.000575540555868059,0.000858389160144639,0.00311450813914743,0.000558524766073243
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0178893493590716,0.00518604774309686,0.00772469578260171,0.0280540029355414,0.000562381592156668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0107365197439167,0.00311301969194901,0.00463500114769664,0.0168380383401368,0.000563806713635133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,-0.0123042217139942,0.00356767929267293,-0.0192968731276332,-0.0053115703003553,0.000564008689501156
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,29566,-0.00910408547658688,0.00265070136864037,-0.014299460159122,-0.00390871079405175,0.000594254656157706
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,24195,0.0101318436353627,0.00295198542729666,0.00434595219786122,0.0159177350728641,0.00059967818065572
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.00507975408373214,0.00148183009912791,0.00217536708944145,0.00798414107802284,0.000608818888856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0162547575430111,0.00477257144811485,0.00690051750470597,0.0256089975813162,0.000660406815014852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.00844568065114232,0.00248728001623894,0.00357061181931399,0.0133207494829707,0.000685986151524937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CX3CL1,Fractalkine,29218,-0.00805934657512287,0.00237613661803905,-0.0127165743464794,-0.00340211880376633,0.000695307308578757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,28797,0.00937610304856519,0.00278444901952445,0.00391858297029727,0.0148336231268331,0.000760046863483333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTG,Protogenin,29725,0.00589727820745673,0.00175329777570445,0.002460814567076,0.00933374184783745,0.000770483075563253
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.020662108331494,0.00616290605023646,0.00858281247303057,0.0327414041899575,0.000801624830184634
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,24229,0.00701804647875645,0.00209567219577338,0.00291052897504063,0.0111255639824723,0.000812778025956159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00714353695516407,0.00214338569816702,-0.0113445729235714,-0.00294250098675672,0.000860978390153486
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWF,von Willebrand factor,29820,0.0169276172867511,0.00510608879853585,0.00691968324162081,0.0269355513318814,0.00091692522012583
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,29478,-0.0272431477679043,0.00822403022817056,-0.0433622470151185,-0.01112404852069,0.000925352683309598
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,0.010690844888162,0.0032273762524802,0.00436518743330083,0.0170165023430232,0.000925838275202552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,29579,0.0354759065643593,0.0107239524124112,0.0144569598360334,0.0564948532926853,0.000940433771173325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS1,Nephrin,24229,-0.00797357003821509,0.00241429281116974,-0.0127055839481078,-0.00324155612832241,0.000959137334019891
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,24793,0.0123263717618684,0.00373538973622936,0.00500500787885885,0.019647735644878,0.000968595295322772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.00763336281821462,0.00231362544231187,0.00309865695128336,0.0121680686851459,0.000970374967860124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,29434,0.0079969114610755,0.00244179853888846,0.00321098632485413,0.0127828365972969,0.00105780810547335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,24867,0.011506927478283,0.00352153910338675,0.00460471083564501,0.0184091441209211,0.00108616524924027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,24195,0.0133758732489201,0.00409590990467651,0.00534788983575414,0.021403856662086,0.00109358949035928
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG4,Desmoglein-4,29242,-0.0113972819657809,0.00349233232901784,-0.0182422533306559,-0.00455231060090594,0.00110165358224521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.0110440698680503,0.00338484374582532,0.0044097761262327,0.017678363609868,0.00110443071156432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0105505269098646,0.00324161590849722,0.0041969597292101,0.0169040940905192,0.00113663826830028
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,24793,0.00800718194318992,0.00247051353503815,0.00316497541451514,0.0128493884718647,0.00119226520884491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.0133594469400555,0.00412488672157797,0.00527466896576271,0.0214442249143484,0.00120189641042959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,0.0112175833797117,0.00347395526529879,0.00440863105972608,0.0180265356996973,0.00124366901383752
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIM,Vimentin,28916,0.0265021059429853,0.00821283866485805,0.0104049421598635,0.042599269726107,0.00125273387288387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,24016,0.0166628120115595,0.00516861859504368,0.00653231956527389,0.0267933044578451,0.00126652002319633
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,0.0198138975712874,0.00614915162090051,0.00776156039432238,0.0318662347482524,0.00127367353258766
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.00692079256074656,0.00215903905655108,-0.0111525091115867,-0.00268907600990644,0.00134976713725916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,28604,-0.0156839561617051,0.00490870335286314,-0.0253050147333169,-0.00606289759009336,0.00139918514718807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,24195,0.0109866744211802,0.00345513581749922,0.00421460821888177,0.0177587406234787,0.00147557619234732
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,24195,0.0141783657680178,0.00445990798868451,0.00543694611019613,0.0229197854258394,0.00147933852234176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00508219731557479,0.00160069869922018,0.00194482786510323,0.00821956676604635,0.0014999571406623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOC,Myocilin,29443,-0.01019403976485,0.00321242078062522,-0.0164903844948754,-0.00389769503482455,0.00150861175942649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,0.0170133123371029,0.0053617691506354,0.00650424480185748,0.0275223798723482,0.00151015544304868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNC,Tenascin,29594,-0.0106416216915548,0.00336018271548461,-0.0172275798139047,-0.00405566356920501,0.00154188868753018
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,24966,0.00569011632712055,0.00180403339891483,0.00215421086524749,0.0092260217889936,0.00161180382906335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0102479309271875,0.00325555892054255,0.0038670354429241,0.0166288264114509,0.00164657811178671
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,29786,-0.00874788295951497,0.0027860137352273,-0.0142084698805605,-0.00328729603846946,0.00169154478488047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,24445,-0.00820296063695313,0.00261443580001097,-0.0133272548049746,-0.00307866646893163,0.00170560259389507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0156409084668215,0.00499046016392987,-0.025422210388124,-0.00585960654551891,0.00172546916619713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,-0.00932933986472954,0.00299492034866421,-0.0151993837481114,-0.0034592959813477,0.0018412567563877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00758485106926072,0.00243583514212465,-0.012359087947825,-0.00281061419069641,0.0018487312316912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,0.00872248926567525,0.00280761948755887,0.00321955507005988,0.0142254234612906,0.00189394864489587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00826332727373561,0.00266439183376104,-0.0134855352679072,-0.00304111927956398,0.0019283454468025
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0126361440553532,0.00407581879672224,0.00464753921377759,0.0206247488969288,0.00193530049507739
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,24229,0.016872461503741,0.00544383723224861,0.00620254052853369,0.0275423824789483,0.00194155423209173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.00608161085907571,0.00196277055927488,0.00223458056289695,0.00992864115525447,0.00194696696553047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,24111,0.00806581551862203,0.00260571090779752,0.00295862213933889,0.0131730088979052,0.00196747980629127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,24229,0.0191053185879797,0.00619745190057938,0.00695831286284408,0.0312523243131152,0.00205314053536689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,0.00578899779328853,0.00188117431666942,0.00210189613261647,0.00947609945396058,0.00209089261447313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0087812469517103,0.00286296289777441,0.00316983967207245,0.0143926542313482,0.00216322022173251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVPL,Envoplakin,24445,-0.00734299594204126,0.00240846973966601,-0.0120635966317866,-0.00262239525229589,0.0022998611740214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0180871200208222,0.00595313638718253,0.00641897270194441,0.0297552673396999,0.00238209863681015
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.00715174183103024,0.00235579746789328,-0.0117691048681011,-0.00253437879395941,0.00240150594512534
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH6,Cadherin-6,29478,0.00817565948741115,0.00270160528022357,0.00288051313817295,0.0134708058366494,0.00247843441597163
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,24203,0.0149317874569279,0.00494720765087176,0.0052352604612193,0.0246283144526366,0.00254524456343767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.0126993383555025,0.00421044460658554,0.00444686692659487,0.0209518097844102,0.00256272255507142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,0.00507959642154809,0.00168697794250149,0.00177311965424516,0.00838607318885102,0.00260596544980914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0144668136840535,0.00482794707662036,0.00500403741387763,0.0239295899542294,0.00273391816700255
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,24793,0.00848569079144772,0.00283234434831723,0.00293429586874594,0.0140370857141495,0.0027382109222242
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,24793,0.00780534057498974,0.00260699615858623,0.00269562810416073,0.0129150530458188,0.00275619691217926
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,0.00642879160008396,0.00214913917514283,0.00221647881680402,0.0106411043833639,0.00278033910470061
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.00699194153340288,0.00233756547453133,0.00241031320332148,0.0115735698634843,0.00278234742741265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0139053732948069,0.00465205975996069,0.00478733616528396,0.0230234104243299,0.00280100788759447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,24343,0.0122158912916556,0.00408905873887026,0.0042013361634699,0.0202304464198413,0.00281588398853168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,28774,0.0120841508476611,0.00404721060455006,0.00415161806274297,0.0200166836325792,0.00283078028955051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.00626887325410783,0.00210356859711123,0.00214587880376982,0.0103918677044458,0.00288419654661534
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00536275548772259,0.00180210299001544,-0.00889487734815285,-0.00183063362729232,0.00292486139625672
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,24966,0.0040808497026408,0.00137236379491183,0.00139101666461362,0.00677068274066798,0.00294617677969802
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.00630270466761627,0.0021252443123891,0.00213722581533364,0.0104681835198989,0.00302304110192264
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.00537114942666391,0.00181425492996991,0.00181520976392288,0.00892708908940494,0.00307404632312148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD177,CD177 antigen,29413,0.0266335130459881,0.00900764675586675,0.00897852540448929,0.044288500687487,0.00311129913820423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.0102237698246996,0.00346960182529222,0.00342335024712684,0.0170241894022723,0.00321522374839059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,24016,0.0150841286569897,0.00512055920555292,0.00504783261410597,0.0251204246998734,0.00322432882027106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,0.0071034258030799,0.00241506361976766,0.00236990110833529,0.0118369504978245,0.0032709734629119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0111484007677119,0.00379387209485267,0.00371241146180065,0.0185843900736231,0.00330036360462155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,24111,0.0104321753882291,0.00356318915727984,0.00344832463996064,0.0174160261364976,0.00341728865511095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,24919,-0.0226363972652292,0.00774887030862064,-0.0378241830701256,-0.00744861146033273,0.00348941457018223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00609975341141962,0.00209512998114788,-0.0102062081744695,-0.00199329864836978,0.00360145597097913
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,24229,-0.0095614485678809,0.00328587980045495,-0.0160017729767726,-0.0031211241589892,0.00361920375298022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00582917678922238,0.00200332034768102,-0.00975568467067718,-0.00190266890776758,0.00362035334347914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,0.011507348874881,0.00396748678556044,0.00373107477518257,0.0192836229745795,0.00373009880104249
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.00988183289073499,0.00341737172381633,0.00318378431205499,0.016579881469415,0.00383570811060829
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0051073587194051,0.00176646633902543,-0.00856963274389494,-0.00164508469491526,0.00384010286772752
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00529014485132229,0.00183183623280324,-0.00888054386761663,-0.00169974583502794,0.00388178349869984
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00654812494309581,0.00226853717176703,-0.0109944577997592,-0.00210179208643243,0.00389903068851532
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0125807075388908,0.00438313015346732,0.00398977243809488,0.0211716426396868,0.0041049611300895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0124086246503778,0.00432397565208902,-0.0208836169284723,-0.00393363237228329,0.00411183229567303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.00745774875588736,0.00261600977893324,0.00233036958917821,0.0125851279225965,0.00436445355990699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0136459745321217,0.00478789536569848,0.00426169961535271,0.0230302494488907,0.0043736723849356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.00644768227909689,0.0022697286959367,0.00199901403506096,0.0108963505231328,0.00450422467763411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,24111,-0.0101328020986992,0.00356841478838567,-0.0171268950839352,-0.00313870911346333,0.00452106667448185
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.004042366883697,0.00142598400988,0.0012474382243322,0.00683729554306179,0.0045886691328459
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,24195,0.00548340585114528,0.00193657946662583,0.00168771009655865,0.00927910160573191,0.00463698992241234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,0.0121338607478155,0.00432103255809126,0.00366463693395658,0.0206030845616743,0.00498748166737953
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.00727894238286183,0.00259581006821908,0.00219115464915244,0.0123667301165712,0.00504945272799051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00556931958444905,0.00198897520816685,0.00167092817644202,0.00946771099245608,0.00511270172042226
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,0.00787347291272096,0.00281284646043266,0.00236029385027296,0.013386651975169,0.00512774462463288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,24229,-0.00522918048594577,0.00187202216153878,-0.00889834392256178,-0.00156001704932977,0.00522089787749651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99,CD99 antigen,29443,-0.00385881528603346,0.00138355739524226,-0.00657058778070829,-0.00114704279135862,0.00528963241484591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEB,Nebulin,24111,0.00747008750376862,0.0026831948297497,0.00221102563745922,0.012729149370078,0.00537303703803806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.00514923579878729,0.00185646129637904,-0.0087878999396902,-0.00151057165788438,0.00554683895047669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,29694,-0.00450148676244767,0.00162768644994337,-0.00769175220433668,-0.00131122132055866,0.00568578766079957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERC2,ERC protein 2,24195,0.0147001215685695,0.00534287635555337,0.00422808391168487,0.0251721592254541,0.00593944165452653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.0102028087756911,0.00371591231126071,-0.0174859969057621,-0.00291962064562014,0.00604253178856692
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,28931,0.00617374468050683,0.00225296434834715,0.00175793455774642,0.0105895548032672,0.00614252252903653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00525130787171807,0.00191717635332339,0.00149364221920423,0.00900897352423192,0.00616471641878622
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.00864540073617158,0.00315984338198767,0.00245210770747575,0.0148386937648674,0.0062232190838341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0163698975621078,0.0059831235039574,0.00464297549435127,0.0280968196298643,0.00622341332897823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,24016,-0.00678687856095501,0.00248505255693155,-0.0116575815725408,-0.00191617554936918,0.00631731505250668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.009057792737116,0.00331812122672272,-0.0155613103414925,-0.00255427513273946,0.00634198050753207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0200362883053089,0.0073400119903777,0.00564986480416862,0.0344227118064492,0.00634311004994301
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,-0.00895576435440601,0.00330035466454642,-0.015424459496917,-0.00248706921189503,0.00666070993980642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIT,Vitrin,24922,0.00722771515776685,0.00266375170391212,0.00200676181809909,0.0124486684974346,0.00666506549594227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,24833,0.00494708104478807,0.00182804739231601,0.00136410815584868,0.00853005393372745,0.00681024015348711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.00495219010192067,0.00183132164399451,0.00136279967969142,0.00854158052414991,0.00685233504098071
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00905415403554781,0.00335648826513278,0.00247543703588757,0.0156328710352081,0.00699078712460091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,23970,-0.00779039023293006,0.00289120194182137,-0.0134571460389,-0.00212363442696017,0.00705400573536506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLC,Galectin-10,29426,0.0125866338336822,0.00467146496404829,0.00343056250414753,0.0217427051632168,0.00705628255763908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,24016,-0.00588940375209628,0.00220474449472981,-0.0102107029617667,-0.00156810454242585,0.00756223536433298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTN,Titin,24111,0.0126655485156403,0.00475271248398853,0.00335023204702282,0.0219808649842578,0.00770603503158282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.00750116890831745,0.00281835686209814,0.00197718945860509,0.0130251483580298,0.00778271320718732
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUK1,Guanylate kinase,24111,-0.00755000609840731,0.00283849594546356,-0.0131134581515159,-0.00198655404529873,0.00782245119312244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.016240496208739,0.00612822969677558,0.00422916600305887,0.0282518264144192,0.00805178006018629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMI,N-myc-interactor,24706,0.0134954713865837,0.00509632453729247,0.00350667529349047,0.0234842674796769,0.00810019877028827
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.0118065416730991,0.00446018187614077,-0.020548498150335,-0.00306458519586322,0.0081238475679907
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.00978460033674723,0.00370479031183123,0.00252321132555802,0.0170459893479364,0.00826984438538562
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.0113217475815384,0.00428688298498021,0.00291945693097723,0.0197240382320996,0.00827006125193034
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0181197229287581,0.00687570330067693,0.00464334445943131,0.0315961013980849,0.00841087168298151
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,0.0202298882573204,0.00768342283707734,0.00517037949664881,0.035289397017992,0.00847066766560511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,24195,-0.00582002231372247,0.00221445835518051,-0.0101603606898763,-0.00147968393756867,0.00858942136272677
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,24111,0.0167809857042396,0.00639156987576715,0.004253508747736,0.0293084626607432,0.00865796814256607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,0.00972157409616103,0.00370732333290592,0.00245522036366544,0.0169879278286566,0.0087394169725162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,0.00850269666641831,0.00324537962921651,0.00214175259315395,0.0148636407396827,0.00880006273642231
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,29536,0.0152489223309041,0.00582843579914077,0.00382518816458815,0.02667265649722,0.00889343147910278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0213359356442936,0.00817867938998462,0.00530572403992377,0.0373661472486635,0.00909343109548361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,24445,0.00423714859425554,0.00163307067712456,0.0010363300670914,0.00743796712141967,0.0094760421490307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0036934365047424,0.00142984185951467,0.000890946460093647,0.00649592654939116,0.00979624970707354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0156248709154435,0.00605344261065658,0.00376012339855662,0.0274896184323304,0.00985290259175649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,24951,-0.0264013483886082,0.0102294271323828,-0.0464510255680785,-0.00635167120913798,0.00985935714368507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.00575675894652653,0.00223961846052455,-0.0101464111291546,-0.00136710676389841,0.010162353191136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,24101,-0.0164457859150155,0.00641307150888711,-0.0290154060724342,-0.00387616575759679,0.0103409524668653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH22,Cadherin-22,24445,-0.00516768937497707,0.00202811553925913,-0.00914279583192496,-0.00119258291802918,0.0108395338234324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,24307,0.0151291879862037,0.00594322647210399,0.00348046410087991,0.0267779118715276,0.0109145529059932
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC2,Mucin-2,24938,0.0164366253495121,0.00647029129002651,0.0037548544210601,0.029118396277964,0.0110810502994641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCIN,Adseverin,24101,0.0132298426239096,0.00521679499948613,0.00300492442491679,0.0234547608229024,0.0112186268989693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0109808015308452,0.0043585526870895,-0.0195235647975406,-0.00243803826414977,0.011762961633557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.00785043015046907,0.00311647600148507,0.00174213718755833,0.0139587231133798,0.0117749605654608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,0.0165158287535909,0.00655996434151541,0.00365829864422071,0.0293733588629611,0.0118197753576362
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0137664451399972,0.00552436551460404,0.00293868873137331,0.0245942015486212,0.0127099624597547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBN,Ameloblastin,28931,-0.00498932262686559,0.00201255910840103,-0.00893393847933161,-0.00104470677439957,0.0131773260126836
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GKN1,Gastrokine-1,28114,0.00490114150085354,0.00197872196541185,0.00102284644864631,0.00877943655306078,0.0132578956130377
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00914133322087492,0.00370908292024834,0.00187153069718818,0.0164111357445617,0.013724206712086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM3,Myomesin-3,24381,-0.0163004021188643,0.00662043751124261,-0.0292764596408998,-0.00332434459682878,0.0138181887502049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,24016,0.0103886971752354,0.0042198235290919,0.00211784305821527,0.0186595512922555,0.0138280855851259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,24793,0.00469599712780016,0.00192110220230835,0.0009306368112758,0.00846135744432452,0.0145150996485697
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0134498615879886,0.00550276110380934,0.00266444982452233,0.024235273351455,0.014523215864174
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,24101,0.0127083676742998,0.0052002699486698,0.00251583857490697,0.0229008967736926,0.0145410080187295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP2,Neuropilin-2,29443,-0.00490297359777832,0.0020154228708328,-0.00885320242461061,-0.000952744770946037,0.0149915126741724
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.00636244611032728,0.00261778048128826,-0.0114932958536523,-0.00123159636700229,0.0150863311266465
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,0.0165745597635032,0.00682312401855774,0.00320123668713004,0.0299478828398764,0.0151391832667529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0060382114880095,0.00249119650839961,-0.0109209566444727,-0.00115546633154627,0.0153654955660763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,24111,-0.00945790230555159,0.00392428977092769,-0.0171495102565699,-0.00176629435453332,0.0159559084325602
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,24195,-0.00494291593411612,0.0020532012511582,-0.00896719038638619,-0.000918641481846057,0.0160731630655924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.00492819636646789,0.00205103498192931,0.000908167801886448,0.00894822493104933,0.0162768438676764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,24938,-0.0150806542727766,0.0062889877761541,-0.0274070703140386,-0.00275423823151458,0.0164945954730319
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPN1,Epsin-1,24445,0.00743666345078149,0.00310133075590402,0.00135805516920961,0.0135152717323534,0.0164970775740818
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,0.00799017533518946,0.00333469794425019,0.0014541673644591,0.0145261833059198,0.0165781008341603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,24195,0.0053037427284291,0.00221852756788354,0.000955428695377373,0.00965205676148083,0.0168257713488234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,0.00780118716130488,0.00327182454667268,0.00138841104982641,0.0142139632727833,0.0171155843920093
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK1,Kallikrein-1,29199,-0.0212984309916624,0.00896095546533808,-0.038861903703725,-0.00373495827959976,0.0174697939601565
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,24349,-0.00617946548688613,0.00260386428825215,-0.0112830394918603,-0.00107589148191191,0.0176428961480803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.0241316309249999,0.0101773240414907,0.00418407580367809,0.0440791860463217,0.0177422414910926
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,0.0053448618953149,0.00225492913140383,0.000925200797763399,0.0097645229928664,0.0177813721625747
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,28774,0.00927134560079697,0.00391343992788528,0.00160100334214182,0.0169416878594521,0.0178378119359356
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,24111,-0.00768024959996138,0.00326583305781451,-0.0140812823932778,-0.00127921680664494,0.0186959987667171
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00686780894835059,0.00292847163636308,-0.0126076133556222,-0.00112800454107895,0.0190256908761302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,0.014007582098836,0.00599252434785739,0.00226223437703553,0.0257529298206365,0.0194195334099719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTN,Neuroplastin,28797,-0.013454563560468,0.00576122222009562,-0.0247465591118555,-0.00216256800908062,0.0195311327844131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,-0.00859450553754132,0.00368533860516169,-0.0158177692036582,-0.00137124187142441,0.0197044361256957
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,24867,0.00585899280910605,0.00251241616375862,0.000934657128139158,0.0107833284900729,0.0197078343823745
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00878959015170146,0.00377144645363931,0.0013975551025684,0.0161816252008345,0.0197850538975918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,24240,0.0141767777088853,0.00608726481583812,0.00224573866984257,0.026107816747928,0.01987126799586
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,0.0170289188324797,0.00731428534443096,0.00269291955739503,0.0313649181075644,0.0199111430252186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00603620289183155,0.00259271659428831,0.000954478367026457,0.0111179274166366,0.0199129514656039
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,24195,0.00851792369273539,0.00366350618733511,0.00133745156555856,0.0156983958199122,0.0200762264234306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,24445,-0.00641926621032016,0.0027677304257079,-0.0118440178447076,-0.000994514575932672,0.0203856276082412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP10,Stromelysin-2,29439,0.009630742339081,0.00415664111360416,0.00148372575641684,0.0177777589217452,0.0205131189965198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.0080461713535919,0.00347660592907664,0.00123202373260169,0.0148603189745821,0.0206539887760868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.0130668151984126,0.00565322547086927,0.00198649327550884,0.0241471371213164,0.0208196876931008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4,Interleukin-4,28931,0.0149139829835787,0.00646335619469573,0.00224580484197504,0.0275821611251823,0.0210358101467283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,28916,0.00983363641911269,0.00426205167924946,0.00148001512778375,0.0181872577104416,0.0210476876306476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,28916,0.00987852635128635,0.00429033486111412,0.00146947002350268,0.01828758267907,0.0213136629688516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.0116419204457653,0.00505621977708475,0.00173172968267914,0.0215521112088514,0.0213157268021971
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.00811036874553548,0.00352466939148268,0.00120201673822944,0.0150187207528415,0.021397072341536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,24914,-0.00240132999045612,0.00104565197405761,-0.00445080785960904,-0.000351852121303198,0.0216561049513155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NENF,Neudesin,24793,0.0178417563054611,0.00777962822664151,0.00259368498124378,0.0330898276296785,0.0218336367173212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.00963791783836261,0.00420515539574173,0.00139581326270883,0.0178800224140164,0.0219183527985577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,24938,0.0039015788741284,0.0017072421647574,0.000555384231203892,0.00724777351705291,0.0223029713827321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,0.0427305782963739,0.0187007547921797,0.00607709890370178,0.079384057689046,0.0223234571913131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,0.0062548099493799,0.00275186806070487,0.000861148550398349,0.0116484713483614,0.0230389011736959
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,0.0100894926611597,0.00443989982179441,0.00138728901044265,0.0187916963118767,0.0230660768237755
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,24951,0.00848036065783204,0.00373958882608428,0.00115076655870686,0.0158099547569572,0.0233544645621585
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,0.00851186334908534,0.00375389755423142,0.00115422414279176,0.0158695025553789,0.0233700329183913
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,0.0075722184687074,0.00335440614520972,0.000997582424096354,0.0141468545133184,0.0239923392749564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,-0.00633308621480057,0.00281336338503939,-0.0118472784494778,-0.000818893980123359,0.0243898432328114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),24484,-0.0284565312512337,0.0126523529823173,-0.0532551430965757,-0.00365791940589183,0.0245143657190309
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP13,Collagenase 3,28774,-0.00517319123662016,0.002304558291844,-0.00969012548863441,-0.000656256984605913,0.024790807413662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPJ,Centromere protein J,24445,0.0113888493045314,0.00509528509595709,0.00140209051645554,0.0213756080926073,0.0254149212749549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,23970,0.00560847379027057,0.0025148655285867,0.000679337354240645,0.0105376102263005,0.0257481271858992
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.0104798048774427,0.00474018367896791,0.00118904486666555,0.0197705648882197,0.0270559906439465
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.00212738405259653,0.000963493197658339,0.000238937385186189,0.00401583072000688,0.027254146857099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.0265811558634104,0.0120930440706674,-0.0502835222419186,-0.0028787894849022,0.0279531725055042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,24016,-0.00721402262029299,0.00329282025839681,-0.0136679503267507,-0.000760094913835256,0.0284733874405934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,29443,-0.0044755562216718,0.0020461279329634,-0.00848596697028007,-0.000465145473063542,0.0287263113670877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00540173660118462,0.00248124189484962,0.000538502487279371,0.0102649707150899,0.0294862943481448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,24101,-0.00432289426023093,0.00199743723538922,-0.00823787124159381,-0.000407917278868063,0.0304572385189609
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL3,Insulin-like 3,24845,-0.0115348074777632,0.00533848409072062,-0.0219982362955756,-0.00107137865995078,0.0307288510281116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.0101817888526274,0.00471240307816006,0.000945478819433689,0.0194180988858211,0.0307332731538461
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.00433884046304042,0.00201171937353882,0.000395870490904329,0.00828181043517652,0.0310306761513654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,-0.00392062555081429,0.00182143841487954,-0.00749064484397819,-0.000350606257650393,0.0313669142789476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,-0.00446513306817632,0.00208160617023912,-0.00854508116184499,-0.00038518497450765,0.0319593907077586
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00561842070277355,0.00262119430337991,0.00048087986814894,0.0107559615373982,0.032084632119374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.00778317847985683,0.00363694216929215,0.000654771828044221,0.0149115851316694,0.0323620619075086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPP1,Osteopontin,29757,-0.00689811196923028,0.00324476237609803,-0.0132578462263824,-0.000538377712078145,0.0335179622676459
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH7B,Myosin-7B,24016,-0.00665421650401364,0.00314377504256268,-0.0128160155874365,-0.000492417420590779,0.0343013096240943
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH4,Myosin-4,24111,-0.006955717131941,0.00330496008478191,-0.0134334388981135,-0.000477995365768463,0.0353338827792437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,24101,-0.00522466860528953,0.00249452556812129,-0.0101139387188073,-0.000335398491771794,0.0362299944330067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00643522375830195,0.0030787653899495,0.000400843594000938,0.012469603922603,0.0366105812007454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00750267665027542,0.0035955784556251,-0.0145500104233006,-0.000455342877250212,0.0369312037735017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,24229,0.00982907975215469,0.00471366636394213,0.000590293678828107,0.0190678658254813,0.0370588506301346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,28774,0.00700148543134231,0.00338232567946428,0.000372127099592316,0.0136308437630923,0.0384592763966983
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,24229,0.00442784185805422,0.00214078192821906,0.000231909278744871,0.00862377443736358,0.0386196651753335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,24195,0.0121143386069511,0.00586421331450827,0.00062048051051493,0.0236081967033873,0.0388572426033007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00717873736135907,0.00348981934125192,0.000338691452505308,0.0140187832702128,0.0396920359548246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,0.0113145759569261,0.0055052973484397,0.000524193153984309,0.0221049587598679,0.0398688496947646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.012140564797308,0.00592416819242399,0.000529195140156957,0.023751934454459,0.0404390869606201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,-0.00602838191199503,0.00294361225502075,-0.0117978619318357,-0.000258901892154361,0.0405753838412773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,24867,0.0054084128386208,0.0026461622062967,0.000221934914279261,0.0105948907629623,0.0409768621412573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MELTF,Melanotransferrin,24922,0.00428076919136589,0.00209642751044915,0.000171771270885556,0.00838976711184623,0.0411684676073693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,24195,0.0132541988208286,0.00650810539705131,0.000498312242608023,0.0260100853990491,0.041704229225042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00726159476254832,0.00357761944398185,-0.0142737288727527,-0.000249460652343901,0.0423950206339738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0178533558830638,0.00882681813102781,0.000552792346249296,0.0351539194198783,0.0431209025997777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,24101,-0.00615176303107132,0.00304164228002879,-0.0121133818999277,-0.000190144162214895,0.043134343168531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.00488028111758229,0.00241889772092468,0.000139241584569912,0.00962132065059466,0.0436457734991479
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00534751538358276,0.00265132746823325,0.000150913545845601,0.0105441172213199,0.0437130868871119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNPO1,Transportin-1,24445,-0.00504539983888961,0.00251282218901577,-0.00997053132936051,-0.000120268348418712,0.0446689616562816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,-0.00532835304225548,0.00265856672353075,-0.0105391438203758,-0.000117562264135212,0.0450559965131244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17F,Interleukin-17F,28931,0.0107812936199317,0.00539614403556595,0.000204851310222432,0.0213577359296409,0.0457300709086424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,28774,0.0045600836392822,0.0022898696374865,7.19391498086551e-05,0.00904822812875574,0.0464445852955192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00523143141651354,0.00262802514955143,-0.0103823607096343,-8.05021233927445e-05,0.0465326164193264
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB5,Serpin B5,28916,0.00681515269227817,0.00342888073652512,9.45464486889324e-05,0.0135357589358674,0.0468682939186577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,29694,-0.0043940349870915,0.00221319069157311,-0.00873188874257481,-5.61812316082029e-05,0.047110872114237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCLN,Nicalin,28931,0.00728837064660507,0.00368341618005181,6.88749337035225e-05,0.0145078663595066,0.0478594170135579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,24101,0.0105166220556951,0.00532067769157215,8.80937802136897e-05,0.0209451503311765,0.0481031296477393
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,24966,0.00498794815852851,0.00252979320339148,2.95534798812093e-05,0.00994634283717582,0.0486569291969152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,-0.00788043687949733,0.00400108312839216,-0.015722559811146,-3.83139478486918e-05,0.0488963908370257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSPN,Claspin,28719,0.00475451397631726,0.00244344903405453,-3.4646130429616e-05,0.00954367408306413,0.0516860147687764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00443356011366761,0.00227888358665165,-3.30517161696176e-05,0.00890017194350485,0.0517264684335136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSB,Lupus La protein,28774,0.00814923227869295,0.00419591233902292,-7.47559057919841e-05,0.0163732204631779,0.0521246233553439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,-0.0057599440436339,0.00296894844800446,-0.0115790830017226,5.91949144548359e-05,0.0523834535261413
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERVV_1,,24111,-0.00633315361837874,0.00326702104588618,-0.0127365148683157,7.020763155818e-05,0.0525726704005785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0061340492235819,0.00317880370581958,-9.64060398244773e-05,0.0123645044869883,0.0536588654649657
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.00758758588676818,0.0039333917053595,-0.000121861855736436,0.0152970336292728,0.0537399502115946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,28797,0.0140755956236521,0.00730222319144865,-0.000236761831587226,0.0283879530788915,0.0539176216375275
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,24195,0.00458041229911268,0.00237736591963133,-7.92249033647304e-05,0.00924004950159009,0.0540318073770539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,0.00685104275684145,0.00356350423082064,-0.000133425535567011,0.0138355110492499,0.0545473446575256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,-0.00587538007323284,0.0030564266121419,-0.011865976233031,0.000115216086565279,0.0545792941956728
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,29218,-0.00164311201113294,0.000855946432925555,-0.00332076701966703,3.45429974011457e-05,0.0549126762629583
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BEX3,Protein BEX3,24016,-0.00639754230501198,0.00334742499567268,-0.0129584952965304,0.00016341068650647,0.055992944479342
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00782855821672615,0.00409715778624333,-0.000201871044310782,0.0158589874777631,0.0560512120455284
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00519784520152457,0.00272104166784818,-0.010531086870507,0.000135396467457866,0.0561140553687301
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.00358767485998818,0.00187992228966197,-9.69728277492739e-05,0.00727232254772563,0.0563470974482977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,24195,-0.00509380835327514,0.00267188148931443,-0.0103306960723314,0.00014307936578114,0.0566036939524239
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH23,Cadherin-23,24845,-0.00357477717988226,0.00187672718345614,-0.00725316245945631,0.000103608099691779,0.0568185002879751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSTN,Osteocrin,24195,0.00559109394228715,0.00296546265871758,-0.00022121286879931,0.0114034007533736,0.0593873474813845
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,0.0101897347345039,0.00541784200831978,-0.000429235601802889,0.0208087050708106,0.0600143920289898
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,24229,-0.00722302548184479,0.00386009283020158,-0.0147888074290399,0.000342756465350311,0.0613287037836968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.0043175187670666,0.00231100371182258,-0.000212048508105647,0.00884708604223885,0.0617401974027848
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,24914,0.0029813595883868,0.00159828886119198,-0.000151286579549485,0.00611400575632308,0.0621448611980978
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,-0.00393887861606167,0.00212011055114023,-0.00809429529629652,0.000216538064173173,0.0632000731110209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN2,Contactin-2,29725,-0.00582180436560379,0.00314033416474021,-0.0119768593284946,0.000333250597287017,0.0637661581212585
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,29461,0.0244470614611133,0.0131961867318238,-0.00141746453326145,0.050311587455488,0.0639518211694128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP73,Tumor protein p73,24195,-0.00454161442812121,0.0024525901232269,-0.00934869106964594,0.000265462213403527,0.0640721156010988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD10,Frizzled-10,24195,0.0079045520977085,0.00427114568206967,-0.000466893439148046,0.0162759976345651,0.064226840030948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,24111,-0.00445964913446556,0.00241490559935581,-0.00919286410920295,0.000273565840271825,0.0648003048502837
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,28916,0.0138175624670029,0.00756134303884076,-0.00100266988912495,0.0286377948231308,0.0676506664611718
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAG,S-arrestin,24101,-0.0068417282787027,0.00374950817270022,-0.0141907642971951,0.000507307739789721,0.068058664814766
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,24059,0.0109694173328269,0.00603392874535845,-0.000857083008075656,0.0227959176737294,0.069083286673934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.00429369221618257,0.0023661843962671,-0.000344029200500941,0.00893141363286608,0.0695947642482865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,28774,0.0060425565051951,0.00333440161214499,-0.000492870654609082,0.0125779836649993,0.0699678583506186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.00486211832352806,0.00269178401548065,-0.0101380149938701,0.000413778346814014,0.0708869344870612
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO6,Coronin-6,24101,0.00481417651451777,0.0026685331043168,-0.000416148369943161,0.0100445013989787,0.0712354063235191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,0.00508340442391098,0.00281835890860478,-0.000440579036954393,0.0106073878847763,0.0712947040613297
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,0.0125121349123396,0.00694747183068813,-0.00110490987580917,0.0261291797004883,0.0717213186493132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,29694,-0.0161760141746589,0.00902621513187906,-0.0338673958331418,0.0015153674838241,0.0731247526186815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00613898489132143,0.00342818718053528,-0.0128582317651706,0.000580261982527723,0.0733478428460244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00410437747126548,0.00230389440838009,-0.000411255569159483,0.00862001051169045,0.0748441339262492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,29599,0.0140276460071657,0.00789306398682087,-0.00144275940700318,0.0294980514213346,0.0755436794058786
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,24805,0.0326343178153901,0.0183729479377347,-0.00337666014256986,0.0686452957733501,0.0757096403613917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.003703689632828,0.00208571396989323,-0.000384309748162733,0.00779168901381874,0.0757880280030626
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,0.00947395195596701,0.00534307748480122,-0.000998479914243374,0.0199463838261774,0.0762203252475412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN1,Nectin-1,24229,0.00405717890749381,0.0022938104518635,-0.000438689578158649,0.00855304739314627,0.0769480692775874
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0102759010734494,0.00582070856627956,-0.00113268771645852,0.0216844898633574,0.0775082321411615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,24101,-0.00614749899883907,0.00349776258457454,-0.0130031136646052,0.000708115666927022,0.0788364987419596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN3,Matrilin-3,29169,-0.00396703511037259,0.00226233222864777,-0.00840120627852222,0.000467136057777032,0.0795240322714302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,24445,0.00515592456571145,0.00294531530614134,-0.000616893434325582,0.0109287425657485,0.0800358382323772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00703824340434551,0.00402659481323955,-0.014930369238295,0.000853882429604005,0.0804873210427743
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.00505777341661583,0.00289524087331143,-0.000616898695074574,0.0107324455283062,0.0806627412673644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,0.0124105205883229,0.00712534424136654,-0.0015551541247555,0.0263761953014013,0.0815659701129996
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00495097032516745,0.00285204351546754,-0.0105409756154838,0.000639034965148921,0.0825875361327934
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,29349,-0.00938672546813541,0.00540969336914618,-0.0199897244716619,0.00121627353539109,0.0827215992177808
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,0.00851930349792865,0.00494144560584389,-0.00116592988952537,0.0182045368853827,0.0847113140052684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,29566,-0.00482445496994862,0.00281958521930286,-0.0103508419997822,0.000701932059884997,0.0870821364438336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDAN1,Codanin-1,24845,-0.00272086752540748,0.00159674732242558,-0.00585049227736162,0.000408757226546649,0.0883924184274247
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00571723746584233,0.0033573712815953,-0.00086321024608445,0.0122976851777691,0.0886013629850036
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00655505837628292,0.00385896330555523,-0.0141186264551712,0.00100850970260533,0.0893965809591582
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,0.00639150141831841,0.00376635614887227,-0.000990556633471236,0.0137735594701081,0.0897096474324015
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.00452257244487294,0.00267048087538825,-0.00975671496063392,0.000711570070888035,0.0903651612820548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM1,Myomesin-1,24101,0.00572580477551016,0.00338770368910107,-0.000914094455127933,0.0123657040061483,0.0910078318458289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP3,Stromelysin-1,29443,-0.00575522402074359,0.00344902725017677,-0.0125153174310901,0.00100486938960287,0.0951971309551539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,-0.00366701784795577,0.00220649772408609,-0.0079917533871645,0.000657717691252957,0.0965401015449425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD82,CD82 antigen,24445,-0.00490018861454754,0.00295211245990189,-0.0106863290359553,0.000885951806860165,0.0969489633869519
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,0.00466423687475458,0.00281637486305662,-0.000855857856836393,0.0101843316063456,0.0977118243590988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,29349,-0.00222615484636035,0.00134512809255443,-0.00486260590776703,0.000410296215046342,0.0979400432022192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,-0.00439304616683248,0.00265561743668253,-0.00959805634273023,0.000811964009065284,0.0980904384215776
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,0.00622195663472476,0.00377474351249958,-0.00117654064977441,0.0136204539192239,0.0992995189790512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,-0.00503816744079418,0.00305927681580849,-0.0110343499997788,0.000958015118190473,0.0996016551476424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.00303143338067708,0.00184214777085995,-0.000579176250208429,0.00664204301156259,0.0998592924624872
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,24111,0.00389773403778827,0.00236907899245453,-0.000745660787422612,0.00854112886299915,0.0999307150780476
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALLD,Palladin,24229,-0.00464567765235918,0.00283157454235439,-0.0101955637553738,0.00090420845065542,0.100879051937996
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.00631561832726595,0.00385965959426307,-0.00124931447748968,0.0138805511320216,0.101786722751337
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO1,Alpha-enolase,29392,0.00906633747699719,0.00554641583695049,-0.00180463756342576,0.0199373125174201,0.102137358124538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,24826,-0.00275602067687775,0.001688191509928,-0.00606487603633662,0.000552834682581128,0.10258089854873
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00388890280416871,0.00238506478153031,-0.00078582416763069,0.00856362977596811,0.103001725331035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.00569329537157051,0.00349478840331567,-0.00115648989892821,0.0125430806420692,0.103308778770397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEO1,Neogenin,24867,0.00252822151996708,0.00155257899484781,-0.000514833309934631,0.0055712763498688,0.103452515384878
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.0051163582009579,0.00314593968157741,-0.0112823999768496,0.00104968357493383,0.103890990453492
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,-0.011212177207305,0.00691843887245948,-0.0247723173973256,0.00234796298271562,0.105109308287969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,24101,0.00708158770108172,0.0043968741933614,-0.00153628571790663,0.0156994611200701,0.10728092369572
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,24101,-0.00389297429012579,0.00242306979558492,-0.00864219108947224,0.000856242509220649,0.10814887696201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,29132,-0.00768142830243761,0.00478491138684419,-0.0170598546206522,0.001696998015777,0.108428987586755
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,24195,-0.00381226018377265,0.0023784479294365,-0.0084740181254682,0.000849497757922892,0.108984093038205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.00552453511241876,0.00344797935893199,-0.00123350443108794,0.0122825746559255,0.109112791778435
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,0.00989871407999999,0.00618624463463656,-0.00222632540388766,0.0220237535638876,0.109585832044923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,28931,0.00488116597894398,0.00306720590963187,-0.00113055760393448,0.0108928895618224,0.111529452413817
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDSN,Corneodesmosin,29676,0.00484725536290534,0.003053690596702,-0.00113797820663057,0.0108324889324413,0.112445568338911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,29443,-0.0045268590635286,0.00286022342879007,-0.0101328969839571,0.00107917885689994,0.113501924218825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,29349,0.00312134854114784,0.0019822859418395,-0.000763931904857572,0.00700662898715325,0.115354798320756
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,29725,-0.00351679457821755,0.00223360600357927,-0.00789466234523292,0.000861073188797825,0.115384418280727
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPLX2,Complexin-2,24016,-0.00342820256929094,0.00218150666940536,-0.00770395564132546,0.000847550502743572,0.11608347665196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TG,Thyroglobulin,24793,-0.0123530600127547,0.00790366324886594,-0.0278442399805319,0.0031381199550226,0.11807624700917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,24111,-0.00568222185801908,0.00366523857688544,-0.0128660894687145,0.00150164575267638,0.121082496743435
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,24445,0.0065914283637906,0.00426838448165108,-0.00177460522024551,0.0149574619478267,0.122542115129272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.00677555746702259,0.00439143345950225,-0.00183165211360182,0.015382767047647,0.122867291355628
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,24195,0.00553032328380266,0.00359164860556579,-0.00150930798310628,0.0125699545507116,0.123628798367537
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.00814159994140213,0.00529019843794192,-0.00222718899696403,0.0185103888797683,0.123817960215075
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,24016,-0.00455516935903607,0.00297948090603434,-0.0103949519348634,0.00128461321679124,0.126315645927745
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00339807989994721,0.00222932918811808,-0.00776756510865866,0.000971405308764235,0.12745409435316
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,24101,-0.0103346316980432,0.00678457935137878,-0.0236324072267456,0.00296314383065923,0.127708517601437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,24240,0.00750121944868433,0.00500430897777322,-0.00230722614775118,0.0173096650451198,0.13389908911881
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENG,Endoglin,29820,-0.00181596432479125,0.00121195302517888,-0.00419139225414184,0.00055946360455935,0.134045535970009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRAS,GTPase Hras,24421,0.0104508043500622,0.00699470648328026,-0.00325882035716713,0.0241604290572915,0.135161911047378
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,-0.00254644974196137,0.00170852172515502,-0.0058951523232652,0.000802252839342469,0.136119203372089
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,24111,-0.00565894797527485,0.00382623450894397,-0.013158367612805,0.00184047166225533,0.139157078927358
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.00876460950516634,0.0059629178637664,-0.00292270950781581,0.0204519285181485,0.141614627825202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,0.00424230051311515,0.00288773776209561,-0.00141766550059225,0.00990226652682255,0.141825768684395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,24101,-0.0048092500362821,0.00327598053527319,-0.0112301718854176,0.00161167181285335,0.142108109396259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,24016,-0.00496215212310316,0.00338088974266755,-0.0115886960187316,0.00166439177252524,0.142197206591272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,24329,0.00317297984531285,0.00216949334531862,-0.00107922711151164,0.00742518680213734,0.143605074200807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00455248987603173,0.00313675603164125,-0.0107005316980486,0.00159555194598512,0.146699131470466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,24111,0.00491065381508176,0.00338883188610931,-0.00173145668169248,0.011552764311856,0.147331114176596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,-0.00346383134109657,0.00239182844997475,-0.00815181510304707,0.00122415242085393,0.147575844376236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM2,Myomesin-2,24111,0.00521901141163123,0.00360997941387607,-0.00185654823956586,0.0122945710628283,0.148269381257862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,24229,-0.00223401993425736,0.00155279284484597,-0.00527749391015547,0.000809454041640745,0.150245384781948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,24229,-0.00443216565743225,0.00311435295395691,-0.0105362974471878,0.00167196613232329,0.154707955755037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,24016,-0.00804164924954217,0.00568705568998795,-0.0191882784019185,0.00310497990283421,0.157366999418024
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,28931,0.00551651899104223,0.00391795503926833,-0.0021626728859237,0.0131957108680082,0.159138925881761
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.0057038585413206,0.00405997599424855,-0.00225369440740656,0.0136614114900478,0.160063965370961
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,0.00759411529077638,0.00543225066686168,-0.00305309601627252,0.0182413265978253,0.162135400870569
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,28626,0.00659650474016105,0.00472124358869453,-0.00265713269368023,0.0158501421740023,0.162365341384975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,24016,0.00524891679445144,0.00376050510963958,-0.00212167322044213,0.012619506809345,0.162787339972256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN7,Septin-7,24445,0.00520370650593327,0.0037408723835176,-0.00212840336576122,0.0125358163776278,0.164225690932071
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,0.00432145879988418,0.00311348729689153,-0.00178097630202322,0.0104238939017916,0.165155904532196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,28797,0.00302778689208972,0.00219703074291858,-0.0012783933640307,0.00733396714821014,0.168174862911432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,-0.0014442979332778,0.00104856546289588,-0.00349948624055372,0.000610890373998126,0.168399870036734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPS,Calcyphosin,24845,0.0092093724545026,0.00670283319948667,-0.00392818061649128,0.0223469255254965,0.169468922944558
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00342490818616246,0.00249912299307085,-0.00832318925258133,0.00147337288025642,0.170561101643681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,24793,-0.00535496498263544,0.00392373198494634,-0.0130454796731303,0.0023355497078594,0.172339883844767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,29443,0.00344841171667141,0.00252797541077875,-0.00150642008845494,0.00840324352179776,0.172546469710394
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31,Interleukin-31,24229,-0.00550161328038085,0.00403662838298644,-0.0134134049110343,0.00241017835027257,0.172919482680556
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,0.00349088148868585,0.00257180355774579,-0.0015498534844959,0.00853161646186761,0.174677270495568
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00289768392760266,0.00213619863699925,-0.00708463325612119,0.00128926540091586,0.174963197283675
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,0.00401071085886912,0.00297418616023254,-0.00181869401518665,0.00984011573292489,0.177507976207221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,24229,-0.00408372534860418,0.00304369407637751,-0.0100493657383041,0.00188191504109575,0.17970576121321
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTR,Methionine synthase,24111,0.00618587994259159,0.00461852773574658,-0.0028664344194717,0.0152381943046549,0.180465528581159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00407669370744641,0.00306872675679736,-0.0100913981507692,0.00193801073587641,0.184037375734553
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL11,Interleukin-11,28931,0.00582785635488692,0.00439456452250725,-0.00278549010922729,0.0144412028190011,0.184800143822206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,24793,0.00322793370890915,0.00243692826760869,-0.00154844569560389,0.00800431311342218,0.185318996219948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGR,Progesterone receptor,24229,0.00950688541360753,0.00722077101320918,-0.00464582577228246,0.0236595965994975,0.187984349697644
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,-0.00320175950879239,0.00244769212772117,-0.00799923607912588,0.0015957170615411,0.190858703923849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,24229,0.00577712950230863,0.00443169079467154,-0.00290898445524758,0.0144632434598648,0.192384134896083
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,24111,0.00395183672862816,0.00303314739542045,-0.00199313216639592,0.00989680562365223,0.192627096671033
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,24445,0.00787371748898438,0.00607445288192629,-0.00403221015959115,0.0197796451375599,0.194918172314885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,-0.0133731217934027,0.0104328705591619,-0.0338215480893599,0.00707530450255464,0.199915777922723
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00396156468025849,0.00309741667013295,-0.00210937199320208,0.0100325013537191,0.200912755646366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00477739929198125,0.00375360704422076,-0.0121344690986539,0.00257967051469144,0.203119285639824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRXN3,Neurexin-3,24195,0.0031841931822565,0.00250223541138543,-0.00172018822405895,0.00808857458857195,0.203193765354428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00319895766980777,0.0025145669978553,-0.00172959364598861,0.00812750898560416,0.203324695203831
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,24240,0.00161759259042231,0.0012754722769486,-0.000882333072396936,0.00411751825324156,0.204727906173649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,24111,-0.00454138336938578,0.00358120485764641,-0.0115605448903728,0.00247777815160119,0.204768761366431
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5,Interleukin-5,28931,0.0126756894897023,0.0100079274681876,-0.0069398483479454,0.03229122732735,0.205321117316769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM1,Dynamin-1,24805,0.0102420435697254,0.00809271895426882,-0.00561968558064146,0.0261037727200923,0.205672714379201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00296447072565615,0.00236118824266891,-0.00759239968128721,0.00166345822997491,0.20930747944327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,24229,-0.00296447223015124,0.00236632784106622,-0.00760247479864103,0.00167353033833855,0.21030033549558
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,-0.00500422941924734,0.00399667425408599,-0.0128377109572559,0.0028292521187612,0.210546170134403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCN,Decorin,28916,0.00200156785459506,0.0016124682112619,-0.00115886983947826,0.00516200554866838,0.214502485216245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,0.0048953000376552,0.00394542347301897,-0.00283772996946197,0.0126283300447724,0.214708668975543
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,-0.00607974028383773,0.0049137787164001,-0.0157107465679819,0.00355126600030647,0.215991576399971
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0057671987522716,0.00468260065786403,-0.00341069853714189,0.0149450960416851,0.218101957546288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00382913940855345,0.00311385643067849,-0.00993229801268329,0.0022740191955764,0.218817680898977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00484029155851927,0.00394029292158972,-0.00288268256779659,0.0125632656848351,0.219303271808696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,0.00345685580394836,0.00282771476604039,-0.00208546513749081,0.00899917674538752,0.221533968528609
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,24229,0.00530257872457416,0.00435092095501567,-0.00322522634725656,0.0138303837964049,0.222960233100133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00345875250509783,0.00284113471874664,-0.00902737655384124,0.00210987154364558,0.223469994671482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLU,Clusterin,24966,-0.00272952144676733,0.00224622819779451,-0.00713212871444456,0.0016730858209099,0.224317455526257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.00672054046351154,0.00554580610947135,-0.0041492395110523,0.0175903204380754,0.225591633416917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,29787,-0.00367078025840687,0.00303366102824771,-0.00961675587377237,0.00227519535695864,0.226282122926315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,24229,-0.00499467817247525,0.00413018036843344,-0.0130898316946048,0.00310047534965428,0.22655467048781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00357318538999305,0.00299158635124482,-0.00943669463843289,0.00229032385844678,0.232328407002989
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,24016,-0.00570355850444101,0.00479076734200159,-0.0150934624947641,0.00368634548588211,0.233849406955331
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,-0.00297560952978333,0.00250080400279291,-0.00787718537525743,0.00192596631569076,0.234110784155179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00403020621069654,0.0033891383854837,-0.0106729174462446,0.00261250502485151,0.234390935624141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSND,Barttin,24016,-0.00284188805497706,0.00240205142284654,-0.00754990884375628,0.00186613273380217,0.236777769075829
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,28774,-0.00429038168929172,0.00363565129026488,-0.0114162582182109,0.00283549483962745,0.237975717901723
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,24016,-0.00343116886153329,0.00291247987335165,-0.00913962941330252,0.00227729169023595,0.238771662718579
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,28774,0.00243560555840315,0.00210496105948703,-0.00169011811819143,0.00656132923499774,0.247249827452531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,24016,0.00508673300354846,0.00440946085750957,-0.00355581027717029,0.0137292762842672,0.248677642695097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,28931,0.00528758056894274,0.00459014555827312,-0.00370910472527258,0.0142842658631581,0.249354510596976
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.0050635049710099,0.00441348018300307,-0.00358691618767612,0.0137139261296959,0.251276299044751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00401579677858572,0.00350295328709363,-0.0108815852212892,0.00284999166411779,0.251639797130759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS2,Podocin,24229,-0.00839614794340437,0.00732703395213061,-0.0227571344895804,0.00596483860277163,0.251842222336969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00327290697241225,0.00285615684698572,-0.00232516044767976,0.00887097439250425,0.251842278554398
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.0040447875861361,0.00355241719035079,-0.00291795010695145,0.0110075252792237,0.254881014074734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.0042228433580911,0.00371141902155754,-0.0114972246403439,0.00305153792416168,0.255216420091371
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00594669094084452,0.00523328722151634,-0.0043105520133275,0.0162039338950165,0.255833808227497
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.00568460156570768,0.00500424550742937,-0.00412371962885389,0.0154929227602692,0.255984247458236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00546915501077935,0.00488085786112366,-0.00409732639702303,0.0150356364185817,0.262498348985876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00210057559167398,0.00187971938077574,-0.00158367439464646,0.00578482557799442,0.263794243936622
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",24793,0.00342080022769033,0.00306842848135718,-0.00259331959576975,0.00943492005115041,0.264930723565936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00324164822422761,0.00291339125610849,-0.00246859863774503,0.00895189508620026,0.265860369249326
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00265875351327827,0.00239619486547924,-0.00203778842306104,0.00735529544961758,0.26719373753865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,24445,-0.0024103578554882,0.00217698991773228,-0.00667725809424347,0.00185654238326708,0.268219437028743
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,24845,0.00541836223812955,0.00489405896965653,-0.00417399334239724,0.0150107178186563,0.26824821020087
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,24922,0.00385738740716357,0.0034844159489795,-0.00297206785283626,0.0106868426671634,0.268287378237588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,24101,0.00451749457217678,0.00409014900085681,-0.00349919746950257,0.0125341866138561,0.269395286255547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.00721265854730753,0.00655714722122056,-0.00563935000628477,0.0200646671008998,0.271356669218248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,24229,-0.00334410292264142,0.00304899206016523,-0.00932012736056528,0.00263192151528244,0.272744264263992
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP4,Caspase-4,24445,0.0130008915070904,0.011948525673371,-0.0104182188127167,0.0364200018268976,0.276572753696861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.00682543889705893,0.00627312778819776,-0.00546989156780868,0.0191207693619265,0.27658457691269
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,24195,0.0017454636378923,0.00162157979695611,-0.00143283276414169,0.00492376003992628,0.281760479828548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00658043448729462,0.00613306097542788,-0.00544036502454402,0.0186012339991333,0.283306583468372
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.00253818573157743,0.00238758092504844,-0.00214147288151751,0.00721784434467236,0.287756701136514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.00848288973997165,0.00802243927793551,-0.00724109124478194,0.0242068707247252,0.290341806909921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,24229,0.00196178212476667,0.00185725796451346,-0.00167844348567972,0.00560200773521305,0.29085141844206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,24101,0.00719192878467354,0.00686439930558064,-0.00626229385426452,0.0206461514236116,0.294780805360816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD109,CD109 antigen,29443,0.0024819893696336,0.00237382101836354,-0.00217069982635894,0.00713467856562613,0.295769492251908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2,Prothrombin,24966,-0.00108786203560673,0.00104753662456643,-0.00314103381975693,0.000965309748543465,0.299049507899839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00409548728846709,0.00394439007738083,-0.00363551726319934,0.0118264918401335,0.299137346066366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,24229,-0.00303201792145731,0.00292059319769846,-0.0087563805889463,0.00269234474603168,0.299209940145623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK12,Kallikrein-12,28797,0.0100495329275986,0.00978158333316096,-0.00912237040539691,0.029221436260594,0.304243950900385
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,24240,-0.00454305252892054,0.00444076118018011,-0.0132469444420736,0.00416083938423248,0.306301681713614
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00259226463305192,0.00253998705909816,-0.00238611000278047,0.00757063926888432,0.30746253737592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,24229,0.00346169867343492,0.00339397836541373,-0.003190498922776,0.0101138962696458,0.30776090550295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,-0.0030350296730727,0.00300936706375858,-0.00893338911803953,0.00286332977189412,0.313211347199964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,0.00842643937670074,0.00840705745422498,-0.00805139323358022,0.0249042719869817,0.316206167231494
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,-0.0031238311528927,0.00312297818167275,-0.00924486838897128,0.00299720608318589,0.317188392363023
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,0.00595644386097592,0.00596279075715707,-0.00573062602305193,0.0176435137450038,0.317835932439322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.0048828985717937,0.00491521749417017,-0.00475092771677983,0.0145167248603672,0.320512945448447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL24,Interleukin-24,28931,0.00340519377710779,0.00343169990400213,-0.00332093803473639,0.010131325588952,0.321071164379559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00349985112601228,0.00353090719205936,-0.00342072697042406,0.0104204292224486,0.321595682518593
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00117266870796889,0.00119219490454356,-0.00116403330493649,0.00350937072087427,0.32531111797194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,24195,-0.00409392845414121,0.00419942413279274,-0.012324799754415,0.00413694284613256,0.329630265919616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,24101,-0.0065134780088393,0.00668897369369546,-0.0196238664484824,0.0065969104308038,0.330183790349298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,28774,0.00359070353922745,0.00372421032666788,-0.0037087487010416,0.0108901557794965,0.334978006400385
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00341189998211583,0.00356477173391172,-0.0103988525805828,0.00357505261635114,0.338518322193236
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,-0.00126068478345161,0.0013218425042736,-0.00385149609182787,0.00133012652492465,0.340228063339764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,28797,0.00612841167353626,0.0064485816593135,-0.0065108083787182,0.0187676317257907,0.341942255525703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00333119351624281,0.00351487553502376,-0.0102203495648894,0.00355796253240375,0.343270557201844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,0.00441527557364864,0.00465920001720113,-0.00471675646006558,0.0135473076073629,0.343318840668896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELB,Transcription factor RelB,24229,0.00330399561727401,0.00350241217785828,-0.00356073225132822,0.0101687234858762,0.345512037447933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH2,Growth hormone variant,28797,0.0110177361441215,0.0116801589908516,-0.0118753754779475,0.0339108477661906,0.345542303114283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.00363057356901074,0.00386171805368132,-0.00393839381620465,0.0111995409542261,0.347152746369328
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.00231236689010482,0.00246435048334404,-0.00251776005724951,0.00714249383745914,0.348085735573131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,0.00428546642340535,0.00458064942405706,-0.00469260644774648,0.0132635392945572,0.349509693890429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00373162848183398,0.00401475315126453,-0.0116005446583125,0.0041372876946445,0.352650247925779
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,24867,-0.00339389186060247,0.00366467035250252,-0.0105766457515074,0.00378886203030246,0.354397243053457
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTTG1,Securin,24445,0.00270783632504415,0.00293661330877941,-0.00304792576016349,0.0084635984102518,0.35648815246533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,24111,-0.00223274573360004,0.00243425313612777,-0.00700388188041047,0.00253839041321039,0.35903653266193
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,-0.00191568404987207,0.00210954855237812,-0.00605039921253319,0.00221903111278904,0.363832204581961
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0055885119098785,0.00617276261986308,-0.00651010282505314,0.0176871266448101,0.365287315780591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00210642842575755,0.00233044426282498,-0.00246124232937941,0.00667409918089451,0.366069644889043
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00421738329223022,0.00467121878359333,-0.0133729721080731,0.00493820552361271,0.366617591790897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.00266762840997422,0.00296169451042015,-0.00313729283044927,0.00847254965039771,0.36775124630329
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3,Interleukin-3,24016,-0.00384825254880715,0.00429270756837786,-0.0122619593828278,0.00456545428521345,0.370014642728464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.00299355413232158,0.00334316040043246,-0.00355904025252605,0.00954614851716921,0.370566679371299
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.00743030457851278,0.00830636062746285,-0.00885016225131441,0.02371077140834,0.371044813459588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESR1,Estrogen receptor,24229,0.00363360611122442,0.00408463789638589,-0.00437228416569192,0.0116394963881408,0.373701084547452
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0026488915540128,0.002983930170766,-0.00319961158068856,0.00849739468871416,0.37469933824179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC5,Glypican-5,29218,-0.00350416012085567,0.00395255543846427,-0.0112511687802456,0.0042428485385343,0.375325512696764
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,29820,-0.00182850231545389,0.00207222508274606,-0.00589006347763617,0.00223305884672839,0.377575242535444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,0.00230507082328248,0.00261903074490152,-0.00282822943672449,0.00743837108328946,0.378801156055691
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00401227123422012,0.00461599539877487,-0.0130596222158189,0.00503507974737863,0.384740717727307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,-0.00173664841194922,0.00199815757647151,-0.00565303726183337,0.00217974043793493,0.384787404281939
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.00238760352386735,0.00275837433245124,-0.00301881016773708,0.00779401721547177,0.386725784723
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.00342046995660492,0.00395573122375178,-0.00433276324194857,0.0111737031551584,0.387219014282266
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,24016,-0.00268580872974727,0.00311143120226251,-0.00878421388618179,0.00341259642668725,0.388032372855687
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAN,Versican core protein,29694,-0.00180590260674352,0.00211341037914914,-0.00594818694987584,0.0023363817363888,0.392836626075285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,24101,-0.00443960014395263,0.00526113866496306,-0.0147514319272802,0.00587223163937498,0.398762856303972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00265365684764374,0.0031586722743949,-0.00353734081017026,0.00884465450545774,0.400850438543374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00149656948938149,0.00179743411205917,-0.00501954034901746,0.00202640137025448,0.405070223986095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,24229,0.00160197691422709,0.00193153032438053,-0.00218382252155875,0.00538777635001294,0.406896333037734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20,Interleukin-20,28931,0.00284924528833507,0.00344858518677167,-0.00390998167773741,0.00960847225440755,0.408693483684213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,24445,-0.00259470227384079,0.00317101827994091,-0.00880989810252497,0.00362049355484339,0.413219448106521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,24111,-0.0027551013529696,0.00336786014150602,-0.00935610723032139,0.00384590452438219,0.413332765287912
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,28916,-0.003070751175748,0.00375391482922515,-0.0104284242410293,0.0042869218895333,0.413356501175146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK15,Kallikrein-15,24754,0.00297667532997219,0.0036632076263756,-0.00420321161772398,0.0101565622776684,0.416462638426375
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLLT1,Protein ENL,24016,-0.0039630606894768,0.00490332172034745,-0.0135735712613578,0.0056474498824042,0.418960452326115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,24016,-0.00306534707049709,0.00379455251801889,-0.0105026700058141,0.00437197586481993,0.419197412706412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00400087984181112,0.0049811339943473,-0.0137639024707318,0.00576214278710959,0.421863240534592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,24111,0.00336392310824095,0.0041918941993411,-0.0048521895224676,0.0115800357389495,0.422281632413841
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,0.00237111354214921,0.00295509548187009,-0.00342087360231617,0.00816310068661458,0.422340334455803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00190336203704047,0.00238316227507665,-0.00657436009619071,0.00276763602210976,0.424489214287442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,24938,-0.00188080130175312,0.00235834734716988,-0.00650316210220608,0.00274155949869984,0.425163551289674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,-0.00187345819147868,0.00235237324276119,-0.00648410974729062,0.00273719336433325,0.425799168840444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00272803985638223,0.00344078651070254,-0.00401590170459476,0.00947198141735922,0.42787094911296
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,24016,-0.0052054169716211,0.00661512478892905,-0.018171061557922,0.00776022761467983,0.431350365107311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.00139127507107921,0.00177514704178983,-0.00487056327298729,0.00208801313082886,0.433191940312303
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH4,Cadherin-4,24101,0.00267752099484787,0.00341653234402034,-0.00401888239943199,0.00937392438912774,0.433226514511968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00402508765364351,0.00515843634745303,-0.0141356228946514,0.00608544758736443,0.435226566423022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.00425273032785983,0.00545542437579526,-0.00643990144869887,0.0149453621044185,0.435668362794133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,24951,-0.00124286105602671,0.00159560195179349,-0.00437024088154195,0.00188451876948854,0.436028774865323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,24016,-0.00225131552292435,0.00289893969691182,-0.00793323732887152,0.00343060628302281,0.437402667324162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00174584781567241,0.00224963252872657,-0.00615512757197649,0.00266343194063166,0.437721676277098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00279975437025384,0.00362047787117225,-0.00429638225724378,0.00989589099775145,0.439346125198503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00324167987450486,0.0041921554038989,-0.0114583044661467,0.00497494471713698,0.439368520036524
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00228364561456396,0.00295382078522709,-0.00807313435360905,0.00350584312448114,0.439461378564627
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,28774,-0.00191902063558419,0.00248227552664878,-0.00678428066781581,0.00294623939664742,0.439475890008495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,29349,-0.00465927283475974,0.00604942354131169,-0.0165161429757307,0.00719759730621117,0.441186797274631
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00172469578646588,0.00224299254185802,-0.00612096116850759,0.00267156959557584,0.441943271797997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,-0.00662208497331574,0.00870606898308292,-0.0236859801801583,0.0104418102335268,0.446885169113698
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.00167544903738102,0.00220292356325672,-0.00264228114660215,0.00599317922136419,0.446927753134452
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,0.00449277575586089,0.00594838532112422,-0.00716605947354257,0.0161516109852644,0.450080411389751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-0.00316014230267054,0.00418596519291319,-0.0113646340807804,0.00504434947543931,0.450293835746933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,24867,0.00845510711350305,0.0112229407533646,-0.0135418567630916,0.0304520709900977,0.451230446681823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00392070147031272,0.00520605656210934,-0.014124572332047,0.00628316939142158,0.451394844975331
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2,Interleukin-2,28931,-0.00166597658259404,0.00222317802658368,-0.00602340551469805,0.00269145234950996,0.453642040474603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00206804564326465,0.00276944655386193,-0.00336006960230474,0.00749616088883404,0.455229960730187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,24793,-0.00301612733065884,0.00409642721958803,-0.0110451246810514,0.00501287001973369,0.461565815031818
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,24867,0.00233657926035915,0.0032008044688718,-0.00393699749862958,0.00861015601934789,0.465398593143453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,0.00163720242973549,0.00225083281176662,-0.00277442988132709,0.00604883474079807,0.467001388514388
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,0.00438171055248586,0.00604050627774521,-0.00745768175189474,0.0162211028568665,0.468221002531551
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00393443480839536,0.00542616320293816,-0.0145697146861542,0.00670084506936344,0.46840613811036
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.00283524882569792,0.00391965551997707,-0.00484727599345713,0.010517773644853,0.469476059284268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.00345684689171028,0.00479238452245599,-0.00593622677230346,0.012849920555724,0.470717993452386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.00282328469525716,0.00392187078143638,-0.00486358203635814,0.0105101514268725,0.471603416253699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,24101,0.00322725919707295,0.0044981512874119,-0.00558911732625438,0.0120436357204003,0.473095131045987
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00147106677492347,0.00205332108870044,-0.0025534425589294,0.00549557610877633,0.473730069550559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00360012562570947,0.00507442237236596,-0.0135459934755468,0.00634574222412782,0.478042666120488
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,24445,0.00269543001275717,0.00380024956751546,-0.00475305913957314,0.0101439191650875,0.478159301531616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,-0.0045510938253022,0.00648239546748067,-0.0172565889415643,0.00815440129095991,0.482642444142273
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00169127516482466,0.00241163905912345,-0.00641808772070663,0.00303553739105731,0.483124503367427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.00450947601980456,0.00643401848958472,-0.0171201522593906,0.0081012002197815,0.483384530758719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,24016,-0.00183353978353206,0.0026221556147558,-0.00697296478845343,0.00330588522138931,0.484403187070442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.00201451758813373,0.00288993806157187,-0.00364976101254714,0.0076787961888146,0.485759363800801
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,24229,-0.00131153103743829,0.00189647210221124,-0.00502861635777231,0.00240555428289574,0.489218069654841
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.0035913720058695,0.00521401060200717,-0.00662808877406456,0.0138108327858036,0.490960323361069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.00319995734609394,0.00466744215188953,-0.00594822927160954,0.0123481439637974,0.492977493951343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,29137,-0.00301760848696714,0.00440746834321716,-0.0116562464396728,0.00562102946573848,0.493565202835641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.00176309952307846,0.00258753622100353,-0.00330847147008846,0.00683467051624537,0.495636422877179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00290044159385252,0.00431762191989076,-0.0113629805568384,0.00556209736913337,0.501737644205854
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.0028984275195103,0.00431681429524938,-0.00556252849917849,0.0113593835381991,0.501954713072334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,29725,-0.00216499456560335,0.00322569752166628,-0.00848736170806926,0.00415737257686256,0.502116831471816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,24016,0.00372128862697217,0.00556178876706729,-0.00717981735647972,0.0146223946104241,0.503450079848907
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,-0.00194519723151355,0.00292060502556884,-0.00766958308162848,0.00377918861860138,0.505401196737911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,24845,0.00185468127593979,0.00279573054865797,-0.00362495059942983,0.00733431315130941,0.507082023397455
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00217217924003823,0.00330660457258915,-0.0043087657222365,0.00865312420231295,0.511236563527429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.00282372775198665,0.00430671407631547,-0.011264887341565,0.00561743183759167,0.512050992935308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,-0.00854706395924838,0.0130587944630024,-0.0341423011067331,0.0170481731882363,0.512790766471902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,29531,0.001279986859543,0.00197748113351801,-0.0025958761621523,0.00515584988123831,0.517454837317507
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.0029201564287149,0.00452308789025871,-0.00594509583619217,0.011785408693622,0.518537321142613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00248648808846841,0.00385611959289245,-0.00507150631360079,0.0100444824905376,0.519052492871792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00282786163641141,0.00443040148824695,-0.0115114485533754,0.00585572528055261,0.523293825598142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.00273708939357167,0.00430334430170859,-0.00569746543777717,0.0111716442249205,0.524756858918534
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,-0.00217230498344218,0.00348785269703095,-0.00900849626962283,0.00466388630273847,0.533408603531506
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,23603,0.00307682840223501,0.00496126284067019,-0.00664724676547856,0.0128009035699486,0.535151592277229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,23970,-0.00347758144841675,0.00565364797155403,-0.0145587314726627,0.00760356857582915,0.538491887236359
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,0.00276053371297473,0.00449296916685214,-0.00604568585405547,0.0115667532800049,0.538948999318102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,24111,0.00173898613407467,0.00283441989537057,-0.00381647686085165,0.00729444912900098,0.539535359322718
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.0012784973556784,0.00210806267190083,-0.00541030019260402,0.00285330548124722,0.544201738424932
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.00168911867816369,0.00278998332851059,-0.00377924864571706,0.00715748600204445,0.544903821621494
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,-0.00262737927182107,0.00437731010458216,-0.0112069070768021,0.00595214853315996,0.548360675677642
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,24938,0.00198435935073934,0.0033081670087603,-0.00449964798643085,0.00846836668790953,0.54862065211916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG3,Desmoglein-3,29589,0.00143590780452527,0.00240571023573161,-0.00327928425750869,0.00615109986655923,0.550595545221669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,29820,0.000998296939283502,0.00167378613594651,-0.00228232388717166,0.00427891776573866,0.550892264656262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,24229,0.00157724484783013,0.00268215989729773,-0.00367978855087343,0.00683427824653368,0.556504036265784
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.0038960040849258,0.00662957631653282,-0.0168899736653301,0.00909796549547852,0.556759245971796
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,0.00249406980375157,0.00426333874286025,-0.00586207413225453,0.0108502137397577,0.558550572307106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESPL1,Separin,24016,-0.00229308952242891,0.00393092659652367,-0.0099977056516153,0.00541152660675749,0.559666017134787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,28353,-0.00129413208134913,0.00221971174487606,-0.0056447671013062,0.00305650293860794,0.559885767765547
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00287367400451505,0.00493059860532788,-0.00679029926192759,0.0125376472709577,0.560016838814914
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,24101,0.00267940627262442,0.00460437569917547,-0.00634517009775949,0.0117039826430083,0.560621923125922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,0.00263087608327696,0.00454492797001502,-0.00627718273795248,0.0115389349045064,0.562689129418905
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGLAP,Osteocalcin,24938,0.00361990961678038,0.00626324818715239,-0.00865605683003829,0.0158958760635991,0.563296056173514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13,Interleukin-13,28931,0.00195700599544544,0.00339191362835016,-0.00469114471612087,0.00860515670701174,0.563969473051676
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,28916,-0.00288116483332452,0.00502917747352054,-0.0127383526814248,0.00697602301477573,0.566723720051406
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANK2,Ankyrin-2,24111,-0.00292499700657311,0.00510787332332184,-0.0129364287202839,0.0070864347071377,0.566890574492139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRP15,RRP15-like protein,24101,-0.00369595663330849,0.00646485464940397,-0.0163670717461403,0.00897515847952329,0.567530649805102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A16,Protein S100-A16,28722,0.00246127254995264,0.00432978038064748,-0.00602509699611642,0.0109476420960217,0.569732499722094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,-0.00362103370594713,0.00644729006971474,-0.016257722242588,0.00901565483069375,0.574367955639217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00101927895188632,0.00181803113575302,-0.00458261997796224,0.0025440620741896,0.575041294050269
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.00184803538802982,0.00331698227543446,-0.00834932064788136,0.00465324987182172,0.577434507150626
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.000917949426371329,0.00165477848310923,-0.00232541640052277,0.00416131525326543,0.579086891521533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,0.00100599309291086,0.00183792551912455,-0.00259634092457324,0.00460832711039497,0.584140758888587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00222311677930669,0.00406885295960128,-0.00575183502151181,0.0101980685801252,0.584813735509054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00145656801411482,0.00268054356558841,-0.0067104334026681,0.00379729737443846,0.586869542330988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,-0.0029767593485143,0.0055132554070287,-0.0137827399462906,0.00782922124926196,0.589251861517682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,28931,-0.00178467909035513,0.00331988330537213,-0.0082916503688845,0.00472229218817424,0.590876123220397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,29349,0.00108811613829259,0.00206343634428075,-0.00295621909649767,0.00513245137308286,0.597967002256231
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,24016,0.00273271112297889,0.00519872907386546,-0.00745679786179741,0.0129222201077552,0.599136374758256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00155350077123107,0.00295946387176096,-0.00424704841742041,0.00735404995988255,0.599639155661479
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,-0.00185401818627244,0.00359436970810141,-0.0088989828141512,0.00519094644160631,0.605989849260886
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.00107896701758854,0.00209651285741888,-0.00518813221812955,0.00303019818295247,0.606802572317638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0021073523088021,0.00410572914899002,-0.00593987682321834,0.0101545814408225,0.607766371619361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0028051315182269,0.00547134656601937,-0.0135289707876249,0.00791870775117108,0.608169454349791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,24111,-0.00183687942429126,0.00359790360499333,-0.00888877049007819,0.00521501164149567,0.609676762325792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00195270741195819,0.00383274764347441,-0.00555947796925166,0.00946489279316804,0.610420654385339
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00152351256391495,0.00305304263914892,-0.00750747613664684,0.00446045100881693,0.617773722216713
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,24195,-0.00170275563606215,0.00342727329509729,-0.00842021129445284,0.00501470002232855,0.619316861020218
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THPO,Thrombopoietin,28916,-0.00134023834942295,0.00271521264710583,-0.00666205513775038,0.00398157843890448,0.621590009524067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00197274011398158,0.0040893398775367,-0.00604236604599034,0.00998784627395351,0.629518828987084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC4,Syndecan-4,29478,0.00155793823610554,0.00325968606188606,-0.00483104644519114,0.00794692291740222,0.632695609046257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,29478,-0.00114448766703047,0.00239786155547927,-0.00584429631576985,0.0035553209817089,0.633155511423645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,24016,-0.00173283080638018,0.00363148746060712,-0.00885054622917013,0.00538488461640977,0.633246605627849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC1,Hamartin,24229,0.00253326244690586,0.00532212150355096,-0.00789809570005402,0.0129646205938657,0.634087692863027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.00190695133990299,0.00401109671567121,-0.00595479822281259,0.00976870090261857,0.634492710029074
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,-0.00120932945777413,0.00257207637972278,-0.00625059916203078,0.00383194024648252,0.638233277062471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.00184459854309742,0.00394838772546762,-0.00958343848501395,0.00589424139881911,0.640377015546087
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.00178563057543221,0.00383295834484872,-0.00572696778047128,0.0092982289313357,0.641318261095162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00153770041157624,0.00334385229272043,-0.0050162500821558,0.00809165090530827,0.645621593840569
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00119019276983557,0.00263945549145664,-0.00636352553309057,0.00398313999341944,0.652048671718349
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMCH,Pro-MCH,24111,0.00265076584321741,0.00592379191994217,-0.00895986631986924,0.0142613980063041,0.654534078658077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL9,Interleukin-9,24445,-0.00177396505382195,0.00403021738144525,-0.00967319112145463,0.00612526101381073,0.65982070684427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTPN,Myotrophin,28916,0.000996469045700609,0.00230937381512742,-0.00352990363194913,0.00552284172335035,0.666116178516621
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.0010470765933083,0.00244207098968773,-0.00583353573309625,0.00373938254647965,0.668097489512144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.00257743533634195,0.00602766590333796,-0.0143916605068844,0.00923678983420045,0.668944946575915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.00190787771577228,0.00447005545453998,-0.00685343097512609,0.0106691864066706,0.669519308188825
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,24101,-0.00139826545445883,0.00337497617576595,-0.00801321875896008,0.00521668785004243,0.678655320518175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,-0.000977453768382428,0.00237099072766975,-0.00562459559461513,0.00366968805785027,0.680155905140774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00127139379408314,0.00308614767503232,-0.0047774556489802,0.00732024323714648,0.680366509147302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,-0.00105550050994036,0.00258506586035699,-0.00612222959624006,0.00401122857635933,0.683051230490132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,24111,0.00170496941147136,0.00429523497141883,-0.00671369113250954,0.0101236299554523,0.691411986892175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPGN,Epigen,24793,0.00133093644798525,0.00339739687704093,-0.00532796143101498,0.00798983432698549,0.695244957882294
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,24195,-0.00190121136970601,0.00491982443807494,-0.0115440672683329,0.00774164452892088,0.699175071727244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL25,Interleukin-25,23913,-0.000937490031920097,0.00245178930413839,-0.00574299706803134,0.00386801700419114,0.702190534397282
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-0.000833125307977256,0.00217912799253371,-0.00510421617334333,0.00343796555738882,0.702226921352189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00459837975456505,0.0122181505814322,-0.0285459548941723,0.0193491953850422,0.706655140002639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.00104570352384305,0.00280180999493705,-0.00444584406623357,0.00653725111391968,0.70898480516115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.000765693990526887,0.00206674540849585,-0.00328512701012497,0.00481651499117875,0.711025898950224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPN3,Calpain-3,24793,0.000987463182959962,0.00268588904183756,-0.00427687933904165,0.00625180570496157,0.713138456689123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,24195,0.00177838980531719,0.00485356788518833,-0.00773460324965193,0.0112913828602863,0.714063287476387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,28774,-0.00168350705715774,0.00460616595219158,-0.0107115923234532,0.00734457820913776,0.71474844497832
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTOA,Otoancorin,24101,0.00138960868177426,0.00381434242124055,-0.00608650246385722,0.00886571982740573,0.715628636174648
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,28931,-0.00105417656543132,0.00289764357705971,-0.00673355797646835,0.0046252048456057,0.716006457494661
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.000930297461569194,0.00256335088137102,-0.00409387026591801,0.0059544651890564,0.716665503549791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00212055219959041,0.0059178636925866,-0.0137195650370601,0.00947846063787932,0.720098947148423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,0.00198150420265801,0.00554467521651426,-0.00888605922170994,0.012849067627026,0.720817430565054
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,24229,-0.000707665833715233,0.00198113999309531,-0.00459070022018205,0.00317536855275158,0.720944205645441
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,28797,0.00218597810039717,0.00613442386272418,-0.00983749267054222,0.0142094488713366,0.721583991331307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00177355388153413,0.00500422928896155,-0.0115818432878988,0.00803473552483052,0.72303399704245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.00173135846139479,0.00493004388367489,-0.007931527550608,0.0113942444733976,0.725451892656116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,24016,-0.00157096380557896,0.00448627506644389,-0.010364062935809,0.00722213532465106,0.726213378520837
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,24805,0.00278583883584626,0.00802295850846747,-0.01293915984075,0.0185108375124425,0.728418958452861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00141127139185635,0.00407013489839735,-0.00938873579271516,0.00656619300900246,0.728791011570608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.00208486310405545,0.00601518628233481,-0.00970490200932079,0.0138746282174317,0.728894931200022
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,29639,-0.00060370324583117,0.00179075275853532,-0.00411357865256041,0.00290617216089807,0.736026861150209
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00111807770733444,0.00335743525619805,-0.00769865080948263,0.00546249539481374,0.739125531528716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,24111,0.00110832686627907,0.00338695097662091,-0.00553009704789791,0.00774675078045606,0.743493447903215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.000448322247149384,0.00137588576216233,-0.00224841384668878,0.00314505834098755,0.744546149199333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.00108687354954521,0.00337167167150198,-0.00552160292659867,0.00769535002568909,0.747186526111489
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,-0.000721242531196374,0.00225934064260112,-0.00514955019069458,0.00370706512830183,0.749557143072555
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMP,Olfactory marker protein,24101,-0.00111313688139533,0.00350569631431038,-0.00798430165744367,0.005758027894653,0.750850046616561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,24454,0.000552205139816924,0.00177873881853715,-0.00293412294451589,0.00403853322414974,0.756223273156376
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,24016,0.00132530923919768,0.0042841810724988,-0.00707168566289997,0.00972230414129532,0.757058371915521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.00145077251620907,0.00470060007166549,-0.0077624036242553,0.0106639486566734,0.757601369905245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.000648984687825164,0.00210769548338938,-0.00348209845961801,0.00478006783526834,0.758151962332703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,0.000964948282150021,0.0032358164357612,-0.00537725193194193,0.00730714849624197,0.765546532246529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.000936878037889226,0.00315325107661785,-0.00524349407228176,0.00711725014806021,0.766381311556647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.00112186219109476,0.00378293364839852,-0.00629268775976633,0.00853641214195585,0.766805940784405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,24793,0.00164134744168211,0.00560993727099651,-0.00935412960947104,0.0126368244928353,0.769846743378996
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,0.000940772456952143,0.00321556104655562,-0.00536172719429688,0.00724327210820116,0.769854304644041
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,24229,-0.00113480185352409,0.00390354167422274,-0.00878574353500065,0.00651613982795248,0.771274975035049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.000823322771440261,0.00284899559954608,-0.00476070860367007,0.00640735414655059,0.772593756279856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,24111,-0.000993575897058823,0.00346089477267792,-0.00777692965150755,0.00578977785738991,0.774048616948649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.000837406613169732,0.00293991556927123,-0.00659964112894134,0.00492482790260187,0.775768887897781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HK2,Hexokinase-2,28916,0.000545536621407221,0.00193410213251121,-0.00324530355831476,0.0043363768011292,0.777898027242509
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.0010703200739677,0.00385680434662893,-0.00648901644542499,0.0086296565933604,0.78138723763373
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.000960207944833865,0.00346163961087845,-0.00774502158215563,0.0058246056924879,0.781486656112184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,28797,0.00168819245204795,0.00613597810645331,-0.0103383246366005,0.0137147095406964,0.783218239203224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00130279660479324,0.00502935148529373,-0.011160325515969,0.00855473230638248,0.795607604672042
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK7,Kallikrein-7,23801,-0.000711953778785974,0.00278025235787383,-0.00616124840021867,0.00473734084264673,0.797894957744503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,0.000878099941637511,0.00343349898623341,-0.00585155807137998,0.007607757954655,0.798149998356681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.000486837850367176,0.00191394877682249,-0.0032645017522049,0.00423817745293925,0.799217199670715
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.000460577251779009,0.00181153584787739,-0.00309003301006068,0.00401118751361869,0.799306667528639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00119154699900322,0.00475623190106109,-0.0081306675270765,0.010513761525083,0.80218478068161
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.000509967406999718,0.0020785711740667,-0.00458396690817045,0.00356403209417102,0.806191273930939
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,24229,0.000801477544542147,0.00332013297427714,-0.00570598308504105,0.00730893817412535,0.809247753196985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.000564082020606457,0.00234151123596688,-0.00515344404310154,0.00402528000188863,0.80963037785002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.000560316410271911,0.00232775207834997,-0.00512271048383786,0.00400207766329404,0.809780868578711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,24016,-0.00198392609279418,0.00827017607562437,-0.0181934712010179,0.0142256190154296,0.810418186178058
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM2,Isthmin-2,24938,-0.0007408039177327,0.00311053405389239,-0.00683745066336178,0.00535584282789638,0.811759175318072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.000848795075394957,0.00363836480241633,-0.00628239993734105,0.00797999008813097,0.815537995055425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC1,Glypican-1,29725,0.000466308915373409,0.00207230006225188,-0.00359539920664027,0.00452801703738709,0.821965279749335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,0.00084884301126557,0.00390185308315375,-0.00679878903171579,0.00849647505424693,0.827782618657059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00076101344314102,0.00350016803016229,-0.00609931589597706,0.0076213427822591,0.827881323495588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.000498186545555802,0.00242519367398474,-0.00525156614656589,0.00425519305545428,0.837244358787027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG3,Secretogranin-3,29497,0.000480698846724012,0.00234287478736093,-0.00411133573650342,0.00507273342995144,0.837436980133254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,0.000566504914991071,0.00277314638775558,-0.00486886200500986,0.006001871834992,0.838134571792734
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,-0.000783890032070247,0.00387179584509835,-0.00837260988846301,0.00680482982432251,0.839557297438656
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.000827478583069128,0.00422984825507346,-0.00911798116301311,0.00746302399687485,0.844902654646543
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.000927296495196766,0.00474335573033188,-0.0102242737266472,0.00836968073625371,0.845008062547538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,-0.000367662761395255,0.00190834268013621,-0.00410801441446222,0.00337268889167171,0.847226226594643
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,-0.000547872025068805,0.00289096642750735,-0.0062141662229832,0.00511842217284559,0.849693371443466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,0.000672626525955167,0.00356030460368444,-0.00630557049726634,0.00765082354917668,0.850154070011324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,24195,0.000797709208100527,0.00426837738191514,-0.00756831046045315,0.0091637288766542,0.851749888078591
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRN1,Neuritin,24867,0.000464505018025337,0.00253101863278357,-0.00449629150223046,0.00542530153828113,0.854387656609862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,29594,0.000377803094146114,0.00212731244245996,-0.0037917292930754,0.00454733548136763,0.859041144889115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.000941484142653919,0.00548668574129527,-0.00981241991028481,0.0116953881955926,0.863757909831325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000473172534367876,0.00285192813773941,-0.00511660661560136,0.00606295168433711,0.868226648864292
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,28931,-0.000737896193117039,0.00459728176089172,-0.0097485684444648,0.00827277605823072,0.872482779479544
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.000447539591323203,0.00286905302127128,-0.00517580433036851,0.00607088351301492,0.876043311468458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.00087093057566844,0.00564666451636625,-0.0101965318764094,0.0119383930277463,0.877423308369552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,24793,0.000420442643226492,0.00279266407585788,-0.00505317894545495,0.00589406423190794,0.880329935132738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.000295521878016829,0.00199725971622436,-0.00361910716578292,0.00421015092181658,0.882372452043499
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,24229,-0.000497853556618195,0.00337968615829197,-0.00712203842687046,0.00612633131363407,0.882890437055522
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,29157,-0.000290581187154213,0.00198319980642793,-0.00417765280775296,0.00359649043344454,0.883510820866377
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,0.000266948351611425,0.00185238846521284,-0.00336373304020573,0.00389762974342858,0.885414529950749
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.000460019909817032,0.0032990149838133,-0.00600604945845704,0.0069260892780911,0.889102160179346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.000349358835253934,0.00259865646035807,-0.00474400782704789,0.00544272549755575,0.893057153351616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,24195,-0.000438122235438834,0.0033653797834007,-0.0070342666109042,0.00615802214002653,0.896421081651424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.000577653490495259,0.00444288675810813,-0.00813040455539667,0.00928571153638719,0.896553584740847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,24229,-0.00025796351936265,0.00212935604251987,-0.00443150136270159,0.00391557432397629,0.903576194497336
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A3,Protein S100-A3,24793,0.000364016690527697,0.00314381173973423,-0.00579785431935139,0.00652588770040679,0.907821243097111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,-0.000211697673125186,0.00182980105519376,-0.00379810774130495,0.00337471239505457,0.907895741000382
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,24016,-0.00050926316870893,0.00450513527984223,-0.0093393283171997,0.00832080197978185,0.909999317358898
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.000503252285235901,0.0044769294293461,-0.00927803396675427,0.00827152939628246,0.910499135486121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.000281761043825569,0.00250676897081733,-0.00463150613897639,0.00519502822662753,0.910507120116403
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,-0.000273456544178638,0.00253009557179259,-0.00523244386489211,0.00468553077653483,0.913931933615347
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,24195,-0.000498113609635471,0.00464066517657096,-0.00959381735571456,0.00859759013644362,0.914522773832724
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,24101,0.000564348359630389,0.00548147466588903,-0.0101793419855121,0.0113080387047729,0.917999088994166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.000452992600292984,0.00444540551796385,-0.00826000221491615,0.00916598741550212,0.918835728662456
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.000358480885219411,0.00356630653778003,-0.00663147992882944,0.00734844169926826,0.919933287742208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00049347549500523,0.00491044718865334,-0.00913100099475532,0.0101179519847658,0.919952171272691
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,0.000222294658986763,0.00226044841780328,-0.00420818423990766,0.00465277355788119,0.921662378574477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.000317101390714479,0.00325421534198912,-0.0060611606795842,0.00669536346101315,0.922375051946453
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD70,CD70 antigen,29434,0.000255242467281921,0.00300718245174007,-0.00563883513812862,0.00614932007269246,0.932359267612126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.000527817308604417,0.00642803687673884,-0.0131267695870125,0.0120711349698037,0.934558534179076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.000496892706622812,0.00611018981413337,-0.0124728647423242,0.0114790793290786,0.935186573294643
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,-0.000314304909039342,0.00398466970841308,-0.00812425753752898,0.0074956477194503,0.937129891862291
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,27585,0.000270882053124838,0.00344926901870605,-0.00648968522353902,0.00703144932978869,0.937404510479654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,24016,0.00022303133307623,0.00290446582783943,-0.00546972168948905,0.00591578435564151,0.938791957678087
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,-0.000148968709853484,0.00199155187736526,-0.00405241038948939,0.00375447296978243,0.940374208234858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.000257949922461049,0.00355047750178377,-0.00721688582595724,0.00670098598103514,0.942083507803424
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,29566,0.000127626922114008,0.00193427966827739,-0.00366356122770968,0.0039188150719377,0.947392898393347
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.000485558188564979,0.00749662977746115,-0.0142078361752589,0.0151789525523888,0.948357490627082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.000212804454535034,0.00329889371259592,-0.00625302722215297,0.00667863613122304,0.948566397662928
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,24445,0.000267888282876195,0.00426274521146454,-0.00808709233159429,0.00862286889734669,0.949891181964667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,28931,-0.000119432142183948,0.00213922272903869,-0.00431230869109978,0.00407344440673188,0.955477868195467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.000243472511206157,0.00449153546506301,-0.00855993700031735,0.00904688202272967,0.95677072176098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,29274,-0.000108251795096269,0.00202383842243412,-0.00407497510306714,0.00385847151287461,0.957343171098514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,24016,0.000264500154048457,0.0056287478020866,-0.0107678455380413,0.0112968458461382,0.962520838798696
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,24445,-0.000171855639872706,0.00421375042367699,-0.0084308064702796,0.00808709519053419,0.967468041714387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.000110700421273857,0.00363097537094554,-0.0070060113057794,0.00722741214832711,0.975678282048503
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,24229,5.56743560429914e-05,0.00201057826076428,-0.00388505903505499,0.00399640774714097,0.977909054856444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-9.46307193105172e-05,0.00347526968287119,-0.00690615929773805,0.00671689785911701,0.978276715033462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,-7.26323338259518e-05,0.00273010849390781,-0.00542364498188525,0.00527838031423335,0.978775648492287
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,2.93175671350399e-05,0.00345688538844329,-0.00674617779421381,0.00680481292848389,0.993233345062446
